<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS One</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-title-group><journal-title>PLOS One</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40408399</article-id><article-id pub-id-type="pmc">PMC12101696</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0319547</article-id><article-id pub-id-type="publisher-id">PONE-D-25-05617</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Medical Conditions</subject><subj-group><subject>Parasitic Diseases</subject><subj-group><subject>Malaria</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Medical Conditions</subject><subj-group><subject>Tropical Diseases</subject><subj-group><subject>Malaria</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Medical Conditions</subject><subj-group><subject>Infectious Diseases</subject><subj-group><subject>Bacterial Diseases</subject><subj-group><subject>Typhoid</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Clinical Medicine</subject><subj-group><subject>Signs and Symptoms</subject><subj-group><subject>Fevers</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Epidemiology</subject><subj-group><subject>Medical Risk Factors</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Eukaryota</subject><subj-group><subject>Protozoans</subject><subj-group><subject>Parasitic Protozoans</subject><subj-group><subject>Malarial Parasites</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Medical Conditions</subject><subj-group><subject>Parasitic Diseases</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Parasitology</subject><subj-group><subject>Quantitative Parasitology</subject><subj-group><subject>Parasitemia</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Medical Conditions</subject><subj-group><subject>Infectious Diseases</subject><subj-group><subject>Bacterial Diseases</subject><subj-group><subject>Salmonellosis</subject></subj-group></subj-group></subj-group></subj-group></subj-group></article-categories><title-group><article-title>Serological evidence and factors associated to liver damage in malaria-typhoid infected patients consulting in two health facilities, Yaound&#x000e9;-Cameroon</article-title><alt-title alt-title-type="running-head">Liver damage in malaria-tyhoid infected patients, Yaound&#x000e9;-Cameroon</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Essam</surname><given-names>Madeleine Yvanna Nyangono</given-names></name><role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role><role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role><role content-type="http://credit.niso.org/contributor-roles/software/">Software</role><role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x02013; original draft</role><role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="aff001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-2629-6394</contrib-id><name><surname>Kouam</surname><given-names>Arnaud Fondjo</given-names></name><role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role content-type="http://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role><role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role><role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role><role content-type="http://credit.niso.org/contributor-roles/software/">Software</role><role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role><role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x02013; original draft</role><role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="aff001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="cor001" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Fepa</surname><given-names>Armelle Gaelle Kwesseu</given-names></name><role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role><role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role><role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x02013; original draft</role><role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="aff001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-5501-3111</contrib-id><name><surname>Seukep</surname><given-names>Armel Jackson</given-names></name><role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role><role content-type="http://credit.niso.org/contributor-roles/validation/">Validation</role><role content-type="http://credit.niso.org/contributor-roles/visualization/">Visualization</role><role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="aff002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Zeuko&#x02019;o</surname><given-names>Elisabeth Menkem</given-names></name><role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role content-type="http://credit.niso.org/contributor-roles/software/">Software</role><role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role><role content-type="http://credit.niso.org/contributor-roles/validation/">Validation</role><role content-type="http://credit.niso.org/contributor-roles/visualization/">Visualization</role><role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="aff002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Douanla Somene</surname><given-names>Felicit&#x000e9; Syntia</given-names></name><role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role content-type="http://credit.niso.org/contributor-roles/validation/">Validation</role><role content-type="http://credit.niso.org/contributor-roles/visualization/">Visualization</role><role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="aff003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Nembo</surname><given-names>Nembu Erastus</given-names></name><role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role content-type="http://credit.niso.org/contributor-roles/software/">Software</role><role content-type="http://credit.niso.org/contributor-roles/validation/">Validation</role><role content-type="http://credit.niso.org/contributor-roles/visualization/">Visualization</role><role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="aff002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Moundipa</surname><given-names>Paul Fewou</given-names></name><role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role content-type="http://credit.niso.org/contributor-roles/resources/">Resources</role><role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role><role content-type="http://credit.niso.org/contributor-roles/validation/">Validation</role><role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="aff001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Njayou</surname><given-names>Fr&#x000e9;d&#x000e9;ric Nico</given-names></name><role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role content-type="http://credit.niso.org/contributor-roles/resources/">Resources</role><role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role><role content-type="http://credit.niso.org/contributor-roles/validation/">Validation</role><role content-type="http://credit.niso.org/contributor-roles/visualization/">Visualization</role><role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="aff001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="cor001" ref-type="corresp">*</xref></contrib></contrib-group><aff id="aff001"><label>1</label>
<addr-line>Department of Biochemistry, Faculty of Science, University of Yaound&#x000e9; 1, Yaound&#x000e9;, Cameroon</addr-line></aff><aff id="aff002"><label>2</label>
<addr-line>Department of Biomedical Sciences, Faculty of Health Sciences, University of Buea, Buea, Cameroon</addr-line></aff><aff id="aff003"><label>3</label>
<addr-line>Department of Nursing Sciences, Faculty of Health Sciences, University of Buea, Buea, Cameroon</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Onohuean</surname><given-names>Hope</given-names></name><role>Editor</role><xref rid="edit1" ref-type="aff"/></contrib></contrib-group><aff id="edit1">
<addr-line>Kampala International University - Western Campus, UGANDA</addr-line>
</aff><author-notes><corresp id="cor001">* E-mail: <email>arnaudkouam@yahoo.fr</email>, <email>kouam.fondjo@ubuea.cm</email> (AFK); <email>njayou@yahoo.com</email> (FNN)</corresp><fn fn-type="COI-statement" id="coi001"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn></author-notes><pub-date pub-type="epub"><day>23</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>20</volume><issue>5</issue><elocation-id>e0319547</elocation-id><history><date date-type="received"><day>3</day><month>2</month><year>2025</year></date><date date-type="accepted"><day>15</day><month>4</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; 2025 Essam et al</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>Essam et al</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="pone.0319547.pdf"/><abstract><p>Malaria and typhoid fever remain major health issues in developing countries like Cameroon, with frequent co-infections. The potential liver damage caused by their respective causative pathogens is overlooked in health management, posing a significant risk of severe liver injury and worsening patient conditions. Accordingly, this study investigated the risk factors associated with liver damage in febrile patients with malaria, typhoid fever, or co-infection at the Obili District Medical Center and Mvog-Betsi Dominican Hospital Center, Yaound&#x000e9;, Cameroon. Over 8 months, 350 febrile patients were evaluated for their adherence to preventive measures concerning malaria and typhoid fever using a structured questionnaire. Blood samples were analyzed for <italic toggle="yes">Plasmodium</italic> species and <italic toggle="yes">Salmonella</italic> antibodies and liver enzyme levels were measured. Liver damage was assessed using the Roussel Uclaf Causality Assessment Method. Risk factors for infections and liver damage were identified using Fisher&#x02019;s Exact and Chi-Square tests, with significance set at P&#x02009;&#x0003c;&#x02009;0.05. Among participants tested, 129 (36.86%) and 106 (30.29%) were positive for malaria and typhoid, respectively, while 56 (16.00%) were co-infected. Men (49.2% and 37.3%) were more affected than women (30.6% and 26.7%) for both malaria and typhoid, respectively. Participants aged between 20 and 40 years were the most affected by malaria (21.4%) and typhoid fever (17.4%). The non-use of mosquito nets, presence of standing water, bushes, and garbage dumps near residences were significant risk factors (Relative risk: RR&#x02009;&#x0003e;&#x02009;2.1; P&#x02009;&#x0003c;&#x02009;0.0001) for contracting malaria or typhoid fever. The co-infection status (Chi-2&#x02009;=&#x02009;18.30; P&#x02009;&#x0003c;&#x02009;0.0001), parasite density (Chi-2&#x02009;=&#x02009;9.8; P&#x02009;=&#x02009;0.0074), and delay before consulting (Chi-2&#x02009;=&#x02009;13.23; P&#x02009;=&#x02009;0.0013) were significant risk factors for the occurrence of liver injuries. Our findings demonstrated that the alteration of liver enzyme activity, reflecting liver damage among patients with malaria, typhoid, or malaria-typhoid co-infection, is a reality and should be considered during the patient treatment.</p></abstract><funding-group><funding-statement>The author(s) received no specific funding for this work.</funding-statement></funding-group><counts><fig-count count="3"/><table-count count="9"/><page-count count="23"/></counts><custom-meta-group><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>All relevant data are within the manuscript and its <xref rid="sec034" ref-type="sec">Supporting Information</xref> files.</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>All relevant data are within the manuscript and its <xref rid="sec034" ref-type="sec">Supporting Information</xref> files.</p></notes></front><body><sec sec-type="intro" id="sec001"><title>Introduction</title><p>Malaria and typhoid fever are diseases that can affect the same person at once, persistently remaining endemic, posing a major public health issue as they account for hundreds of thousands of deaths each year despite the efforts made by the World Health Organization (WHO) and the governments in tropical areas, especially in sub-Saharan Africa [<xref rid="pone.0319547.ref001" ref-type="bibr">1</xref>,<xref rid="pone.0319547.ref002" ref-type="bibr">2</xref>].</p><p>Malaria, an acute feverish disease spread by the bite of the female Anopheles mosquito, is caused by a protozoan belonging to the genus <italic toggle="yes">Plasmodium</italic> [<xref rid="pone.0319547.ref003" ref-type="bibr">3</xref>]. Five species are capable of infecting humans: <italic toggle="yes">P. malariae</italic>, <italic toggle="yes">P. vivax</italic>, <italic toggle="yes">P. ovale</italic>, <italic toggle="yes">P. knowlesi</italic>, and <italic toggle="yes">P. falciparum</italic>, the latter being the most virulent [<xref rid="pone.0319547.ref004" ref-type="bibr">4</xref>]. In 2022, 249 million cases of malaria and over 600,000 deaths were reported [<xref rid="pone.0319547.ref005" ref-type="bibr">5</xref>]. Sub-Saharan Africa accounted roughly 93.6% (233 million) of the incidents and 95.4% (580,000) of the fatalities globally. About 80% of all fatalities in this area were noted among children younger than 5 and expectant mothers, rendering them at high-risk demographic [<xref rid="pone.0319547.ref002" ref-type="bibr">2</xref>,<xref rid="pone.0319547.ref005" ref-type="bibr">5</xref>]. Throughout the same timeframe, Cameroon documented close to 6.3 million cases with around 4,000 fatalities, positioning malaria as a primary reason for hospital visits [<xref rid="pone.0319547.ref006" ref-type="bibr">6</xref>].</p><p>Similarly, typhoid fever is a severe systemic infection resulting from an enterobacterium called <italic toggle="yes">Salmonella Enterica Serotype Typhi</italic>. Various subtypes can also contribute to typhoid fever, specifically: <italic toggle="yes">S. para-typhi A</italic>, <italic toggle="yes">S. para-typhi B</italic>, and <italic toggle="yes">S. para-typhi C</italic> [<xref rid="pone.0319547.ref007" ref-type="bibr">7</xref>]. This infection is usually linked to poor socio-economic conditions. Transmission mainly takes place via the fecal-oral route, as well as through the intake of contaminated food and water [<xref rid="pone.0319547.ref008" ref-type="bibr">8</xref>]. The enhancement of living standards and the use of antibiotics have resulted in its elimination in developed nations. Nevertheless, in developing countries, typhoid fever accounts for around 110,000 fatalities annually [<xref rid="pone.0319547.ref001" ref-type="bibr">1</xref>]. In Cameroon, various studies report typhoid fever being commonly diagnosed in healthcare settings, with a prevalence around 50% among patients with fever [<xref rid="pone.0319547.ref009" ref-type="bibr">9</xref>,<xref rid="pone.0319547.ref010" ref-type="bibr">10</xref>].</p><p>Although these two infections are transmitted by distinct pathogens and through different mechanisms, they both share similar symptoms as well as a mandatory hepatic stage during their infectious cycle in humans [<xref rid="pone.0319547.ref011" ref-type="bibr">11</xref>&#x02013;<xref rid="pone.0319547.ref014" ref-type="bibr">14</xref>]; which is not without adverse consequences on the liver, an organ performing many functions in the body [<xref rid="pone.0319547.ref006" ref-type="bibr">6</xref>,<xref rid="pone.0319547.ref015" ref-type="bibr">15</xref>,<xref rid="pone.0319547.ref016" ref-type="bibr">16</xref>]. Indeed, <italic toggle="yes">Plasmodium</italic> or <italic toggle="yes">Salmonella</italic> species are capable of invading liver cells, causing congestion of the organ as well as inflammation followed by cellular necrosis [<xref rid="pone.0319547.ref007" ref-type="bibr">7</xref>,<xref rid="pone.0319547.ref017" ref-type="bibr">17</xref>,<xref rid="pone.0319547.ref018" ref-type="bibr">18</xref>]. If treatment is not initiated early, or is poorly administered, malaria and typhoid fever can lead to severe liver damage [<xref rid="pone.0319547.ref015" ref-type="bibr">15</xref>,<xref rid="pone.0319547.ref019" ref-type="bibr">19</xref>,<xref rid="pone.0319547.ref020" ref-type="bibr">20</xref>].</p><p>Regrettably, in areas where malaria and typhoid fever are common, their adverse impacts on the liver are not always considered during healthcare management. Additionally, the population seems not realize that inadequate handling of malaria and/or typhoid fever can cause significant liver injury, posing a risk for liver failure, which may result in the patient&#x02019;s death [<xref rid="pone.0319547.ref021" ref-type="bibr">21</xref>&#x02013;<xref rid="pone.0319547.ref023" ref-type="bibr">23</xref>]. In light of this situation, one might question what kinds of liver damage are caused by malaria and typhoid fever? What risk behaviors in populations lead to malaria and typhoid fever and subsequently to liver damage in infected patients? To address these questions, the present study aimed to determine the type of liver damage and the associated risk factors in malaria, typhoid fever, or malaria-typhoid co-infected patients among febrile patients consulting at the Obili District Medical Center (CMA) and the Dominican Hospital Center (CHD) Saint Martin de Porres in Mvog-Betsi, Yaound&#x000e9;, Cameroon.</p></sec><sec sec-type="materials|methods" id="sec002"><title>Materials and methods</title><sec id="sec003"><title>Description of the study area</title><p>This study was conducted in two hospitals in the city of Yaound&#x000e9;, specifically the District Medical Center (CMA) of Obili and the Saint Martin de Pores Dominican Hospital (CHD) of Mvog-Betsi, situated in the Yaound&#x000e9; III and VI municipalities, respectively. Yaound&#x000e9; serves as the Political Capital of Cameroon. It is a city community consisting of seven municipalities. The estimated population was 4.1 million residents in 2020. Its geographic coordinates are 3&#x000b0; 52&#x02019; 12&#x0201d; North and 11&#x000b0; 31&#x02019; 12&#x0201d; East, at an elevation of 750 m above sea level. The city of Yaound&#x000e9; features a tropical savanna climate, although tempered by altitude and a relative humidity exceeding 80%. The average monthly temperature ranges from 23&#x000b0;C (August) to 26&#x000b0;C (February). It is characterized by several months of heavy rainfall, with a slight lull in July-August, and a dry season that lasts from the end of November to February [<xref rid="pone.0319547.ref024" ref-type="bibr">24</xref>]. Owing to the dense population, tight living conditions, and lack of proper waste management and treatment facilities, Yaound&#x000e9; ranks among the cities in Cameroon where malaria and typhoid fever continue to be significant health problems.</p></sec><sec id="sec004"><title>Study design and target population</title><p>From October 2023 to May 2024, this cross-sectional study followed by laboratory investigations targeted all febrile patients who came for consultation at the CMA of Obili or at the CHD of Mvog-Betsi, and who presented at least one of the following clinical symptoms: fever, headache, abdominal pain, muscle aches, joint pain, nausea, vomiting, and chills. Overall, the inclusion criteria were: patients presenting at least one of the clinical signs of malaria or typhoid fever, patients who voluntarily, freely, and without coercion agreed to participate in the study by signing the informed consent form and the guardians of children who provided their consent. Patients arriving in a critical condition, patients suffering from hepatitis or with a recent history of liver disease were excluded from the study.</p></sec><sec id="sec005"><title>Sampling technique and sample size estimation</title><p>Participants were recruited through convenience random sampling. After approaching a potential participant, the goals of the study, the procedures, as well as the potential risks and benefits were clearly explained to them; and only participants who gave their consent by signing the informed consent form were enrolled in the study (Additional information S1 File). The estimated sample size for this study was calculated using the Lorentz formula (<xref rid="pone.0319547.e001" ref-type="disp-formula">1</xref>).</p><disp-formula id="pone.0319547.e001">
<alternatives><graphic xlink:href="pone.0319547.e001.jpg" id="pone.0319547.e001g" position="anchor"/><mml:math id="M1" display="block" overflow="scroll"><mml:mrow><mml:mi>N</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msup><mml:mi>Z</mml:mi><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mi>&#x000d7;</mml:mi><mml:mi>p</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mn>1</mml:mn><mml:mo>&#x02212;</mml:mo><mml:mi>p</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:msup><mml:mi>d</mml:mi><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mfrac></mml:mrow></mml:math></alternatives>
<label>(1)</label>
</disp-formula><p>Where: <italic toggle="yes">N</italic> is the calculated sample size; <italic toggle="yes">Z</italic>&#x02009;=&#x02009;1.96 is the typical value of the degree of confidence at 95%; <italic toggle="yes">p</italic>&#x02009;=&#x02009;77.01% is the prevalence of malaria among febrile patients [<xref rid="pone.0319547.ref025" ref-type="bibr">25</xref>]; <italic toggle="yes">d</italic>&#x02009;=&#x02009;5% is the margin error permitted.</p><p>After calculation, <italic toggle="yes">N</italic>&#x02009;&#x02248;&#x02009;322 participants. For a better representation of the population, the minimum sample size was rounded to 350 participants.</p></sec><sec id="sec006"><title>Ethical considerations</title><p>This study was conducted in accordance with the guidelines of the Declaration of Helsinki. The study protocol was reviewed and approved by the Joint Institutional Review Board for Animal &#x00026; Human Bioethics of the University of Yaound&#x000e9; I, which subsequently issued an ethical clearance (reference number: BTC-JIRB2023&#x02013;072). In addition, administrative authorizations were granted respectively by the directors of the CMA of Obili and the CHD of Mvog-Betsi. The information collected during the interview was not disclosed, and the participant&#x02019;s names were replaced with codes during the data collection.</p></sec><sec id="sec007"><title>Data collection procedure</title><sec id="sec008"><title>Determination of patients&#x02019; attitudes towards adherence to preventive measures and management against malaria and typhoid fever.</title><p>The outlook of febrile patients seeking consultation at the CMA or CHD about the routine implementation of barrier measures and the treatment of malaria and typhoid fever was determined through a structured questionnaire (Additional information S1 File) given in person. The survey was organized into four main sections to gather information as follows:</p><list list-type="bullet"><list-item><p>The socio-demographic characteristics of the patient encompass gender, age, marital status, level of educational, profession, housing type, toilet facilities, and the sources of drinking and running water.</p></list-item><list-item><p>The clinical symptoms experienced by the patient include fever, headaches, chills, muscles aches, join pain, vomiting, nausea, abdominal pain, fatigue, diarrhea, etc.</p></list-item><list-item><p>The respect of the preventive measures and factors that facilitate the transmission of the disease, including the presence of bushes or crops, stagnant water, and garbage deposits near homes; the presence or absence of a ceiling in the house, the availability of mosquito nets on windows, the regularity of the use of insecticides or mosquito nets, the washing of fruits and vegetables before consumption, hand hygiene before meals, and the intake of preventive medication or vaccines.</p></list-item><list-item><p>The patient&#x02019;s approach to proper disease management and treatment, which involved the duration before consulting a professional from the emergence of initial symptoms, the care setting (hospital care, self-treatment, herbal remedies), and the type of medication administered.</p></list-item></list><p>At the end of the interview, 5&#x02009;mL of blood were collected via venipuncture into a tube containing the anticoagulant (Ethylene Diamine Tetra-Acetic acid tube) and another tube free of anticoagulant (dry tube). The blood in the EDTA tube was used for the microscopic diagnosis of malaria, while the blood in the dry tube was centrifuged (3000&#x02009;&#x000d7;&#x02009;g, 5&#x02009;min, 4&#x000b0;C). The obtained serum was used for the diagnosis of typhoid fever and the measurement of some biochemical markers of liver damage.</p></sec><sec id="sec009"><title>Determination of the prevalence of malaria and typhoid fever among febrile patients.</title><p>The detection of the <italic toggle="yes">Plasmodium</italic> parasite responsible for malaria in febrile patients was done by microscopy using Giemsa staining as reported elsewhere [<xref rid="pone.0319547.ref006" ref-type="bibr">6</xref>]. Every positive slide was quantified by tallying the number of parasites against 200 white blood cells, and the parasite density or parasitemia (number of parasites/&#x000b5;L of blood) was estimated by assuming a leucocyte count of 8000/&#x000b5;L as previously described reported [<xref rid="pone.0319547.ref026" ref-type="bibr">26</xref>]. The diagnosis of typhoid fever was performed through the Widal serological test, which relies on the principle of mixing a suspension of somatic antigens from the cell wall (O antigen) and flagellar antigens (H antigen) of Salmonella bacteria with the patient&#x02019;s serum, allowing the visualization of agglutination if the specific antibodies are present. The Widal assay kit (Ref N&#x000b0; IS-SAW.078, RECKON DIAGNOSTICS P. LTD. Gorwa Vadodara, India) was used to conduct the test in two stages: first, a qualitative test on a glass slide to identify specific antibodies against the <italic toggle="yes">Salmonella</italic> genus, followed by a semi-quantitative tube test to confirm the result observed on the glass slide. The procedure was performed according to the manufacturer&#x02019;s instructions. Finally, the prevalence of malaria or typhoid fever, and the parasitemia (number of parasites/&#x000b5;L of blood) for every malaria-positive patient were determined using equations (<xref rid="pone.0319547.e002" ref-type="disp-formula">2</xref>) and (<xref rid="pone.0319547.e003" ref-type="disp-formula">3</xref>), respectively.</p><disp-formula id="pone.0319547.e002">
<alternatives><graphic xlink:href="pone.0319547.e002.jpg" id="pone.0319547.e002g" position="anchor"/><mml:math id="M2" display="block" overflow="scroll"><mml:mrow><mml:mtable columnspacing="" displaystyle="true" rowspacing="3pt"><mml:mtr><mml:mtd columnalign="right"><mml:mi>P</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>v</mml:mi><mml:mi>a</mml:mi><mml:mi>l</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi><mml:mi>c</mml:mi><mml:mi>e</mml:mi><mml:mtext>&#x000a0;</mml:mtext><mml:mi>o</mml:mi><mml:mi>f</mml:mi><mml:mtext>&#x000a0;</mml:mtext><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>l</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>i</mml:mi><mml:mi>a</mml:mi><mml:mtext>&#x000a0;</mml:mtext><mml:mi>o</mml:mi><mml:mi>r</mml:mi><mml:mtext>&#x000a0;</mml:mtext><mml:mi>t</mml:mi><mml:mi>y</mml:mi><mml:mi>p</mml:mi><mml:mi>h</mml:mi><mml:mi>o</mml:mi><mml:mi>i</mml:mi><mml:mi>d</mml:mi><mml:mtext>&#x000a0;</mml:mtext><mml:mi>f</mml:mi><mml:mi>e</mml:mi><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mtext>&#x000a0;</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mi>%</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mtext>Nomber&#x000a0;of&#x000a0;positif&#x000a0;patients</mml:mtext></mml:mrow><mml:mrow><mml:mtext>Total&#x000a0;number&#x000a0;of&#x000a0;tested&#x000a0;febrile&#x000a0;patients</mml:mtext></mml:mrow></mml:mfrac><mml:mi>&#x000d7;</mml:mi><mml:mn>100</mml:mn></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives>
<label>(2)</label>
</disp-formula><disp-formula id="pone.0319547.e003">
<alternatives><graphic xlink:href="pone.0319547.e003.jpg" id="pone.0319547.e003g" position="anchor"/><mml:math id="M3" display="block" overflow="scroll"><mml:mrow><mml:mtable columnspacing="" displaystyle="true" rowspacing="3pt"><mml:mtr><mml:mtd columnalign="right"><mml:mi>P</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>a</mml:mi><mml:mi>s</mml:mi><mml:mi>i</mml:mi><mml:mi>t</mml:mi><mml:mi>e</mml:mi><mml:mi>m</mml:mi><mml:mi>i</mml:mi><mml:mi>a</mml:mi><mml:mtext>&#x000a0;</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mi>p</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>a</mml:mi><mml:mi>s</mml:mi><mml:mi>i</mml:mi><mml:mi>t</mml:mi><mml:mi>e</mml:mi><mml:mi>s</mml:mi><mml:mo>/</mml:mo><mml:mi>&#x003bc;</mml:mi><mml:mi>L</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mtext>&#x000a0;</mml:mtext><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mtext>Total&#x000a0;number&#x000a0;of&#x000a0;parasite/200&#x000a0;white&#x000a0;blood&#x000a0;cells</mml:mtext></mml:mrow><mml:mrow><mml:mtext>Total&#x000a0;number&#x000a0;of&#x000a0;white&#x000a0;blood&#x000a0;cells/field</mml:mtext></mml:mrow></mml:mfrac><mml:mi>&#x000d7;</mml:mi><mml:mn>8000</mml:mn></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives>
<label>(3)</label>
</disp-formula><p>For more sensitivity, a parasite density lower than 500, between 500 and 2500, or higher than 2500 parasites/&#x000b5;L was considered low, medium, or high, respectively. This classification was adapted from the study of Sumbele et al. [<xref rid="pone.0319547.ref027" ref-type="bibr">27</xref>].</p></sec><sec id="sec010"><title>Evaluation of some biochemical markers of liver damage in infected patients.</title><p>The evaluation of biochemical markers of liver injury in malaria, typhoid or malaria-typhoid co-infected febrile patients was carried out by measuring the serum activity of some liver enzymes, including alanine aminotransferase (ALT), aspartate aminotransferase (AST), and alkaline phosphatase (ALP) using commercial assay kits (Catalog N&#x000b0; REF_80227, Catalog N&#x000b0; REF_80225, and Catalog N&#x000b0; REF_80014 respectively for ALT, AST and ALP) purchased from BIOLABO, Les Hautes Rives, Maizy, France. The assays were performed in accordance with the manufacturer&#x02019;s instructions using a semi-automatic spectrophotometer.</p></sec><sec id="sec011"><title>Estimation of the level of alteration of serum liver enzyme activities.</title><p>The level of alteration of the serum liver enzyme activities in feverish patients suffering from malaria and/or typhoid fever was estimated by considering the normal range of values (reference values) for each parameter evaluated. In our laboratory, these reference values in humans are: from 10 to 42 UI/L, from 8 to 39 UI/L, and from 40 to 129 UI/L respectively for ALT, AST, and ALP. Accordingly, any value found: within its normal range, less than 2 times the upper limit of the normal range of values (ULN), between 2 and 5 times the ULN, or higher than 5 times the ULN, the level of alteration was qualified as &#x0201c;normal&#x0201d;, &#x0201c;mild&#x0201d;, &#x0201c;moderate&#x0201d;, and &#x0201c;severe&#x0201d;, respectively.</p></sec><sec id="sec012"><title>Estimation of the type of liver damages.</title><p>The type of liver damage caused by the impact of malaria and/or typhoid fever in febrile patients was estimated using the &#x0201c;RUCAM&#x0201d; method (Roussel Uclaf Causality Assessment Method) [<xref rid="pone.0319547.ref028" ref-type="bibr">28</xref>]. The RUCAM method consists of determining whether the hepatic injury is &#x0201c;hepatocellular&#x0201d; (cytolysis), &#x0201c;cholestatic&#x0201d;, or &#x0201c;mixed&#x0201d;. It is based on the profile of serum liver enzymes activities, particularly ALT and ALP, and the type of liver damage is defined based on the &#x0201c;R Ratio,&#x0201d; calculated using formula (<xref rid="pone.0319547.e004" ref-type="disp-formula">4</xref>).</p><disp-formula id="pone.0319547.e004">
<alternatives><graphic xlink:href="pone.0319547.e004.jpg" id="pone.0319547.e004g" position="anchor"/><mml:math id="M4" display="block" overflow="scroll"><mml:mrow><mml:mi>R</mml:mi><mml:mtext>&#x000a0;</mml:mtext><mml:mi>R</mml:mi><mml:mi>a</mml:mi><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>o</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mrow><mml:mi>A</mml:mi><mml:mi>L</mml:mi><mml:mi>T</mml:mi></mml:mrow><mml:mrow><mml:mi>v</mml:mi><mml:mi>a</mml:mi><mml:mi>l</mml:mi><mml:mi>u</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:msub><mml:mtext>&#x000a0;</mml:mtext><mml:mi>&#x000f7;</mml:mi><mml:mtext>&#x000a0;</mml:mtext><mml:msub><mml:mrow><mml:mi>A</mml:mi><mml:mi>L</mml:mi><mml:mi>T</mml:mi></mml:mrow><mml:mrow><mml:mi>U</mml:mi><mml:mi>L</mml:mi><mml:mi>N</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mrow><mml:mi>A</mml:mi><mml:mi>L</mml:mi><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mi>v</mml:mi><mml:mi>a</mml:mi><mml:mi>l</mml:mi><mml:mi>u</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:msub><mml:mtext>&#x000a0;</mml:mtext><mml:mi>&#x000f7;</mml:mi><mml:mtext>&#x000a0;</mml:mtext><mml:msub><mml:mrow><mml:mi>A</mml:mi><mml:mi>L</mml:mi><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mi>U</mml:mi><mml:mi>L</mml:mi><mml:mi>N</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mfrac></mml:mrow></mml:math></alternatives>
<label>(4)</label>
</disp-formula><p>Where: ALT<sub>value</sub> and ALP<sub>value</sub> are the respective values of ALT and ALP obtained after analysis, while ALT<sub>ULN</sub> and ALP<sub>ULN</sub> are the upper limit of the normal range of values for ALAT and ALP, respectively.</p><p>Thus, R ratios&#x02009;&#x0003e;&#x02009;5,&#x02009;&#x0003c;&#x02009;2, or between 2 and 5 respectively define a hepatocellular, a cholestatic, or a mixed pattern of hepatocellular/cholestasis. However, if the ALT value is more than twice the ULN and the ALP value is normal, the hepatic damage is considered as hepatocellular, and it is not necessary to calculate the R ratio. Similarly, if the ALP value obtained after the analysis is more than twice the ULN and the ALT value is normal, the damage is considered cholestatic, and the R ratio need not to be determined.</p></sec></sec><sec id="sec013"><title>Data management and statistical analysis</title><p>After checking that all sections of the questionnaire had been completed, the data collected and the results of the laboratory analyses for each participant were saved in Excel 2016 (Microsoft Corporation, USA) (Additional information <xref rid="pone.0319547.s003" ref-type="supplementary-material">S3 File</xref>), and then exported to the statistical analysis software SPSS (Statistical Package for Social Sciences) version 25.0 (SPSS Inc., USA) or GraphPad Prism version 8.0.2. Descriptive statistics were performed using SPSS software. Qualitative variables were presented as frequency and percentage (%). Quantitative variables were first tested for normality using the Kolmogorov-Smirnov test. Variables that followed a normal distribution and those that did not pass the test were expressed as mean&#x02009;&#x000b1;&#x02009;standard deviation or median-interquartile range respectively. Comparison of median values between two groups was done by the non-parametric Mann Whitney <italic toggle="yes">U</italic> test. The Chi-square test or Fisher&#x02019;s exact with the Relative Risk (RR) were calculated from the contingency tables to determine the risk factors associated with malaria, typhoid or malaria-typhoid co-infections, the alteration of serum activities of liver enzymes, and the type of hepatic damage. The significance threshold was declared at <italic toggle="yes">P</italic>&#x02009;&#x0003c;&#x02009;0.05.</p></sec></sec><sec sec-type="results" id="sec014"><title>Results</title><sec id="sec015"><title>Distribution of febrile patients enrolled in the study according to their socio-demographic characteristics</title><p>The distribution of febrile patients who attended consultations at the CMA of Obili and CHD of Mvog-Betsi and participated in this study based on their socio-demographic characteristics is presented in the Additional information <xref rid="pone.0319547.s002" ref-type="supplementary-material">S2 File</xref>, Table S1). Out of the 350 febrile patients enrolled in the study, the gender ratio was 1.97 in favor of women, who constituted 66.3% (232/350) of the participants. The median age was 28 years, with interquartile ranges of 25% and 75% being 20 and 42.25 years, respectively. The most represented age group was between}20&#x02013;40] years (48.9%; 171/350), while 19 patients were under 5 years of age. Regarding marital status and education level, 57.7% (202/350) were single, while 56.9% (199/350) were university attendants. Less than one-fifth (13.4%; 47/350) of the patients were civil servants, and a large majority (86.6%; 310/350) lived in cement houses. Nearly one-third (32.6%; 114/350) of the participants used pit latrine toilet, and the use of borehole water represented 47.1% (165/350) and 60.3% (211/350) as sources of running water and drinking water, respectively.</p></sec><sec id="sec016"><title>Distribution of the study population according to the clinical symptoms experienced</title><p>The clinical symptoms experienced by the participants of this study were recorded and presented in the Additional information <xref rid="pone.0319547.s002" ref-type="supplementary-material">S2 File</xref>, Table S2. The majority (83.4%; 292/350) of participants experienced fever, while less than half (47.7%; 167/350) had headaches. Regarding chills, asthenia, and muscle aches, the proportions were 32.9% (115/350), 49.7% (174/350), and 32.6% (114/350), respectively. The patients who experienced abdominal pain, diarrhea, and vomiting, were 33.1% (116/350), 13.1% (46/350), and 22.0% (77/350), respectively.</p></sec><sec id="sec017"><title>Distribution of the participants based on their attitude towards the practice of preventive measures against malaria and typhoid fever</title><p>It appears that 62.3% (218/350) and 14.0% (49/350) were regular users of mosquito nets and insecticides, respectively. Additionally, 28.3% (99/350), 17.1% (60/350), 15.4% (54/350), 41.7% (113/350), and 18.0% (63/350) of patients reported staying out late at night, having standing water, crops, bushes, and garbage dumps near their homes, respectively. Only 7.1% (25/350) of patients declared they took prophylaxis against malaria. The majority of participants were in favor of the practice of handwashing before meals (88.6%; 310/350) and washing fruits and vegetables before consumption (92.0%; 322/350). Conversely, the majority of patients (77.7%; 272/350) stated not to purify water before drinking (Additional information <xref rid="pone.0319547.s002" ref-type="supplementary-material">S2 File</xref>, Table S3).</p></sec><sec id="sec018"><title>Distribution of the feverish patients based on their attitude towards management and treatment of malaria and typhoid fever</title><p>From the survey, 48.3% (169/350) and 7.4% (26/350) of participants attended the hospital 3 and 7 days after the onset of the first symptoms, respectively. The proportions of participants who referred to a health center for the treatment of malaria and typhoid fever were 60.9% (213/350) and 75.7% (265/350), respectively. Self-medication was more practiced for the treatment of malaria (32.0%; 112/350) compared to typhoid fever (4.0%; 14/350). In addition, participants turned more to traditional medicine to treat typhoid fever (20.3%; 71/350) compared to malaria (7.1%; 25/350). The Artemisinin-Based Combination Therapy (ACT) (73.4%; 257/350) and antibiotics: Ceftriaxone (49.7%; 174/350) and Ciprofloxacin (30.0%; 105/350) were the main medications used for the treatment of malaria and typhoid fever, respectively (Additional information <xref rid="pone.0319547.s002" ref-type="supplementary-material">S2 File</xref>, Table S4).</p></sec><sec id="sec019"><title>Seroprevalence of malaria, typhoid fever, and malaria-typhoid co-infection among febrile patients</title><p>Out of the 350 febrile patients enrolled, 179 participants tested positive for at least one infection, resulting in an overall incidence of 51.14% (<xref rid="pone.0319547.g001" ref-type="fig">Fig 1A</xref>). Distinguishing between each infection, 129/350 (36.86%) participants were tested positive for malaria (<xref rid="pone.0319547.g001" ref-type="fig">Fig 1B</xref>), while 106/350 (30.29%) patients were tested positive for typhoid fever (<xref rid="pone.0319547.g001" ref-type="fig">Fig 1C</xref>). Furthermore, the Venn diagram (<xref rid="pone.0319547.g001" ref-type="fig">Fig 1D</xref>) showing the prevalence of mono-infections and co-infections reveals that among the 179 patients with at least one infection, malaria mono-infection, typhoid fever mono-infection, and malaria/typhoid co-infection accounted for 20.86% (73/350), 14.28% (50/350), and 16.00% (56/350) respectively. Also, <xref rid="pone.0319547.g001" ref-type="fig">Fig 1E</xref> highlights the different Salmonella serotypes of identified from typhoid-infected patients. The predominant species was <italic toggle="yes">Salmonella typhi</italic> (84 cases), followed by <italic toggle="yes">Salmonella para-typhi A</italic> (49 cases), <italic toggle="yes">Salmonella para-typhi C</italic> (45 cases), and <italic toggle="yes">Salmonella para-typhi B</italic> (26 cases).</p><fig position="float" id="pone.0319547.g001"><object-id pub-id-type="doi">10.1371/journal.pone.0319547.g001</object-id><label>Fig 1</label><caption><title>Prevalence of malaria and typhoid fever in the study population.</title><p>(A): <italic toggle="yes">Overall prevalence of at least one infection; (B): Prevalence of malaria; (C): Prevalence of typhoid fever; (D): Venn diagram showing the rate of co-infection between malaria/typhoid fever; (E): Frequency of detection of different serotypes of Salmonella typhi in patients suffering from typhoid fever.</italic></p></caption><graphic xlink:href="pone.0319547.g001" position="float"/></fig></sec><sec id="sec020"><title>Effect of socio-demographic characteristics on malaria and typhoid fever infection rate among febrile patients</title><p><xref rid="pone.0319547.t001" ref-type="table">Table 1</xref> summarizes the statistical association between malaria and the various socio-demographic of febrile patients consulting at the CMA of Obili and the CHD of Mvog-Betsi. For both malaria and typhoid fever, men (58/118 and 44/118) were more affected than women (71/232 and 62/232), with significant relative risks (RR) of [RR&#x02009;=&#x02009;1.61, P&#x02009;=&#x02009;0.001] and [RR&#x02009;=&#x02009;1.40; P&#x02009;=&#x02009;0.049], respectively. Aged groups:}0&#x02013;5],}5&#x02013;20], and}20&#x02013;40] were significantly (P&#x02009;&#x0003c;&#x02009;0.05) three times more at risk (RR&#x02009;&#x0003e;&#x02009;3) of being affected by malaria compared to patients above 60 years. No significant association (RR&#x02009;&#x02248;&#x02009;1; P&#x02009;&#x0003e;&#x02009;0.05) was found between age group, marital status, level of education, profession, and typhoid fever. However, being single (92/202; RR&#x02009;=&#x02009;3.41; P&#x02009;=&#x02009;0.015) and having attained university (83/199; RR&#x02009;=&#x02009;1.55; P&#x02009;=&#x02009;0.011) represented a significant risk for malaria infection. Additionally, households with pit latrine (51/114; RR&#x02009;=&#x02009;1.92; P&#x02009;&#x0003c;&#x02009;0.0001) and the use of tap water (39/78; RR&#x02009;=&#x02009;2.38; P&#x02009;&#x0003c;&#x02009;0.0001) as a source of running water were significantly (P&#x02009;&#x0003c;&#x02009;0.05) associated with typhoid fever.</p><table-wrap position="float" id="pone.0319547.t001"><object-id pub-id-type="doi">10.1371/journal.pone.0319547.t001</object-id><label>Table 1</label><caption><title>Association between malaria or typhoid fever infection and the socio-demographic characteristics.</title></caption><alternatives><graphic xlink:href="pone.0319547.t001" id="pone.0319547.t001g" position="float"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="2" colspan="1">Variables</th><th align="left" rowspan="2" colspan="1">Categories</th><th align="left" colspan="5" rowspan="1">Malaria</th><th align="left" colspan="5" rowspan="1">Typhoid fever</th></tr><tr><th align="left" rowspan="1" colspan="1">Positive<break/>n (%)</th><th align="left" rowspan="1" colspan="1">Negative<break/>n (%)</th><th align="left" rowspan="1" colspan="1">RR</th><th align="left" rowspan="1" colspan="1">
<italic toggle="yes">[95% CI]</italic>
</th><th align="left" rowspan="1" colspan="1">
<italic toggle="yes">P-value</italic>
</th><th align="left" rowspan="1" colspan="1">Positive<break/>n (%)</th><th align="left" rowspan="1" colspan="1">Negative<break/>n (%)</th><th align="left" rowspan="1" colspan="1">RR</th><th align="left" rowspan="1" colspan="1">
<italic toggle="yes">[95% CI]</italic>
</th><th align="left" rowspan="1" colspan="1">
<italic toggle="yes">P-value</italic>
</th></tr></thead><tbody><tr><td align="left" rowspan="3" colspan="1">
<bold>Gender</bold>
</td><td align="left" rowspan="1" colspan="1">Male</td><td align="left" rowspan="1" colspan="1">58 (16.6)</td><td align="left" rowspan="1" colspan="1">60 (17.1)</td><td align="left" rowspan="1" colspan="1">
<bold>1.61</bold>
</td><td align="left" rowspan="1" colspan="1">[1.2 &#x02013; 2.1]</td><td align="left" rowspan="1" colspan="1">
<bold>0.001*</bold>
</td><td align="left" rowspan="1" colspan="1">44 (12.6)</td><td align="left" rowspan="1" colspan="1">74 (21.1)</td><td align="left" rowspan="1" colspan="1">
<bold>1.40</bold>
</td><td align="left" rowspan="1" colspan="1">[1.01 - 1.90]</td><td align="left" rowspan="1" colspan="1">
<bold>0.049*</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Female</td><td align="left" rowspan="1" colspan="1">71 (20.3)</td><td align="left" rowspan="1" colspan="1">161 (46.0)</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">62 (17.7)</td><td align="left" rowspan="1" colspan="1">170 (48.6)</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Total</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>129 (36.9)</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>221 (63.1)</bold>
</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">
<bold>106 (30.3)</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>244 (69.7)</bold>
</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td></tr><tr><td align="left" rowspan="6" colspan="1">
<bold>Age group</bold>
</td><td align="left" rowspan="1" colspan="1">]0&#x02013;5]</td><td align="left" rowspan="1" colspan="1">9 (2.6)</td><td align="left" rowspan="1" colspan="1">10 (2.9)</td><td align="left" rowspan="1" colspan="1">
<bold>3.88</bold>
</td><td align="left" rowspan="1" colspan="1">[1.5 &#x02013; 9.8]</td><td align="left" rowspan="1" colspan="1">
<bold>0.006*</bold>
</td><td align="left" rowspan="1" colspan="1">5 (1.4)</td><td align="left" rowspan="1" colspan="1">14 (4.0)</td><td align="left" rowspan="1" colspan="1">1.32</td><td align="left" rowspan="1" colspan="1">[0.5 &#x02013; 3.1]</td><td align="left" rowspan="1" colspan="1">0.314</td></tr><tr><td align="left" rowspan="1" colspan="1">]5&#x02013;20]</td><td align="left" rowspan="1" colspan="1">29 (8.4)</td><td align="left" rowspan="1" colspan="1">39 (11.1)</td><td align="left" rowspan="1" colspan="1">
<bold>3.49</bold>
</td><td align="left" rowspan="1" colspan="1">[1.6 &#x02013; 8.3]</td><td align="left" rowspan="1" colspan="1">
<bold>0.001*</bold>
</td><td align="left" rowspan="1" colspan="1">21 (6.0)</td><td align="left" rowspan="1" colspan="1">47 (13.4)</td><td align="left" rowspan="1" colspan="1">1.57</td><td align="left" rowspan="1" colspan="1">[0.8 &#x02013; 3.0]</td><td align="left" rowspan="1" colspan="1">0.207</td></tr><tr><td align="left" rowspan="1" colspan="1">]20&#x02013;40]</td><td align="left" rowspan="1" colspan="1">75 (21.4)</td><td align="left" rowspan="1" colspan="1">96 (27.4)</td><td align="left" rowspan="1" colspan="1">
<bold>3.59</bold>
</td><td align="left" rowspan="1" colspan="1">[1.7 &#x02013; 8.4]</td><td align="left" rowspan="1" colspan="1">
<bold>0.000*</bold>
</td><td align="left" rowspan="1" colspan="1">61 (17.4)</td><td align="left" rowspan="1" colspan="1">110 (31.4)</td><td align="left" rowspan="1" colspan="1">
<bold>1.82</bold>
</td><td align="left" rowspan="1" colspan="1">[1.0 &#x02013; 3.3]</td><td align="left" rowspan="1" colspan="1">
<bold>0.039*</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">]40&#x02013;60]</td><td align="left" rowspan="1" colspan="1">11 (3.1)</td><td align="left" rowspan="1" colspan="1">40 (11.4)</td><td align="left" rowspan="1" colspan="1">1.76</td><td align="left" rowspan="1" colspan="1">[0.7 &#x02013; 4.6]</td><td align="left" rowspan="1" colspan="1">0.279</td><td align="left" rowspan="1" colspan="1">10 (2.9)</td><td align="left" rowspan="1" colspan="1">41 (11.7)</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x0003e;60</td><td align="left" rowspan="1" colspan="1">5 (1.4)</td><td align="left" rowspan="1" colspan="1">36 (10.3)</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">9 (2.6)</td><td align="left" rowspan="1" colspan="1">32 (9.1)</td><td align="left" rowspan="1" colspan="1">1.12</td><td align="left" rowspan="1" colspan="1">[0.5 &#x02013; 2.4]</td><td align="left" rowspan="1" colspan="1">0.801</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Total</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>129 (36.9)</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>221 (63.1)</bold>
</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">
<bold>106 (30.3)</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>244 (69.7)</bold>
</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td></tr><tr><td align="left" rowspan="5" colspan="1">
<bold>Marital status</bold>
</td><td align="left" rowspan="1" colspan="1">Single</td><td align="left" rowspan="1" colspan="1">92 (26.3)</td><td align="left" rowspan="1" colspan="1">110 (31.4)</td><td align="left" rowspan="1" colspan="1">
<bold>3.41</bold>
</td><td align="left" rowspan="1" colspan="1">[1.2 &#x02013; 12.2]</td><td align="left" rowspan="1" colspan="1">
<bold>0.015*</bold>
</td><td align="left" rowspan="1" colspan="1">74 (21.1)</td><td align="left" rowspan="1" colspan="1">128 (36.6)</td><td align="left" rowspan="1" colspan="1">2.19</td><td align="left" rowspan="1" colspan="1">[0.6 &#x02013; 12.2]</td><td align="left" rowspan="1" colspan="1">0.4</td></tr><tr><td align="left" rowspan="1" colspan="1">Married</td><td align="left" rowspan="1" colspan="1">32 (9.1)</td><td align="left" rowspan="1" colspan="1">95 (27.1)</td><td align="left" rowspan="1" colspan="1">1.89</td><td align="left" rowspan="1" colspan="1">[0.6 &#x02013; 6.9]</td><td align="left" rowspan="1" colspan="1">0.522</td><td align="left" rowspan="1" colspan="1">28 (8.0)</td><td align="left" rowspan="1" colspan="1">99 (28.3)</td><td align="left" rowspan="1" colspan="1">1.3</td><td align="left" rowspan="1" colspan="1">[0.3 &#x02013; 7.4]</td><td align="left" rowspan="1" colspan="1">&#x0003e;0.999</td></tr><tr><td align="left" rowspan="1" colspan="1">Divorced</td><td align="left" rowspan="1" colspan="1">3 (0.9)</td><td align="left" rowspan="1" colspan="1">3 (0.9)</td><td align="left" rowspan="1" colspan="1">3.75</td><td align="left" rowspan="1" colspan="1">[0.9 &#x02013; 14.4]</td><td align="left" rowspan="1" colspan="1">0.144</td><td align="left" rowspan="1" colspan="1">1 (0.3)</td><td align="left" rowspan="1" colspan="1">5 (1.4)</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td></tr><tr><td align="left" rowspan="1" colspan="1">Widow(er)</td><td align="left" rowspan="1" colspan="1">2 (0.6)</td><td align="left" rowspan="1" colspan="1">13 (3.7)</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">3 (0.9)</td><td align="left" rowspan="1" colspan="1">12 (3.4)</td><td align="left" rowspan="1" colspan="1">1.20</td><td align="left" rowspan="1" colspan="1">[0.2 &#x02013; 7.8]</td><td align="left" rowspan="1" colspan="1">&#x0003e;0.999</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Total</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>129 (36.9)</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>221 (63.1)</bold>
</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">
<bold>106 (30.3)</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>244 (69.7)</bold>
</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td></tr><tr><td align="left" rowspan="5" colspan="1">
<bold>Level of education</bold>
</td><td align="left" rowspan="1" colspan="1">Not-schooled</td><td align="left" rowspan="1" colspan="1">5 (1.4)</td><td align="left" rowspan="1" colspan="1">4 (1.1)</td><td align="left" rowspan="1" colspan="1">2.06</td><td align="left" rowspan="1" colspan="1">[0.6 &#x02013; 6.9]</td><td align="left" rowspan="1" colspan="1">0.119</td><td align="left" rowspan="1" colspan="1">3 (0.9)</td><td align="left" rowspan="1" colspan="1">6 (1.7)</td><td align="left" rowspan="1" colspan="1">1.33</td><td align="left" rowspan="1" colspan="1">[0.4 &#x02013; 2.9]</td><td align="left" rowspan="1" colspan="1">0.692</td></tr><tr><td align="left" rowspan="1" colspan="1">Primary</td><td align="left" rowspan="1" colspan="1">13 (3.7)</td><td align="left" rowspan="1" colspan="1">26 (7.4)</td><td align="left" rowspan="1" colspan="1">1.23</td><td align="left" rowspan="1" colspan="1">[0.6 &#x02013; 6.9]</td><td align="left" rowspan="1" colspan="1">0.534</td><td align="left" rowspan="1" colspan="1">12 (3.4)</td><td align="left" rowspan="1" colspan="1">27 (7.7)</td><td align="left" rowspan="1" colspan="1">1.23</td><td align="left" rowspan="1" colspan="1">[0.6 &#x02013; 2.1]</td><td align="left" rowspan="1" colspan="1">0.526</td></tr><tr><td align="left" rowspan="1" colspan="1">Secondary</td><td align="left" rowspan="1" colspan="1">28 (8.0)</td><td align="left" rowspan="1" colspan="1">76 (21.7)</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">26 (7.4)</td><td align="left" rowspan="1" colspan="1">78 (22.3)</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td></tr><tr><td align="left" rowspan="1" colspan="1">University</td><td align="left" rowspan="1" colspan="1">83 (23.7)</td><td align="left" rowspan="1" colspan="1">115 (32.9)</td><td align="left" rowspan="1" colspan="1">
<bold>1.55</bold>
</td><td align="left" rowspan="1" colspan="1">[1.1 &#x02013; 2.2]</td><td align="left" rowspan="1" colspan="1">
<bold>0.011*</bold>
</td><td align="left" rowspan="1" colspan="1">65 (18.6)</td><td align="left" rowspan="1" colspan="1">133 (38.0)</td><td align="left" rowspan="1" colspan="1">1.31</td><td align="left" rowspan="1" colspan="1">[0.9 &#x02013; 1.9]</td><td align="left" rowspan="1" colspan="1">0.187</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Total</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>129 (36.9)</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>221 (63.1)</bold>
</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">
<bold>106 (30.3)</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>244 (69.7)</bold>
</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td></tr><tr><td align="left" rowspan="4" colspan="1">
<bold>Profession</bold>
</td><td align="left" rowspan="1" colspan="1">Employee</td><td align="left" rowspan="1" colspan="1">24 (6.9)</td><td align="left" rowspan="1" colspan="1">46 (13.1)</td><td align="left" rowspan="1" colspan="1">1.34</td><td align="left" rowspan="1" colspan="1">[0.7 &#x02013; 2.4]</td><td align="left" rowspan="1" colspan="1">0.414</td><td align="left" rowspan="1" colspan="1">11 (3.1)</td><td align="left" rowspan="1" colspan="1">36 (10.3)</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td></tr><tr><td align="left" rowspan="1" colspan="1">Self-employee</td><td align="left" rowspan="1" colspan="1">93 (26.6)</td><td align="left" rowspan="1" colspan="1">140 (40.0)</td><td align="left" rowspan="1" colspan="1">1.56</td><td align="left" rowspan="1" colspan="1">[0.9 &#x02013; 2.7]</td><td align="left" rowspan="1" colspan="1">0.070</td><td align="left" rowspan="1" colspan="1">25 (7.1)</td><td align="left" rowspan="1" colspan="1">45 (12.9)</td><td align="left" rowspan="1" colspan="1">1.52</td><td align="left" rowspan="1" colspan="1">[0.8 &#x02013; 2.8]</td><td align="left" rowspan="1" colspan="1">0.220</td></tr><tr><td align="left" rowspan="1" colspan="1">Civil servant</td><td align="left" rowspan="1" colspan="1">12 (3.4)</td><td align="left" rowspan="1" colspan="1">35 (10.0)</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">70 (20.0)</td><td align="left" rowspan="1" colspan="1">163 (46.6)</td><td align="left" rowspan="1" colspan="1">1.28</td><td align="left" rowspan="1" colspan="1">[0.9 &#x02013; 2.2]</td><td align="left" rowspan="1" colspan="1">0.480</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Total</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>129 (36.9)</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>221 (63.1)</bold>
</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">
<bold>106 (30.3)</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>244 (69.7)</bold>
</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td></tr><tr><td align="left" rowspan="4" colspan="1">
<bold>Type of house</bold>
</td><td align="left" rowspan="1" colspan="1">Cement</td><td align="left" rowspan="1" colspan="1">118 (33.7)</td><td align="left" rowspan="1" colspan="1">192 (54.8)</td><td align="left" rowspan="1" colspan="1">1.71</td><td align="left" rowspan="1" colspan="1">[0.6 &#x02013; 6.0]</td><td align="left" rowspan="1" colspan="1">0.491</td><td align="left" rowspan="1" colspan="1">98 (28.0)</td><td align="left" rowspan="1" colspan="1">212 (60.6)</td><td align="left" rowspan="1" colspan="1">1.96</td><td align="left" rowspan="1" colspan="1">[0.9 &#x02013; 4.5]</td><td align="left" rowspan="1" colspan="1">0.099</td></tr><tr><td align="left" rowspan="1" colspan="1">Mud</td><td align="left" rowspan="1" colspan="1">9 (2.6)</td><td align="left" rowspan="1" colspan="1">22 (6.3)</td><td align="left" rowspan="1" colspan="1">1.30</td><td align="left" rowspan="1" colspan="1">[0.4 &#x02013; 4.9]</td><td align="left" rowspan="1" colspan="1">&#x0003e;0.999</td><td align="left" rowspan="1" colspan="1">5 (1.4)</td><td align="left" rowspan="1" colspan="1">26 (7.4)</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td></tr><tr><td align="left" rowspan="1" colspan="1">Wood</td><td align="left" rowspan="1" colspan="1">2 (0.6)</td><td align="left" rowspan="1" colspan="1">7 (2.00)</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">3 (0.9)</td><td align="left" rowspan="1" colspan="1">6 (1.7)</td><td align="left" rowspan="1" colspan="1">2.06</td><td align="left" rowspan="1" colspan="1">[0.6 &#x02013; 6.2]</td><td align="left" rowspan="1" colspan="1">0.347</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Total</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>129 (36.9)</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>221 (63.1)</bold>
</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">
<bold>106 (30.3)</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>244 (69.7)</bold>
</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td></tr><tr><td align="left" rowspan="3" colspan="1">
<bold>Type of toilet</bold>
</td><td align="left" rowspan="1" colspan="1">Pit latrine</td><td align="left" rowspan="1" colspan="1">50 (14.3)</td><td align="left" rowspan="1" colspan="1">64 (18.3)</td><td align="left" rowspan="1" colspan="1">1.31</td><td align="left" rowspan="1" colspan="1">[0.9 &#x02013; 1.7]</td><td align="left" rowspan="1" colspan="1">0.075</td><td align="left" rowspan="1" colspan="1">51 (14.6)</td><td align="left" rowspan="1" colspan="1">63 (18.00)</td><td align="left" rowspan="1" colspan="1">
<bold>1.92</bold>
</td><td align="left" rowspan="1" colspan="1">[1.4 &#x02013; 2.6]</td><td align="left" rowspan="1" colspan="1">
<bold>&#x0003c;0.0001*</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Water system</td><td align="left" rowspan="1" colspan="1">79 (22.6)</td><td align="left" rowspan="1" colspan="1">157 (44.8)</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">55 (15.7)</td><td align="left" rowspan="1" colspan="1">181 (51.7)</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Total</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>129 (36.9)</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>221 (63.1)</bold>
</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">
<bold>106 (30.3)</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>244 (69.7)</bold>
</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td></tr><tr><td align="left" rowspan="5" colspan="1">
<bold>Source of running water</bold>
</td><td align="left" rowspan="1" colspan="1">Borehole</td><td align="left" rowspan="1" colspan="1">52 (14.8)</td><td align="left" rowspan="1" colspan="1">113 (32.3)</td><td align="left" rowspan="1" colspan="1">1.02</td><td align="left" rowspan="1" colspan="1">[0.5 &#x02013; 1.9]</td><td align="left" rowspan="1" colspan="1">&#x0003e;0.999</td><td align="left" rowspan="1" colspan="1">42 (12.00)</td><td align="left" rowspan="1" colspan="1">123 (35.2)</td><td align="left" rowspan="1" colspan="1">1.21</td><td align="left" rowspan="1" colspan="1">[0.7 &#x02013; 2.0]</td><td align="left" rowspan="1" colspan="1">0.525</td></tr><tr><td align="left" rowspan="1" colspan="1">Well</td><td align="left" rowspan="1" colspan="1">27 (7.7)</td><td align="left" rowspan="1" colspan="1">54 (15.4)</td><td align="left" rowspan="1" colspan="1">1.08</td><td align="left" rowspan="1" colspan="1">[0.5 &#x02013; 2.1]</td><td align="left" rowspan="1" colspan="1">&#x0003e;0.999</td><td align="left" rowspan="1" colspan="1">17 (4.8)</td><td align="left" rowspan="1" colspan="1">64 (18.3)</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td></tr><tr><td align="left" rowspan="1" colspan="1">Tap water</td><td align="left" rowspan="1" colspan="1">42 (12.0)</td><td align="left" rowspan="1" colspan="1">36 (10.3)</td><td align="left" rowspan="1" colspan="1">
<bold>1.75</bold>
</td><td align="left" rowspan="1" colspan="1">[1.0 &#x02013; 3.3]</td><td align="left" rowspan="1" colspan="1">
<bold>0.045*</bold>
</td><td align="left" rowspan="1" colspan="1">39 (11.1)</td><td align="left" rowspan="1" colspan="1">39 (11.1)</td><td align="left" rowspan="1" colspan="1">
<bold>2.38</bold>
</td><td align="left" rowspan="1" colspan="1">[1.5 &#x02013; 3.8]</td><td align="left" rowspan="1" colspan="1">
<bold>&#x0003c;0.0001*</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Spring</td><td align="left" rowspan="1" colspan="1">8 (2.3)</td><td align="left" rowspan="1" colspan="1">18 (5.1)</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">8 (2.3)</td><td align="left" rowspan="1" colspan="1">18 (5.1)</td><td align="left" rowspan="1" colspan="1">1.4</td><td align="left" rowspan="1" colspan="1">[0.7 &#x02013; 2.8]</td><td align="left" rowspan="1" colspan="1">0.301</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Total</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>129 (36.9)</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>221 (63.1)</bold>
</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">
<bold>106 (30.3)</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>244 (69.7)</bold>
</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td></tr><tr><td align="left" rowspan="5" colspan="1">
<bold>Source of drinking water</bold>
</td><td align="left" rowspan="1" colspan="1">Mineral</td><td align="left" rowspan="1" colspan="1">20 (5.7)</td><td align="left" rowspan="1" colspan="1">34 (9.7)</td><td align="left" rowspan="1" colspan="1">1.33</td><td align="left" rowspan="1" colspan="1">[0.6 &#x02013; 3.1]</td><td align="left" rowspan="1" colspan="1">0.574</td><td align="left" rowspan="1" colspan="1">38 (10.9)</td><td align="left" rowspan="1" colspan="1">29 (8.3)</td><td align="left" rowspan="1" colspan="1">
<bold>2.65</bold>
</td><td align="left" rowspan="1" colspan="1">[1.8 &#x02013; 3.7]</td><td align="left" rowspan="1" colspan="1">
<bold>&#x0003c;0.0001*</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Borehole</td><td align="left" rowspan="1" colspan="1">73 (20.9)</td><td align="left" rowspan="1" colspan="1">138 (39.4)</td><td align="left" rowspan="1" colspan="1">1.24</td><td align="left" rowspan="1" colspan="1">[0.6 &#x02013; 2.8]</td><td align="left" rowspan="1" colspan="1">0.616</td><td align="left" rowspan="1" colspan="1">45 (12.8)</td><td align="left" rowspan="1" colspan="1">166 (47.4)</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td></tr><tr><td align="left" rowspan="1" colspan="1">Tap water</td><td align="left" rowspan="1" colspan="1">31 (8.9)</td><td align="left" rowspan="1" colspan="1">36 (10.3)</td><td align="left" rowspan="1" colspan="1">1.66</td><td align="left" rowspan="1" colspan="1">[0.8 &#x02013; 3.8]</td><td align="left" rowspan="1" colspan="1">0.188</td><td align="left" rowspan="1" colspan="1">16 (4.6)</td><td align="left" rowspan="1" colspan="1">38 (10.9)</td><td align="left" rowspan="1" colspan="1">1.38</td><td align="left" rowspan="1" colspan="1">[0.8 &#x02013; 2.2]</td><td align="left" rowspan="1" colspan="1">0.207</td></tr><tr><td align="left" rowspan="1" colspan="1">Spring</td><td align="left" rowspan="1" colspan="1">5 (1.4)</td><td align="left" rowspan="1" colspan="1">13 (3.7)</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">7 (2.00)</td><td align="left" rowspan="1" colspan="1">11 (3.1)</td><td align="left" rowspan="1" colspan="1">1.82</td><td align="left" rowspan="1" colspan="1">[0.9 &#x02013; 3.1]</td><td align="left" rowspan="1" colspan="1">0.137</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Total</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>129 (36.9)</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>221 (63.1)</bold>
</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">
<bold>106 (30.3)</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>244 (69.7)</bold>
</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t001fn001"><p>
<italic toggle="yes">The statistical association was performed using Fisher&#x02019;s Exact Test. P values &#x0003c;0.05 were considered significantly different. RR: Relative Risk; CI: 95% Confidence Interval; n: sample size of the category. All categories where RR&#x02009;=&#x02009;1.00 were considered as reference during the analysis.</italic>
</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec021"><title>Effect of clinical symptoms on the rates of malaria and typhoid fever infection in febrile patients</title><p>The association between the clinical symptoms experienced by the febrile patients and malaria or typhoid fever infection is presented in <xref rid="pone.0319547.t002" ref-type="table">Table 2</xref>. A significant association (RR&#x02009;&#x0003e;&#x02009;1; P&#x02009;&#x0003c;&#x02009;0.05) was observed between the presence of fever (116/292; RR&#x02009;=&#x02009;1.77; P&#x02009;=&#x02009;0.016), headaches (95/167; RR&#x02009;=&#x02009;3.06; P&#x02009;&#x0003c;&#x02009;0.0001), chills (73/115; RR&#x02009;=&#x02009;2.66; P&#x02009;&#x0003c;&#x02009;0.0001), muscle aches (73/114; RR&#x02009;=&#x02009;2.69; P&#x02009;&#x0003c;&#x02009;0.0001), vomiting (36/77; RR&#x02009;=&#x02009;1.37; P&#x02009;=&#x02009;0.045), and the detection of malaria parasite. Similarly, a significant association (RR&#x02009;&#x0003e;&#x02009;1; P&#x02009;&#x0003c;&#x02009;0.05) was observed between patients who experienced abdominal pain (76/116; RR&#x02009;=&#x02009;4.27; P&#x02009;&#x0003c;&#x02009;0.0001), asthenia (75/174; RR&#x02009;=&#x02009;2.44; P&#x02009;&#x0003c;&#x02009;0.0001), vomiting (40/77; RR&#x02009;=&#x02009;2.14; P&#x02009;&#x0003c;&#x02009;0.0001), and the detection of <italic toggle="yes">Salmonella</italic> serotypes.</p><table-wrap position="float" id="pone.0319547.t002"><object-id pub-id-type="doi">10.1371/journal.pone.0319547.t002</object-id><label>Table 2</label><caption><title>Association between malaria or typhoid fever infection and the clinical symptoms experienced by febrile patients.</title></caption><alternatives><graphic xlink:href="pone.0319547.t002" id="pone.0319547.t002g" position="float"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="2" colspan="1">Clinical symptoms</th><th align="left" rowspan="2" colspan="1">Categories</th><th align="left" colspan="5" rowspan="1">Malaria</th><th align="left" colspan="5" rowspan="1">Typhoid fever</th></tr><tr><th align="left" rowspan="1" colspan="1">Positive<break/>n (%)</th><th align="left" rowspan="1" colspan="1">Negative<break/>n (%)</th><th align="left" rowspan="1" colspan="1">RR</th><th align="left" rowspan="1" colspan="1">
<italic toggle="yes">[95% CI]</italic>
</th><th align="left" rowspan="1" colspan="1">
<italic toggle="yes">P-value</italic>
</th><th align="left" rowspan="1" colspan="1">Positive<break/>n (%)</th><th align="left" rowspan="1" colspan="1">Negative<break/>n (%)</th><th align="left" rowspan="1" colspan="1">RR</th><th align="left" rowspan="1" colspan="1">
<italic toggle="yes">[95% CI]</italic>
</th><th align="left" rowspan="1" colspan="1">
<italic toggle="yes">P-value</italic>
</th></tr></thead><tbody><tr><td align="left" rowspan="3" colspan="1">
<bold>Fever</bold>
</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">116 (33.2)</td><td align="left" rowspan="1" colspan="1">176 (50.3)</td><td align="left" rowspan="1" colspan="1">
<bold>1.77</bold>
</td><td align="left" rowspan="1" colspan="1">[1.1 &#x02013; 2.9]</td><td align="left" rowspan="1" colspan="1">
<bold>0.016*</bold>
</td><td align="left" rowspan="1" colspan="1">92 (26.3)</td><td align="left" rowspan="1" colspan="1">200 (57.1)</td><td align="left" rowspan="1" colspan="1">1.30</td><td align="left" rowspan="1" colspan="1">[0.8 &#x02013; 2.1]</td><td align="left" rowspan="1" colspan="1">0.347</td></tr><tr><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">13 (3.7)</td><td align="left" rowspan="1" colspan="1">45 (12.8)</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">14 (4.0)</td><td align="left" rowspan="1" colspan="1">44 (12.6)</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Total</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>129 (36.9)</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>221 (63.1)</bold>
</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">
<bold>106 (30.3)</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>244 (69.7)</bold>
</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td></tr><tr><td align="left" rowspan="3" colspan="1">
<bold>Headaches</bold>
</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">95 (27.2)</td><td align="left" rowspan="1" colspan="1">72 (20.6)</td><td align="left" rowspan="1" colspan="1">
<bold>3.06</bold>
</td><td align="left" rowspan="1" colspan="1">[2.2 &#x02013; 4.2]</td><td align="left" rowspan="1" colspan="1">
<bold>&#x0003c;0.0001*</bold>
</td><td align="left" rowspan="1" colspan="1">55 (15.7)</td><td align="left" rowspan="1" colspan="1">112 (32.0)</td><td align="left" rowspan="1" colspan="1">1.18</td><td align="left" rowspan="1" colspan="1">[0.8 &#x02013; 1.6]</td><td align="left" rowspan="1" colspan="1">0.351</td></tr><tr><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">34 (9.7)</td><td align="left" rowspan="1" colspan="1">149 (42.5)</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">51 (14.6)</td><td align="left" rowspan="1" colspan="1">132 (37.7)</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Total</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>129 (36.9)</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>221 (63.1)</bold>
</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">
<bold>106 (30.3)</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>244 (69.7)</bold>
</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td></tr><tr><td align="left" rowspan="3" colspan="1">
<bold>Chills</bold>
</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">73 (20.9)</td><td align="left" rowspan="1" colspan="1">42 (12.0)</td><td align="left" rowspan="1" colspan="1">
<bold>2.66</bold>
</td><td align="left" rowspan="1" colspan="1">[2.0 &#x02013; 3.4]</td><td align="left" rowspan="1" colspan="1">
<bold>&#x0003c;0.0001*</bold>
</td><td align="left" rowspan="1" colspan="1">39 (11.2)</td><td align="left" rowspan="1" colspan="1">76 (21.7)</td><td align="left" rowspan="1" colspan="1">1.18</td><td align="left" rowspan="1" colspan="1">[0.8 &#x02013; 1.6]</td><td align="left" rowspan="1" colspan="1">0.323</td></tr><tr><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">56 (16.0)</td><td align="left" rowspan="1" colspan="1">179 (51.1)</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">67 (19.1)</td><td align="left" rowspan="1" colspan="1">168 (48.0)</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Total</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>129 (36.9)</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>221 (63.1)</bold>
</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">
<bold>106 (30.3)</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>244 (69.7)</bold>
</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td></tr><tr><td align="left" rowspan="3" colspan="1">
<bold>Muscle aches</bold>
</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">73 (20.9)</td><td align="left" rowspan="1" colspan="1">41 (11.7)</td><td align="left" rowspan="1" colspan="1">
<bold>2.69</bold>
</td><td align="left" rowspan="1" colspan="1">[2.0 &#x02013; 3.5]</td><td align="left" rowspan="1" colspan="1">
<bold>&#x0003c;0.0001*</bold>
</td><td align="left" rowspan="1" colspan="1">33 (9.4)</td><td align="left" rowspan="1" colspan="1">81 (23.1)</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td></tr><tr><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">56 (16.0)</td><td align="left" rowspan="1" colspan="1">180 (51.4)</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">73 (20.9)</td><td align="left" rowspan="1" colspan="1">163 (46.6)</td><td align="left" rowspan="1" colspan="1">1.06</td><td align="left" rowspan="1" colspan="1">[0.7 &#x02013; 1.5]</td><td align="left" rowspan="1" colspan="1">0.804</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Total</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>129 (36.9)</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>221 (63.1)</bold>
</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">
<bold>106 (30.3)</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>244 (69.7)</bold>
</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td></tr><tr><td align="left" rowspan="3" colspan="1">
<bold>Abdominal pain</bold>
</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">38 (10.9)</td><td align="left" rowspan="1" colspan="1">78 (22.3)</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">72 (20.6)</td><td align="left" rowspan="1" colspan="1">44 (12.6)</td><td align="left" rowspan="1" colspan="1">
<bold>4.27</bold>
</td><td align="left" rowspan="1" colspan="1">[3.0 &#x02013; 6.0]</td><td align="left" rowspan="1" colspan="1">
<bold>&#x0003c;0.0001*</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">91 (26.0)</td><td align="left" rowspan="1" colspan="1">143 (40.8)</td><td align="left" rowspan="1" colspan="1">1.18</td><td align="left" rowspan="1" colspan="1">[0.6 &#x02013; 1.1]</td><td align="left" rowspan="1" colspan="1">0.290</td><td align="left" rowspan="1" colspan="1">34 (9.7)</td><td align="left" rowspan="1" colspan="1">200 (57.1)</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Total</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>129 (36.9)</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>221 (63.1)</bold>
</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">
<bold>106 (30.3)</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>244 (69.7)</bold>
</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="3" colspan="1">
<bold>Asthenia</bold>
</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">62 (17.7)</td><td align="left" rowspan="1" colspan="1">112 (32.0)</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">75 (21.4)</td><td align="left" rowspan="1" colspan="1">99 (28.3)</td><td align="left" rowspan="1" colspan="1">
<bold>2.44</bold>
</td><td align="left" rowspan="1" colspan="1">[1.7 &#x02013; 3.5]</td><td align="left" rowspan="1" colspan="1">
<bold>&#x0003c;0.0001*</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">67 (19.2)</td><td align="left" rowspan="1" colspan="1">109 (31.1)</td><td align="left" rowspan="1" colspan="1">1.06</td><td align="left" rowspan="1" colspan="1">[0.8 &#x02013; 1.4]</td><td align="left" rowspan="1" colspan="1">0.658</td><td align="left" rowspan="1" colspan="1">31 (8.9)</td><td align="left" rowspan="1" colspan="1">145 (41.4)</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Total</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>129 (36.9)</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>221 (63.1)</bold>
</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">
<bold>106 (30.3)</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>244 (69.7)</bold>
</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td></tr><tr><td align="left" rowspan="3" colspan="1">
<bold>Diarrhea</bold>
</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">12 (3.5)</td><td align="left" rowspan="1" colspan="1">34 (9.7)</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">19 (5.4)</td><td align="left" rowspan="1" colspan="1">27 (7.7)</td><td align="left" rowspan="1" colspan="1">1.44</td><td align="left" rowspan="1" colspan="1">[0.9 &#x02013; 2.0]</td><td align="left" rowspan="1" colspan="1">0.087</td></tr><tr><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">117 (33.4)</td><td align="left" rowspan="1" colspan="1">187 (53.4)</td><td align="left" rowspan="1" colspan="1">1.47</td><td align="left" rowspan="1" colspan="1">[0.9 &#x02013; 2.5]</td><td align="left" rowspan="1" colspan="1">0.139</td><td align="left" rowspan="1" colspan="1">87 (24.9)</td><td align="left" rowspan="1" colspan="1">217 (62.0)</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Total</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>129 (36.9)</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>221 (63.1)</bold>
</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">
<bold>106 (30.3)</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>244 (69.7)</bold>
</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td></tr><tr><td align="left" rowspan="3" colspan="1">
<bold>Vomiting</bold>
</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">36 (10.3)</td><td align="left" rowspan="1" colspan="1">41 (11.7)</td><td align="left" rowspan="1" colspan="1">
<bold>1.37</bold>
</td><td align="left" rowspan="1" colspan="1">[1.0 &#x02013; 1.8]</td><td align="left" rowspan="1" colspan="1">
<bold>0.045*</bold>
</td><td align="left" rowspan="1" colspan="1">40 (11.4)</td><td align="left" rowspan="1" colspan="1">37 (10.6)</td><td align="left" rowspan="1" colspan="1">
<bold>2.14</bold>
</td><td align="left" rowspan="1" colspan="1">[1.5 &#x02013; 2.8]</td><td align="left" rowspan="1" colspan="1">
<bold>&#x0003c;0.0001*</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">93 (26.6)</td><td align="left" rowspan="1" colspan="1">180 (51.4)</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">66 (18.9)</td><td align="left" rowspan="1" colspan="1">207 (59.1)</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Total</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>129 (36.9)</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>221 (63.1)</bold>
</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">
<bold>106 (30.3)</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>244 (69.7)</bold>
</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t002fn001"><p>
<italic toggle="yes">The statistical association was performed using Fisher&#x02019;s Exact Test. P values &#x0003c;0.05 were considered significantly different. RR: Relative Risk; CI: 95% Confidence Interval; n: sample size of the category. All categories where RR&#x02009;=&#x02009;1.00 were considered as reference during the analysis.</italic>
</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec022"><title>Influence of the attitudes of febrile patients towards adherence to preventive measures on malaria and typhoid fever infections rate</title><p><xref rid="pone.0319547.t003" ref-type="table">Table 3</xref> summarizes the association between patients&#x02019; attitudes regarding adherence to preventive measures and the rate of malaria infection. Risky behaviors such as staying outside late at night (45/99; RR&#x02009;=&#x02009;1.35; P&#x02009;=&#x02009;0.048), irregular use of mosquito nets (35/55; RR&#x02009;=&#x02009;2.75; P&#x02009;&#x0003c;&#x02009;0.0001), or non-use of mosquito nets (48/77; RR&#x02009;=&#x02009;2.83; P&#x02009;&#x0003c;&#x02009;0.0001) were significantly (RR&#x02009;&#x0003e;&#x02009;1; P&#x02009;&#x0003c;&#x02009;0.05) associated with malaria infection. Likewise, environmental factors such as the presence of standing water (38/60; RR&#x02009;=&#x02009;2.01; P&#x02009;&#x0003c;&#x02009;0.0001) and bushes (57/113; RR&#x02009;=&#x02009;1.66; P&#x02009;=&#x02009;0.0004) near residential homes represented significant risk factors (RR&#x02009;&#x0003e;&#x02009;1; P&#x02009;&#x0003c;&#x02009;0.05) for contracting malaria. Regarding typhoid fever, as indicated in <xref rid="pone.0319547.t004" ref-type="table">Table 4</xref>, only the presence of garbage dumps near residential homes (36/63; RR&#x02009;=&#x02009;2.34; P&#x02009;&#x0003c;&#x02009;0.0001) constituted a significant risk (RR&#x02009;&#x0003e;&#x02009;1; P&#x02009;&#x0003c;&#x02009;0.05) for being infected by <italic toggle="yes">Salmonella typhi</italic> serotypes. Other factors such as the purification of water prior drinking, hand washing before meals, and fruits of vegetables washing before consumption were not significantly (RR&#x02009;&#x0003c;&#x02009;1; P&#x02009;&#x0003e;&#x02009;0.05) associated with typhoid fever.</p><table-wrap position="float" id="pone.0319547.t003"><object-id pub-id-type="doi">10.1371/journal.pone.0319547.t003</object-id><label>Table 3</label><caption><title>Association between malaria infection rate and patients&#x02019; attitudes towards compliance with preventive measures.</title></caption><alternatives><graphic xlink:href="pone.0319547.t003" id="pone.0319547.t003g" position="float"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="2" colspan="1">Preventive measures</th><th align="left" rowspan="2" colspan="1">Categories</th><th align="left" colspan="5" rowspan="1">Malaria</th></tr><tr><th align="left" rowspan="1" colspan="1">Positive<break/>n (%)</th><th align="left" rowspan="1" colspan="1">Negative<break/>n (%)</th><th align="left" rowspan="1" colspan="1">RR</th><th align="left" rowspan="1" colspan="1">[<italic toggle="yes">95% CI</italic>]</th><th align="left" rowspan="1" colspan="1">
<italic toggle="yes">P-value</italic>
</th></tr></thead><tbody><tr><td align="left" rowspan="3" colspan="1">
<bold>Stay out late at night</bold>
</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">45 (12.9)</td><td align="left" rowspan="1" colspan="1">54 (15.4)</td><td align="left" rowspan="1" colspan="1">
<bold>1.35</bold>
</td><td align="left" rowspan="1" colspan="1">[1.0 &#x02013; 1.7]</td><td align="left" rowspan="1" colspan="1">
<bold>0.048*</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">84 (24.0)</td><td align="left" rowspan="1" colspan="1">167 (47.7)</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Total</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>129 (36.9)</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>221 (63.1)</bold>
</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td></tr><tr><td align="left" rowspan="3" colspan="1">
<bold>Standing water near the house</bold>
</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">38 (10.9)</td><td align="left" rowspan="1" colspan="1">22 (6.3)</td><td align="left" rowspan="1" colspan="1">
<bold>2.01</bold>
</td><td align="left" rowspan="1" colspan="1">[1.5 &#x02013; 2.5]</td><td align="left" rowspan="1" colspan="1">
<bold>&#x0003c;0.0001*</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">91 (26.0)</td><td align="left" rowspan="1" colspan="1">199 (56.8)</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Total</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>129 (36.9)</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>221 (63.1)</bold>
</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td></tr><tr><td align="left" rowspan="3" colspan="1">
<bold>Crops near the house</bold>
</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">22 (6.3)</td><td align="left" rowspan="1" colspan="1">32 (9.1)</td><td align="left" rowspan="1" colspan="1">1.12</td><td align="left" rowspan="1" colspan="1">[0.7 &#x02013; 1.5]</td><td align="left" rowspan="1" colspan="1">0.541</td></tr><tr><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">107 (30.6)</td><td align="left" rowspan="1" colspan="1">189 (54.0)</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Total</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>129 (36.9)</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>221 (63.1)</bold>
</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td></tr><tr><td align="left" rowspan="3" colspan="1">
<bold>Bushes near the house</bold>
</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">57 (16.3)</td><td align="left" rowspan="1" colspan="1">56 (16.0)</td><td align="left" rowspan="1" colspan="1">
<bold>1.66</bold>
</td><td align="left" rowspan="1" colspan="1">[1.2 &#x02013; 2.1]</td><td align="left" rowspan="1" colspan="1">
<bold>0.0004*</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">72 (20.6)</td><td align="left" rowspan="1" colspan="1">165 (47.1)</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Total</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>129 (36.9)</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>221 (63.1)</bold>
</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td></tr><tr><td align="left" rowspan="3" colspan="1">
<bold>Windows with nets</bold>
</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">53 (15.2)</td><td align="left" rowspan="1" colspan="1">93 (26.5)</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td></tr><tr><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">76 (21.7)</td><td align="left" rowspan="1" colspan="1">128 (36.6)</td><td align="left" rowspan="1" colspan="1">1.02</td><td align="left" rowspan="1" colspan="1">[0.7 &#x02013; 1.3]</td><td align="left" rowspan="1" colspan="1">0.910</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Total</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>129 (36.9)</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>221 (63.1)</bold>
</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td></tr><tr><td align="left" rowspan="4" colspan="1">
<bold>Use of mosquito nets</bold>
</td><td align="left" rowspan="1" colspan="1">Regular</td><td align="left" rowspan="1" colspan="1">48 (13.7)</td><td align="left" rowspan="1" colspan="1">170 (48.5)</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td></tr><tr><td align="left" rowspan="1" colspan="1">Irregular</td><td align="left" rowspan="1" colspan="1">33 (9.4)</td><td align="left" rowspan="1" colspan="1">22 (6.3)</td><td align="left" rowspan="1" colspan="1">
<bold>2.75</bold>
</td><td align="left" rowspan="1" colspan="1">[1.9 &#x02013; 3.7]</td><td align="left" rowspan="1" colspan="1">
<bold>&#x0003c;0.0001*</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Don&#x02019;t use</td><td align="left" rowspan="1" colspan="1">48 (13.7)</td><td align="left" rowspan="1" colspan="1">29 (8.3)</td><td align="left" rowspan="1" colspan="1">
<bold>2.83</bold>
</td><td align="left" rowspan="1" colspan="1">[2.0 &#x02013; 3.8]</td><td align="left" rowspan="1" colspan="1">
<bold>&#x0003c;0.0001*</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Total</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>129 (36.9)</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>221 (63.1)</bold>
</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td></tr><tr><td align="left" rowspan="4" colspan="1">
<bold>Use of insecticide mosquito spray</bold>
</td><td align="left" rowspan="1" colspan="1">Regular</td><td align="left" rowspan="1" colspan="1">24 (6.86)</td><td align="left" rowspan="1" colspan="1">25 (7.1)</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td></tr><tr><td align="left" rowspan="1" colspan="1">Irregular</td><td align="left" rowspan="1" colspan="1">15 (4.28)</td><td align="left" rowspan="1" colspan="1">31 (8.9)</td><td align="left" rowspan="1" colspan="1">0.66</td><td align="left" rowspan="1" colspan="1">[0.3 &#x02013; 1.0]</td><td align="left" rowspan="1" colspan="1">0.144</td></tr><tr><td align="left" rowspan="1" colspan="1">Don&#x02019;t use</td><td align="left" rowspan="1" colspan="1">90 (25.71)</td><td align="left" rowspan="1" colspan="1">165 (47.1)</td><td align="left" rowspan="1" colspan="1">0.72</td><td align="left" rowspan="1" colspan="1">[0.5 &#x02013; 1.0]</td><td align="left" rowspan="1" colspan="1">0.077</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Total</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>129 (36.9)</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>221 (63.1)</bold>
</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td></tr><tr><td align="left" rowspan="3" colspan="1">
<bold>House with ceiling</bold>
</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">120 (34.3)</td><td align="left" rowspan="1" colspan="1">199 (56.8)</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td></tr><tr><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">9 (2.6)</td><td align="left" rowspan="1" colspan="1">22 (6.3)</td><td align="left" rowspan="1" colspan="1">0.77</td><td align="left" rowspan="1" colspan="1">[0.4 &#x02013; 1.2]</td><td align="left" rowspan="1" colspan="1">0.436</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Total</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>129 (36.9)</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>221 (63.1)</bold>
</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td></tr><tr><td align="left" rowspan="3" colspan="1">
<bold>Malaria prophylaxis</bold>
</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">7 (2.0)</td><td align="left" rowspan="1" colspan="1">18 (5.1)</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td></tr><tr><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">122 (34.9)</td><td align="left" rowspan="1" colspan="1">203 (58.0)</td><td align="left" rowspan="1" colspan="1">1.3</td><td align="left" rowspan="1" colspan="1">[0.7 &#x02013; 2.6]</td><td align="left" rowspan="1" colspan="1">0.395</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Total</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>129 (36.9)</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>221 (63.1)</bold>
</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t003fn001"><p>
<italic toggle="yes">The statistical association was performed using Fisher&#x02019;s Exact Test. P values &#x0003c;0.05 were considered significantly different. RR: Relative Risk; CI: 95% Confidence Interval; n: sample size of the category. All categories where RR&#x02009;=&#x02009;1.00 were considered as reference during the analysis.</italic>
</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="pone.0319547.t004"><object-id pub-id-type="doi">10.1371/journal.pone.0319547.t004</object-id><label>Table 4</label><caption><title>Association between typhoid fever infection rate and patients&#x02019; attitudes towards compliance with preventive measures.</title></caption><alternatives><graphic xlink:href="pone.0319547.t004" id="pone.0319547.t004g" position="float"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="2" colspan="1">Preventive measures</th><th align="left" rowspan="2" colspan="1">Categories</th><th align="left" colspan="5" rowspan="1">Typhoid fever</th></tr><tr><th align="left" rowspan="1" colspan="1">Positive<break/>n (%)</th><th align="left" rowspan="1" colspan="1">Negative<break/>n (%)</th><th align="left" rowspan="1" colspan="1">RR</th><th align="left" rowspan="1" colspan="1">
<italic toggle="yes">[95% CI]</italic>
</th><th align="left" rowspan="1" colspan="1">
<italic toggle="yes">P-value</italic>
</th></tr></thead><tbody><tr><td align="left" rowspan="3" colspan="1">
<bold>purify water before drinking</bold>
</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">30 (8.6)</td><td align="left" rowspan="1" colspan="1">48 (13.7)</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td></tr><tr><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">76 (21.7)</td><td align="left" rowspan="1" colspan="1">196 (56.0)</td><td align="left" rowspan="1" colspan="1">0.72</td><td align="left" rowspan="1" colspan="1">[0.5 &#x02013; 1.0]</td><td align="left" rowspan="1" colspan="1">0.093</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Total</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>106 (30.3)</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>244 (69.7)</bold>
</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td></tr><tr><td align="left" rowspan="3" colspan="1">
<bold>washing fruits and vegetables before consumption</bold>
</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">98 (28.0)</td><td align="left" rowspan="1" colspan="1">224 (64.0)</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td></tr><tr><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">8 (2.3)</td><td align="left" rowspan="1" colspan="1">20 (5.7)</td><td align="left" rowspan="1" colspan="1">0.938</td><td align="left" rowspan="1" colspan="1">[0.4 &#x02013; 1.5]</td><td align="left" rowspan="1" colspan="1">&#x0003e;0.999</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Total</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>106 (30.3)</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>244 (69.7)</bold>
</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td></tr><tr><td align="left" rowspan="3" colspan="1">
<bold>hand washing before meals</bold>
</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">96 (27.4)</td><td align="left" rowspan="1" colspan="1">214 (61.1)</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">10 (2.9)</td><td align="left" rowspan="1" colspan="1">30 (8.6)</td><td align="left" rowspan="1" colspan="1">0.80</td><td align="left" rowspan="1" colspan="1">[0.4 &#x02013; 1.5]</td><td align="left" rowspan="1" colspan="1">0.583</td></tr><tr><td align="left" rowspan="1" colspan="1">Total</td><td align="left" rowspan="1" colspan="1">106 (30.3)</td><td align="left" rowspan="1" colspan="1">244 (69.7)</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td></tr><tr><td align="left" rowspan="3" colspan="1">
<bold>garbage dumps near the house</bold>
</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">36 (10.3)</td><td align="left" rowspan="1" colspan="1">27 (7.7)</td><td align="left" rowspan="1" colspan="1">
<bold>2.34</bold>
</td><td align="left" rowspan="1" colspan="1">[1.7 &#x02013; 3.1]</td><td align="left" rowspan="1" colspan="1">
<bold>&#x0003c;0.0001*</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">70 (20.0)</td><td align="left" rowspan="1" colspan="1">217 (62.0)</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Total</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>106 (30.3)</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>244 (69.7)</bold>
</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td><td align="left" rowspan="1" colspan="1">/</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t004fn001"><p>
<italic toggle="yes">The statistical association was performed using Fisher&#x02019;s Exact Test. P values &#x0003c;0.05 were considered significantly different. RR: Relative Risk; CI: 95% Confidence Interval; n: sample size of the category. All categories where RR&#x02009;=&#x02009;1.00 were considered as reference during the analysis.</italic>
</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec023"><title>Variation of biochemical markers of liver damage in malaria, typhoid, and malaria-typhoid co-infected patients</title><sec id="sec024"><title>Influence of infection status and parasitemia on the liver damage parameters in febrile patients.</title><p><xref rid="pone.0319547.g002" ref-type="fig">Fig 2A</xref>, <xref rid="pone.0319547.g002" ref-type="fig">Fig 2B</xref>, and <xref rid="pone.0319547.g002" ref-type="fig">Fig 2C</xref> present the influence of the infection status on serum levels of ALT, AST, and ALP respectively. The serum levels of these biochemical markers of liver injury were significantly (P&#x02009;&#x0003c;&#x02009;0.05) higher in co-infected patients compared to those with malaria or typhoid mono-infection. Similarly, <xref rid="pone.0319547.g002" ref-type="fig">Fig 2D</xref>, <xref rid="pone.0319547.g002" ref-type="fig">Fig 2E</xref>, and <xref rid="pone.0319547.g002" ref-type="fig">Fig 2F</xref> depict the effect of parasitemia on the serum activities of ALT, AST, and ALP in patients suffering from malaria. No significant (P&#x02009;&#x0003e;&#x02009;0.05) variation in the levels of these liver enzymes was observed between patients with a parasitemia lower than 500 parasites/&#x000b5;L and those with parasitemia between 500 and 2500 parasites/&#x000b5;L. However, the serum activities of these liver enzymes were significantly (P&#x02009;&#x0003c;&#x02009;0.05) higher in patients with parasitemia above 2500 parasites/&#x000b5;L, when compared to the previous two groups. Nonetheless, regardless of the patient&#x02019;s group considered, the median values of each of these parameters were at least twice as high as the upper limit of the normal range of their respective reference values.</p><fig position="float" id="pone.0319547.g002"><object-id pub-id-type="doi">10.1371/journal.pone.0319547.g002</object-id><label>Fig 2</label><caption><title>Effect of the infection status and parasitemia on the variation of the biochemical markers of liver injury.</title><p>(A) <italic toggle="yes">and (D), (B) and (E), (C) and (F): Effect of infection status and parasitemia on serum activities of ALT, AST, and ALP, respectively. Values are expressed as median and interquartile ranges and compared using non-parametric Mann Wihtney U test.</italic>
<bold><italic toggle="yes">*</italic></bold>
<italic toggle="yes">Median value significantly different when compared to co-infected patients (P&#x02009;&#x0003c;&#x02009;0.05).</italic>
<bold><italic toggle="yes">&#x00394;</italic></bold>
<italic toggle="yes">Median value significantly different when compared to patients with a parasitemia lower than 500 parasites/&#x000b5;L of blood (P&#x02009;&#x0003c;&#x02009;0.05).</italic>
<sup><bold><italic toggle="yes">ns</italic></bold></sup>
<italic toggle="yes">Median value not significantly different when compared to patients with a parasitemia lower than 500 parasites/&#x000b5;L of blood (P&#x02009;&#x0003e;&#x02009;0.05). ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; ALP: Alkaline phosphatase.</italic></p></caption><graphic xlink:href="pone.0319547.g002" position="float"/></fig></sec><sec id="sec025"><title>Influence of the time taken before consultation and the place of treatment on the variation of biochemical markers of liver injury in febrile patients.</title><p>The effects of the time taken before consultation since the onset of the first symptoms on serum levels of ALT, AST, and ALP are illustrated in <xref rid="pone.0319547.g003" ref-type="fig">Fig 3A</xref>, <xref rid="pone.0319547.g003" ref-type="fig">Fig 3B</xref>, and <xref rid="pone.0319547.g003" ref-type="fig">Fig 3C</xref> respectively. There was no significant change (P&#x02009;&#x0003e;&#x02009;0.05) in the levels of liver enzymes activities between patients who spent less than three days and those whose consultation time varied between three and seven days since the appearance of the first symptoms. However, the serum activity of these liver enzymes was significantly (P&#x02009;&#x0003c;&#x02009;0.05) higher in infected patients whose time taken before consultation exceeded seven days, compared to the previous two groups.</p><fig position="float" id="pone.0319547.g003"><object-id pub-id-type="doi">10.1371/journal.pone.0319547.g003</object-id><label>Fig 3</label><caption><title>Effect of the place of care and the time taken before consultation on the variation of the biochemical markers of liver injury.</title><p>(A), <italic toggle="yes">(B), and (C): Effect of the time elapsed since the onset of the first symptoms before consultation on the serum activities of ALT, AST, and ALP, respectively. (D), (E), and (F): Effect of the initial place of care on the serum activities of ALT, AST, and ALP, respectively. Values are expressed as median and interquartile ranges and compared using non-parametric Mann Wihtney U test.</italic>
<bold><italic toggle="yes">*</italic></bold>
<italic toggle="yes">Median value significantly different when compared to patients with a consultation time of &#x0003c; 3 days (P&#x02009;&#x0003c;&#x02009;0.05).</italic>
<sup><bold><italic toggle="yes">ns</italic></bold></sup>
<italic toggle="yes">Median value not significantly different when compared to patients with a consultation time of &#x0003c; 3 days or those receiving care in a health center (P&#x0003e;0.05). ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; ALP: Alkaline phosphatase.</italic></p></caption><graphic xlink:href="pone.0319547.g003" position="float"/></fig><p>Furthermore, <xref rid="pone.0319547.g003" ref-type="fig">Fig 3D</xref>, <xref rid="pone.0319547.g003" ref-type="fig">3E</xref>, and <xref rid="pone.0319547.g003" ref-type="fig">3F</xref> depict the influence of the place of treatment on the variation of serum activities of ALT, AST, and ALP, respectively. Regardless of the location where infected patients seek health care, no significant (P&#x02009;&#x0003e;&#x02009;0.05) variation in the serum levels of these liver enzymes was observed between patients who seek treatment from a health center or from a traditional practitioner/herbalism and those who engaged in self-medication. Nevertheless, the median values of each of these parameters were more than twice the upper limit of the normal range of their respective reference values.</p></sec></sec><sec id="sec026"><title>Risk factors associated with the alteration of the serum activities of hepatic enzymes</title><sec id="sec027"><title>Association between the infection status and the levels of alteration of hepatic enzymes.</title><p><xref rid="pone.0319547.t005" ref-type="table">Table 5</xref> presents the associations between the infection status (malaria mono-infected, typhoid fever mono-infected, or malaria/typhoid co-infected) and the different levels of alterations in liver enzyme activity (normal, mild, moderate, and severe). The infection status was not significantly associated with the level of alteration of ALT activity (Chi-square&#x02009;=&#x02009;2.13; P&#x02009;=&#x02009;0.343). However, a significant association was found between the infection status and the levels of alteration of AST activity (Chi-square&#x02009;=&#x02009;8.44; P&#x02009;=&#x02009;0.014) and ALP activity (Chi-square&#x02009;=&#x02009;13.35; P&#x02009;=&#x02009;0.001), respectively.</p><table-wrap position="float" id="pone.0319547.t005"><object-id pub-id-type="doi">10.1371/journal.pone.0319547.t005</object-id><label>Table 5</label><caption><title>Association between the infection status and the levels of alteration of hepatic enzymes.</title></caption><alternatives><graphic xlink:href="pone.0319547.t005" id="pone.0319547.t005g" position="float"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="2" colspan="1">Variables</th><th align="left" rowspan="2" colspan="1">Categories</th><th align="left" colspan="3" rowspan="1">Infection status</th><th align="left" colspan="2" rowspan="1">Association</th></tr><tr><th align="left" rowspan="1" colspan="1">Typhoid<break/>Mono-infection<break/><italic toggle="yes">n</italic> (%)</th><th align="left" rowspan="1" colspan="1">Malaria<break/>Mono-infection<break/><italic toggle="yes">n</italic> (%)</th><th align="left" rowspan="1" colspan="1">Malaria/Typhoid<break/>Co-infection<break/><italic toggle="yes">n</italic> (%)</th><th align="left" rowspan="1" colspan="1">
<italic toggle="yes">Chi-</italic>
<sup>
<italic toggle="yes">2</italic>
</sup>
</th><th align="left" rowspan="1" colspan="1">
<italic toggle="yes">P-value</italic>
</th></tr></thead><tbody><tr><td align="left" rowspan="5" colspan="1">
<bold>ALT</bold>
</td><td align="left" rowspan="1" colspan="1">Severe</td><td align="left" rowspan="1" colspan="1">20 (40.0)</td><td align="left" rowspan="1" colspan="1">35 (47.9)</td><td align="left" rowspan="1" colspan="1">46 (82.1)</td><td align="left" rowspan="5" colspan="1">2.13</td><td align="left" rowspan="5" colspan="1">0.343</td></tr><tr><td align="left" rowspan="1" colspan="1">Moderate</td><td align="left" rowspan="1" colspan="1">6 (12.0)</td><td align="left" rowspan="1" colspan="1">11 (15.1)</td><td align="left" rowspan="1" colspan="1">7 (12.5)</td></tr><tr><td align="left" rowspan="1" colspan="1">Mild</td><td align="left" rowspan="1" colspan="1">7 (14.0)</td><td align="left" rowspan="1" colspan="1">18 (24.7)</td><td align="left" rowspan="1" colspan="1">3 (5.4)</td></tr><tr><td align="left" rowspan="1" colspan="1">Normal</td><td align="left" rowspan="1" colspan="1">17 (34.0)</td><td align="left" rowspan="1" colspan="1">9 (12.3)</td><td align="left" rowspan="1" colspan="1">0 (0.0)</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Total</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>50 (100)</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>73 (100)</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>56 (100)</bold>
</td></tr><tr><td align="left" rowspan="5" colspan="1">
<bold>AST</bold>
</td><td align="left" rowspan="1" colspan="1">Severe</td><td align="left" rowspan="1" colspan="1">22 (44.0)</td><td align="left" rowspan="1" colspan="1">34 (46.6)</td><td align="left" rowspan="1" colspan="1">50 (89.2)</td><td align="left" rowspan="5" colspan="1">
<bold>8.44</bold>
</td><td align="left" rowspan="5" colspan="1">
<bold>0.014*</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Moderate</td><td align="left" rowspan="1" colspan="1">3 (6.0)</td><td align="left" rowspan="1" colspan="1">12 (16.4)</td><td align="left" rowspan="1" colspan="1">3 (5.4)</td></tr><tr><td align="left" rowspan="1" colspan="1">Mild</td><td align="left" rowspan="1" colspan="1">11 (22.0)</td><td align="left" rowspan="1" colspan="1">20 (27.4)</td><td align="left" rowspan="1" colspan="1">3 (5.4)</td></tr><tr><td align="left" rowspan="1" colspan="1">Normal</td><td align="left" rowspan="1" colspan="1">14 (28.0)</td><td align="left" rowspan="1" colspan="1">7 (9.6)</td><td align="left" rowspan="1" colspan="1">0 (0.0)</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Total</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>50 (100)</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>73 (100)</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>56 (100)</bold>
</td></tr><tr><td align="left" rowspan="5" colspan="1">
<bold>ALP</bold>
</td><td align="left" rowspan="1" colspan="1">Severe</td><td align="left" rowspan="1" colspan="1">13 (26.0)</td><td align="left" rowspan="1" colspan="1">20 (27.4)</td><td align="left" rowspan="1" colspan="1">38 (67.9)</td><td align="left" rowspan="5" colspan="1">
<bold>13.35</bold>
</td><td align="left" rowspan="5" colspan="1">
<bold>0.001*</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Moderate</td><td align="left" rowspan="1" colspan="1">20 (40.0)</td><td align="left" rowspan="1" colspan="1">28 (38.4)</td><td align="left" rowspan="1" colspan="1">14 (25.0)</td></tr><tr><td align="left" rowspan="1" colspan="1">Mild</td><td align="left" rowspan="1" colspan="1">15 (30.0)</td><td align="left" rowspan="1" colspan="1">21 (28.8)</td><td align="left" rowspan="1" colspan="1">4 (7.1)</td></tr><tr><td align="left" rowspan="1" colspan="1">Normal</td><td align="left" rowspan="1" colspan="1">2 (4.0)</td><td align="left" rowspan="1" colspan="1">4 (5.5)</td><td align="left" rowspan="1" colspan="1">0 (0.0)</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Total</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>50 (100)</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>73 (100)</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>56 (100)</bold>
</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t005fn001"><p>
<italic toggle="yes">The bold Chi-2 and P-value are indicators of a significant association</italic>
</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec028"><title>Association between the parasitemia and the levels of alteration of hepatic enzymes.</title><p>The statistics on the associations between parasitemia (&#x0003c;500;}500&#x02013;2500];&#x02009;&#x0003e;&#x02009;2500 parasites/&#x000b5;L of blood) in malaria-infected patients and the different levels of alteration in liver enzyme activity are summarized in <xref rid="pone.0319547.t006" ref-type="table">Table 6</xref>. A significant association was noted between parasitemia and the levels of alteration in ALT activity (Chi-squared&#x02009;=&#x02009;9.36; P&#x02009;=&#x02009;0.009) and AST activity (Chi-squared&#x02009;=&#x02009;13.75; P&#x02009;=&#x02009;0.001), respectively. No significant association (Chi-squared&#x02009;=&#x02009;1.48; P&#x02009;=&#x02009;0.477) was observed between parasitemia and the variation in ALP activity.</p><table-wrap position="float" id="pone.0319547.t006"><object-id pub-id-type="doi">10.1371/journal.pone.0319547.t006</object-id><label>Table 6</label><caption><title>Association between parasitemia and the levels of alteration of hepatic enzymes.</title></caption><alternatives><graphic xlink:href="pone.0319547.t006" id="pone.0319547.t006g" position="float"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="2" colspan="1">Variables</th><th align="left" rowspan="2" colspan="1">Categories</th><th align="left" colspan="3" rowspan="1">Parasitemia (Number of parasites/&#x000b5;L of blood)</th><th align="left" colspan="2" rowspan="1">Association</th></tr><tr><th align="left" rowspan="1" colspan="1">&#x0003c; 500<break/><italic toggle="yes">n</italic> (%)</th><th align="left" rowspan="1" colspan="1">[500 - 2500]<break/><italic toggle="yes">n</italic> (%)</th><th align="left" rowspan="1" colspan="1">&#x0003e; 2500<break/><italic toggle="yes">n</italic> (%)</th><th align="left" rowspan="1" colspan="1">
<italic toggle="yes">Chi-</italic>
<sup>
<italic toggle="yes">2</italic>
</sup>
</th><th align="left" rowspan="1" colspan="1">
<italic toggle="yes">P-value</italic>
</th></tr></thead><tbody><tr><td align="left" rowspan="5" colspan="1">
<bold>ALT</bold>
</td><td align="left" rowspan="1" colspan="1">Severe</td><td align="left" rowspan="1" colspan="1">32 (74.4)</td><td align="left" rowspan="1" colspan="1">31 (49.2)</td><td align="left" rowspan="1" colspan="1">18 (78.3)</td><td align="left" rowspan="5" colspan="1">
<bold>9.36</bold>
</td><td align="left" rowspan="5" colspan="1">
<bold>0.009*</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Moderate</td><td align="left" rowspan="1" colspan="1">3 (7.0)</td><td align="left" rowspan="1" colspan="1">14 (22.2)</td><td align="left" rowspan="1" colspan="1">1 (4.3)</td></tr><tr><td align="left" rowspan="1" colspan="1">Mild</td><td align="left" rowspan="1" colspan="1">5 (11.6)</td><td align="left" rowspan="1" colspan="1">12 (19.0)</td><td align="left" rowspan="1" colspan="1">4 (17.3)</td></tr><tr><td align="left" rowspan="1" colspan="1">Normal</td><td align="left" rowspan="1" colspan="1">3 (7.0)</td><td align="left" rowspan="1" colspan="1">6 (9.5)</td><td align="left" rowspan="1" colspan="1">0 (0.0)</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Total</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>43 (100)</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>63 (100)</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>23 (100)</bold>
</td></tr><tr><td align="left" rowspan="5" colspan="1">
<bold>AST</bold>
</td><td align="left" rowspan="1" colspan="1">Severe</td><td align="left" rowspan="1" colspan="1">35 (81.4)</td><td align="left" rowspan="1" colspan="1">31 (49.2)</td><td align="left" rowspan="1" colspan="1">18 (78.3)</td><td align="left" rowspan="5" colspan="1">
<bold>13.75</bold>
</td><td align="left" rowspan="5" colspan="1">
<bold>0.001*</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Moderate</td><td align="left" rowspan="1" colspan="1">0 (0.0)</td><td align="left" rowspan="1" colspan="1">13 (20.6)</td><td align="left" rowspan="1" colspan="1">2 (8.7)</td></tr><tr><td align="left" rowspan="1" colspan="1">Mild</td><td align="left" rowspan="1" colspan="1">5 (11.6)</td><td align="left" rowspan="1" colspan="1">15 (23.8)</td><td align="left" rowspan="1" colspan="1">3 (13.0)</td></tr><tr><td align="left" rowspan="1" colspan="1">Normal</td><td align="left" rowspan="1" colspan="1">3 (7.0)</td><td align="left" rowspan="1" colspan="1">4 (6.3)</td><td align="left" rowspan="1" colspan="1">0 (0.0)</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Total</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>43 (100)</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>63 (100)</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>23 (100)</bold>
</td></tr><tr><td align="left" rowspan="5" colspan="1">
<bold>ALP</bold>
</td><td align="left" rowspan="1" colspan="1">Severe</td><td align="left" rowspan="1" colspan="1">21 (48.8)</td><td align="left" rowspan="1" colspan="1">23 (36.5)</td><td align="left" rowspan="1" colspan="1">14 (60.9)</td><td align="left" rowspan="5" colspan="1">1.48</td><td align="left" rowspan="5" colspan="1">0.477</td></tr><tr><td align="left" rowspan="1" colspan="1">Moderate</td><td align="left" rowspan="1" colspan="1">17 (39.5)</td><td align="left" rowspan="1" colspan="1">19 (30.2)</td><td align="left" rowspan="1" colspan="1">6 (26.1)</td></tr><tr><td align="left" rowspan="1" colspan="1">Mild</td><td align="left" rowspan="1" colspan="1">3 (7.0)</td><td align="left" rowspan="1" colspan="1">19 (30.2)</td><td align="left" rowspan="1" colspan="1">3 (13.0)</td></tr><tr><td align="left" rowspan="1" colspan="1">Normal</td><td align="left" rowspan="1" colspan="1">2 (4.7)</td><td align="left" rowspan="1" colspan="1">2 (3.2)</td><td align="left" rowspan="1" colspan="1">0 (0.0)</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Total</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>43 (100)</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>63 (100)</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>23 (100)</bold>
</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t006fn001"><p>
<italic toggle="yes">The bold Chi-2 and P-value are indicators of a significant association</italic>
</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec029"><title>Association between the times elapsed since the appearance of the first symptoms before consultation and the levels of alteration of hepatic enzymes.</title><p><xref rid="pone.0319547.t007" ref-type="table">Table 7</xref> presents the association between the levels of alterations in liver enzyme activity (normal, mild, moderate, and severe) and the time taken by febrile patients since the appearance of the first symptoms before consultation (&#x0003c; 3 days,} 3&#x02013;7] days, and &#x0003e; 7 days). A significant association between the time taken before consultation and the alteration of serum ALT (Chi-square&#x02009;=&#x02009;7.46; P&#x02009;=&#x02009;0.024) and AST (Chi-square&#x02009;=&#x02009;7.15; P&#x02009;=&#x02009;0.027) activity was observed. However, no significant association (Chi-square&#x02009;=&#x02009;4.82; P&#x02009;=&#x02009;0.089) was found between the time taken before consultation and the alteration of ALP activity.</p><table-wrap position="float" id="pone.0319547.t007"><object-id pub-id-type="doi">10.1371/journal.pone.0319547.t007</object-id><label>Table 7</label><caption><title>Association between the levels of alterations in liver enzyme activities and the time taken by febrile patients since the appearance of the first symptoms before consultation.</title></caption><alternatives><graphic xlink:href="pone.0319547.t007" id="pone.0319547.t007g" position="float"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="2" colspan="1">Variables</th><th align="left" rowspan="2" colspan="1">Categories</th><th align="left" colspan="3" rowspan="1">Time taken since the appearance of the first symptoms before consultation</th><th align="left" colspan="2" rowspan="1">Association</th></tr><tr><th align="left" rowspan="1" colspan="1">&#x0003c; 3 days <italic toggle="yes">n</italic> (%)</th><th align="left" rowspan="1" colspan="1">[3&#x02013;7] days<break/><italic toggle="yes">n</italic> (%)</th><th align="left" rowspan="1" colspan="1">&#x0003e; 7 days<break/><italic toggle="yes">n</italic> (%)</th><th align="left" rowspan="1" colspan="1">
<italic toggle="yes">Chi-</italic>
<sup>
<italic toggle="yes">2</italic>
</sup>
</th><th align="left" rowspan="1" colspan="1">
<italic toggle="yes">P-value</italic>
</th></tr></thead><tbody><tr><td align="left" rowspan="5" colspan="1">
<bold>ALT</bold>
</td><td align="left" rowspan="1" colspan="1">Severe</td><td align="left" rowspan="1" colspan="1">35 (46.7)</td><td align="left" rowspan="1" colspan="1">55 (60.4)</td><td align="left" rowspan="1" colspan="1">11 (84.6)</td><td align="left" rowspan="5" colspan="1">
<bold>7.46</bold>
</td><td align="left" rowspan="5" colspan="1">
<bold>0.024*</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Moderate</td><td align="left" rowspan="1" colspan="1">15 (20.0)</td><td align="left" rowspan="1" colspan="1">9 (9.9)</td><td align="left" rowspan="1" colspan="1">0 (0.0)</td></tr><tr><td align="left" rowspan="1" colspan="1">Mild</td><td align="left" rowspan="1" colspan="1">13 (17.3)</td><td align="left" rowspan="1" colspan="1">14 (15.4)</td><td align="left" rowspan="1" colspan="1">1 (7.7)</td></tr><tr><td align="left" rowspan="1" colspan="1">Normal</td><td align="left" rowspan="1" colspan="1">12 (16.0)</td><td align="left" rowspan="1" colspan="1">13 (14.3)</td><td align="left" rowspan="1" colspan="1">1 (7.7)</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Total</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>75 (100)</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>91 (100)</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>13 (100)</bold>
</td></tr><tr><td align="left" rowspan="5" colspan="1">
<bold>AST</bold>
</td><td align="left" rowspan="1" colspan="1">Severe</td><td align="left" rowspan="1" colspan="1">37 (49.3)</td><td align="left" rowspan="1" colspan="1">58 (63.7)</td><td align="left" rowspan="1" colspan="1">11 (84.6)</td><td align="left" rowspan="5" colspan="1">
<bold>7.15</bold>
</td><td align="left" rowspan="5" colspan="1">
<bold>0.027*</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Moderate</td><td align="left" rowspan="1" colspan="1">12 (16.0)</td><td align="left" rowspan="1" colspan="1">6 (6.6)</td><td align="left" rowspan="1" colspan="1">0 (0.0)</td></tr><tr><td align="left" rowspan="1" colspan="1">Mild</td><td align="left" rowspan="1" colspan="1">14 (18.7)</td><td align="left" rowspan="1" colspan="1">19 (20.9)</td><td align="left" rowspan="1" colspan="1">1 (7.7)</td></tr><tr><td align="left" rowspan="1" colspan="1">Normal</td><td align="left" rowspan="1" colspan="1">12 (16.0)</td><td align="left" rowspan="1" colspan="1">8 (8.8)</td><td align="left" rowspan="1" colspan="1">1 (7.7)</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Total</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>75 (100)</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>91 (100)</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>13 (100)</bold>
</td></tr><tr><td align="left" rowspan="5" colspan="1">
<bold>ALP</bold>
</td><td align="left" rowspan="1" colspan="1">Severe</td><td align="left" rowspan="1" colspan="1">24 (32.0)</td><td align="left" rowspan="1" colspan="1">37 (40.7)</td><td align="left" rowspan="1" colspan="1">10 (76.9)</td><td align="left" rowspan="5" colspan="1">4.82</td><td align="left" rowspan="5" colspan="1">0.089</td></tr><tr><td align="left" rowspan="1" colspan="1">Moderate</td><td align="left" rowspan="1" colspan="1">25 (33.3)</td><td align="left" rowspan="1" colspan="1">35 (38.5)</td><td align="left" rowspan="1" colspan="1">2 (15.4)</td></tr><tr><td align="left" rowspan="1" colspan="1">Mild</td><td align="left" rowspan="1" colspan="1">23 (30.7)</td><td align="left" rowspan="1" colspan="1">16 (17.6)</td><td align="left" rowspan="1" colspan="1">1 (7.7)</td></tr><tr><td align="left" rowspan="1" colspan="1">Normal</td><td align="left" rowspan="1" colspan="1">3 (4.0)</td><td align="left" rowspan="1" colspan="1">3 (3.3)</td><td align="left" rowspan="1" colspan="1">0 (0.0)</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Total</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>75 (100)</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>91 (100)</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>13 (100)</bold>
</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t007fn001"><p>
<italic toggle="yes">The bold Chi-2 and P-value are indicators of a significant association</italic>
</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec030"><title>Association between the place of treatment and the levels of alteration of hepatic enzymes.</title><p><xref rid="pone.0319547.t008" ref-type="table">Table 8</xref> summarizes the statistics of associations between the levels of alteration in liver enzyme activity and the different places of care (Health center, self-medication, and herbalism). Overall, no significant association was found between the places of care and the level of alteration in AST (Chi-2&#x02009;=&#x02009;1.26; P&#x02009;=&#x02009;0.532) or in ALP (Chi-2&#x02009;=&#x02009;4.13; P&#x02009;=&#x02009;0.126) activity. In contrast, a significant association was observed between the places of treatment and the alteration of ALT activity (Chi-2&#x02009;=&#x02009;6.37; P&#x02009;=&#x02009;0.041). The infection status, the parasitemia, the time taken before consultation, and place of care are considered as significant risk factors that can lead to the alterations in biochemical markers of liver injury.</p><table-wrap position="float" id="pone.0319547.t008"><object-id pub-id-type="doi">10.1371/journal.pone.0319547.t008</object-id><label>Table 8</label><caption><title>Association between the levels of alteration in liver enzyme activities and the different places of care.</title></caption><alternatives><graphic xlink:href="pone.0319547.t008" id="pone.0319547.t008g" position="float"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="2" colspan="1">Variables</th><th align="left" rowspan="2" colspan="1">Categories</th><th align="left" colspan="3" rowspan="1">Places of care</th><th align="left" colspan="2" rowspan="1">Association</th></tr><tr><th align="left" rowspan="1" colspan="1">Health Center<break/><italic toggle="yes">n</italic> (%)</th><th align="left" rowspan="1" colspan="1">Self-<break/>Medication<break/><italic toggle="yes">n</italic> (%)</th><th align="left" rowspan="1" colspan="1">Herbalism<break/><italic toggle="yes">n</italic> (%)</th><th align="left" rowspan="1" colspan="1">
<italic toggle="yes">Chi-</italic>
<sup>
<italic toggle="yes">2</italic>
</sup>
</th><th align="left" rowspan="1" colspan="1">
<italic toggle="yes">P-value</italic>
</th></tr></thead><tbody><tr><td align="left" rowspan="5" colspan="1">
<bold>ALT</bold>
</td><td align="left" rowspan="1" colspan="1">Severe</td><td align="left" rowspan="1" colspan="1">44 (46.3)</td><td align="left" rowspan="1" colspan="1">50 (68.5)</td><td align="left" rowspan="1" colspan="1">7 (63.6)</td><td align="left" rowspan="5" colspan="1">
<bold>6.37</bold>
</td><td align="left" rowspan="5" colspan="1">
<bold>0.041*</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Moderate</td><td align="left" rowspan="1" colspan="1">17 (17.9)</td><td align="left" rowspan="1" colspan="1">7 (9.6)</td><td align="left" rowspan="1" colspan="1">0 (0.0)</td></tr><tr><td align="left" rowspan="1" colspan="1">Mild</td><td align="left" rowspan="1" colspan="1">17 (17.9)</td><td align="left" rowspan="1" colspan="1">10 (13.7)</td><td align="left" rowspan="1" colspan="1">1(9.1)</td></tr><tr><td align="left" rowspan="1" colspan="1">Normal</td><td align="left" rowspan="1" colspan="1">17 (17.9)</td><td align="left" rowspan="1" colspan="1">6 (8.2)</td><td align="left" rowspan="1" colspan="1">3 (27.3)</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Total</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>95 (100)</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>73 (100)</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>11 (100)</bold>
</td></tr><tr><td align="left" rowspan="5" colspan="1">
<bold>AST</bold>
</td><td align="left" rowspan="1" colspan="1">Severe</td><td align="left" rowspan="1" colspan="1">50 (52.6)</td><td align="left" rowspan="1" colspan="1">49 (47.9)</td><td align="left" rowspan="1" colspan="1">7 (63.6)</td><td align="left" rowspan="5" colspan="1">1.26</td><td align="left" rowspan="5" colspan="1">0.532</td></tr><tr><td align="left" rowspan="1" colspan="1">Moderate</td><td align="left" rowspan="1" colspan="1">9 (9.5)</td><td align="left" rowspan="1" colspan="1">9 (12.3)</td><td align="left" rowspan="1" colspan="1">0 (0.0)</td></tr><tr><td align="left" rowspan="1" colspan="1">Mild</td><td align="left" rowspan="1" colspan="1">22 (23.2)</td><td align="left" rowspan="1" colspan="1">9 (12.3)</td><td align="left" rowspan="1" colspan="1">1(9.1)</td></tr><tr><td align="left" rowspan="1" colspan="1">Normal</td><td align="left" rowspan="1" colspan="1">14 (14.7)</td><td align="left" rowspan="1" colspan="1">6 (8.2)</td><td align="left" rowspan="1" colspan="1">3 (27.3)</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Total</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>95 (100)</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>73 (100)</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>11 (100)</bold>
</td></tr><tr><td align="left" rowspan="5" colspan="1">
<bold>ALP</bold>
</td><td align="left" rowspan="1" colspan="1">Severe</td><td align="left" rowspan="1" colspan="1">32 (33.7)</td><td align="left" rowspan="1" colspan="1">35 (47.9)</td><td align="left" rowspan="1" colspan="1">4 (36.4)</td><td align="left" rowspan="5" colspan="1">4.13</td><td align="left" rowspan="5" colspan="1">0.126</td></tr><tr><td align="left" rowspan="1" colspan="1">Moderate</td><td align="left" rowspan="1" colspan="1">36 (37.9)</td><td align="left" rowspan="1" colspan="1">20 (27.4)</td><td align="left" rowspan="1" colspan="1">6 (54.5)</td></tr><tr><td align="left" rowspan="1" colspan="1">Mild</td><td align="left" rowspan="1" colspan="1">22 (23.2)</td><td align="left" rowspan="1" colspan="1">17 (23.3)</td><td align="left" rowspan="1" colspan="1">1 (9.1)</td></tr><tr><td align="left" rowspan="1" colspan="1">Normal</td><td align="left" rowspan="1" colspan="1">5 (5.3)</td><td align="left" rowspan="1" colspan="1">1 (1.4)</td><td align="left" rowspan="1" colspan="1">0 (0.0)</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Total</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>95 (100)</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>73 (100)</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>11 (100)</bold>
</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t008fn001"><p>
<italic toggle="yes">The bold Chi-2 and P-value are indicators of a significant association</italic>
</p></fn></table-wrap-foot></table-wrap></sec></sec><sec id="sec031"><title>Risk factors related to the occurrence of liver injury in febrile patients suffering from malaria, typhoid fever, and malaria-typhoid co-infection</title><p><xref rid="pone.0319547.t009" ref-type="table">Table 9</xref> presents the statistical associations between factors influencing the serum levels of liver enzymes (infection status, parasite density, time taken before consultation, and place of treatment) and the occurrence of different types of liver injuries (no injury, hepatocellular cytolysis, hepatic cholestasis, mixed lesion &#x02018;cytolysis/cholestasis&#x02019;) in malaria and/or typhoid fever infected patients.</p><table-wrap position="float" id="pone.0319547.t009"><object-id pub-id-type="doi">10.1371/journal.pone.0319547.t009</object-id><label>Table 9</label><caption><title>Association between factors influencing the serum levels of liver enzymes activities and the occurrence of different types of liver injuries.</title></caption><alternatives><graphic xlink:href="pone.0319547.t009" id="pone.0319547.t009g" position="float"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="2" colspan="1">Variables</th><th align="left" rowspan="2" colspan="1">Categories</th><th align="left" colspan="4" rowspan="1">Type of hepatic injuries</th><th align="left" colspan="2" rowspan="1">Association</th></tr><tr><th align="left" rowspan="1" colspan="1">Mixed<break/><italic toggle="yes">n</italic> (%)</th><th align="left" rowspan="1" colspan="1">Cholestasis<break/><italic toggle="yes">n</italic> (%)</th><th align="left" rowspan="1" colspan="1">Hepato-cellular<break/><italic toggle="yes">n</italic> (%)</th><th align="left" rowspan="1" colspan="1">No injury<break/><italic toggle="yes">n</italic> (%)</th><th align="left" rowspan="1" colspan="1">
<italic toggle="yes">Chi-</italic>
<sup>
<italic toggle="yes">2</italic>
</sup>
</th><th align="left" rowspan="1" colspan="1">
<italic toggle="yes">P-value</italic>
</th></tr></thead><tbody><tr><td align="left" rowspan="3" colspan="1">
<bold>Infection status</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>Co-infection</bold>
<break/>
<bold>Malaria/ Typhoid -56)</bold>
<break/>
<bold><italic toggle="yes">n</italic> (%)</bold>
</td><td align="left" rowspan="1" colspan="1">29<break/>(51.8)</td><td align="left" rowspan="1" colspan="1">23<break/>(41.1)</td><td align="left" rowspan="1" colspan="1">2<break/>(3.6)</td><td align="left" rowspan="1" colspan="1">2<break/>(3.6)</td><td align="left" rowspan="3" colspan="1">
<bold>18.03</bold>
</td><td align="left" rowspan="3" colspan="1">
<bold>0.0001*</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Mono-infection</bold>
<break/>
<bold>Malaria (N&#x02009;=&#x02009;73)</bold>
<break/>
<bold><italic toggle="yes">n</italic> (%)</bold>
</td><td align="left" rowspan="1" colspan="1">28<break/>(38.4)</td><td align="left" rowspan="1" colspan="1">19<break/>(26.0)</td><td align="left" rowspan="1" colspan="1">10<break/>(13.7)</td><td align="left" rowspan="1" colspan="1">16<break/>(21.9)</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Mono-infection</bold>
<break/>
<bold>Typhoid (N&#x02009;=&#x02009;50) <italic toggle="yes">n</italic> (%)</bold>
</td><td align="left" rowspan="1" colspan="1">5<break/>(10.0)</td><td align="left" rowspan="1" colspan="1">28<break/>(56.0)</td><td align="left" rowspan="1" colspan="1">2<break/>(4.0)</td><td align="left" rowspan="1" colspan="1">15<break/>(30.0)</td></tr><tr><td align="left" rowspan="3" colspan="1">
<bold>Parasitemia (Trophozoite/&#x000b5;L)</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>&#x0003e; 2500 (N&#x02009;=&#x02009;23)</bold>
<break/>
<bold><italic toggle="yes">n</italic> (%)</bold>
</td><td align="left" rowspan="1" colspan="1">15 (65.2)</td><td align="left" rowspan="1" colspan="1">5<break/>(21.7)</td><td align="left" rowspan="1" colspan="1">1<break/>(4.3)</td><td align="left" rowspan="1" colspan="1">2<break/>(8.7)</td><td align="left" rowspan="3" colspan="1">
<bold>9.80</bold>
</td><td align="left" rowspan="3" colspan="1">
<bold>0.0074*</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>[500&#x02013;2500] (N&#x02009;=&#x02009;63)</bold>
<break/>
<bold><italic toggle="yes">n</italic> (%)</bold>
</td><td align="left" rowspan="1" colspan="1">28 (44.4)</td><td align="left" rowspan="1" colspan="1">14<break/>(22.2)</td><td align="left" rowspan="1" colspan="1">9<break/>(14.3)</td><td align="left" rowspan="1" colspan="1">12<break/>(19.0)</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>&#x0003c; 500 (N&#x02009;=&#x02009;43)</bold>
<break/>
<bold><italic toggle="yes">n</italic> (%)</bold>
</td><td align="left" rowspan="1" colspan="1">14 (32.6)</td><td align="left" rowspan="1" colspan="1">23<break/>(53.5)</td><td align="left" rowspan="1" colspan="1">2<break/>(4.7)</td><td align="left" rowspan="1" colspan="1">4<break/>(9.3)</td></tr><tr><td align="left" rowspan="3" colspan="1">
<bold>Time taken before consultation</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>&#x0003e; 7 days (<italic toggle="yes">N&#x02009;=&#x02009;13</italic>)</bold>
<break/>
<bold><italic toggle="yes">n</italic> (%)</bold>
</td><td align="left" rowspan="1" colspan="1">11<break/>(84.6)</td><td align="left" rowspan="1" colspan="1">1<break/>(7.7)</td><td align="left" rowspan="1" colspan="1">0<break/>(0.0)</td><td align="left" rowspan="1" colspan="1">1<break/>(7.7)</td><td align="left" rowspan="3" colspan="1">
<bold>13.29</bold>
</td><td align="left" rowspan="3" colspan="1">
<bold>0.0013*</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>[3&#x02013;7] days (<italic toggle="yes">N&#x02009;=&#x02009;91</italic>)</bold>
<break/>
<bold><italic toggle="yes">n</italic> (%)</bold>
</td><td align="left" rowspan="1" colspan="1">35<break/>(38.5)</td><td align="left" rowspan="1" colspan="1">37<break/>(40.7)</td><td align="left" rowspan="1" colspan="1">4<break/>(4.4)</td><td align="left" rowspan="1" colspan="1">15<break/>(16.5)</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>&#x0003c; 3 days (<italic toggle="yes">N&#x02009;=&#x02009;75</italic>)</bold>
<break/>
<bold><italic toggle="yes">n</italic> (%)</bold>
</td><td align="left" rowspan="1" colspan="1">16<break/>(21.3)</td><td align="left" rowspan="1" colspan="1">32<break/>(42.7)</td><td align="left" rowspan="1" colspan="1">10<break/>(13.3)</td><td align="left" rowspan="1" colspan="1">17<break/>(22.7)</td></tr><tr><td align="left" rowspan="3" colspan="1">
<bold>Place of care</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>Herbalism (<italic toggle="yes">N&#x02009;=&#x02009;11</italic>)</bold>
<break/>
<bold><italic toggle="yes">n</italic> (%)</bold>
</td><td align="left" rowspan="1" colspan="1">3<break/>(27.3)</td><td align="left" rowspan="1" colspan="1">7<break/>(63.6)</td><td align="left" rowspan="1" colspan="1">0<break/>(0.0)</td><td align="left" rowspan="1" colspan="1">1<break/>(9.1)</td><td align="left" rowspan="3" colspan="1">2.78</td><td align="left" rowspan="3" colspan="1">0.248</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Self-</bold>
<break/>
<bold>Medication (<italic toggle="yes">N&#x02009;=&#x02009;73</italic>)</bold>
<break/>
<bold><italic toggle="yes">n</italic> (%)</bold>
</td><td align="left" rowspan="1" colspan="1">30<break/>(41.1)</td><td align="left" rowspan="1" colspan="1">25<break/>(34.2)</td><td align="left" rowspan="1" colspan="1">6<break/>(8.2)</td><td align="left" rowspan="1" colspan="1">12<break/>(16.4)</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Health Center (<italic toggle="yes">N&#x02009;=&#x02009;95</italic>)</bold>
<break/>
<bold><italic toggle="yes">n</italic> (%)</bold>
</td><td align="left" rowspan="1" colspan="1">29<break/>(30.5)</td><td align="left" rowspan="1" colspan="1">38<break/>(40.0)</td><td align="left" rowspan="1" colspan="1">8<break/>(8.4)</td><td align="left" rowspan="1" colspan="1">20<break/>(21.1)</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t009fn001"><p>
<italic toggle="yes">The bold Chi-2 and P-value are indicators of a significant association</italic>
</p></fn></table-wrap-foot></table-wrap><p>The risk factors significantly associated with the occurrence of liver damage were respectively: infection status (Chi-squared&#x02009;=&#x02009;18.03; P&#x02009;=&#x02009;0.0001), time taken before consultation (Chi-squared&#x02009;=&#x02009;13.29; P&#x02009;=&#x02009;0.0013), and parasitemia (Chi-squared&#x02009;=&#x02009;9.80; P&#x02009;=&#x02009;0.0074). No significant association was found between the occurrence of liver damage and the place of treatment (Chi-squared&#x02009;=&#x02009;2.78; P&#x02009;=&#x02009;0.248).</p></sec></sec><sec sec-type="conclusions" id="sec032"><title>Discussion</title><p>Malaria and typhoid fever continue to be endemic in tropical regions, particularly in sub-Saharan Africa, including Cameroon, where they represent a significant public health concern, causing hundreds of thousands of fatalities annually. Current diagnostic procedures and management approaches fail to evaluate liver damage in infected individuals. Even though the causative organisms, <italic toggle="yes">Plasmodium</italic> species for malaria and <italic toggle="yes">Salmonella</italic> serotypes for typhoid fever, have a critical hepatic phase in their pathogenic mechanisms, this aspect is often overlooked. Neglecting liver health can lead to adverse consequences that increase morbidity and mortality due to complications from liver injuries. Accordingly, continuous monitoring of biomarkers of liver injury in patients infected with malaria, typhoid, or both could help avert or lessen fatalities associated with liver damage. Thus, the present study aimed to identify the risk factors linked to liver damage in malaria, typhoid, and malaria-typhoid co-infected patients among febrile patients attending the CMA of Obili and the CHD of Mvog-Betsi in Yaound&#x000e9;, while also emphasizing the patient&#x02019;s attitudes towards adherence to preventive strategies and the effective management of these conditions.</p><p>Out of the 350 feverish patients enrolled in this study, microscopic and serological diagnoses revealed an overall prevalence of 51.14% (197/350) for at least one infection. The infection rates of malaria and typhoid fever were 36.86% (129/350) and 30.29% (106/350), respectively, with a co-infection prevalence of 16.00% (56/350). Although the prevalence of malaria and typhoid observed in this study is lower than their respective prevalence reported by Kouam et al. (2023), who found a malaria prevalence of 75% (113/150) among febrile patients consulting at the Deido District Hospital in Douala, Cameroon, and by Nodem et al. (2023), who reported a typhoid fever prevalence of 64.3% (133/208) among febrile patients attending the regional hospital in the city of Ngaound&#x000e9;r&#x000e9;, the headquarters of the Adamawa region of Cameroon. These results, on one hand, confirm that malaria is still endemic in Cameroon, and the female Anopheles mosquitoes, the vectors responsible for its transmission, are proliferating everywhere in Cameroon, regardless of the city or region considered. Indeed, malaria accounts for nearly one-quarter of consultations and almost half of hospital admissions in Cameroon, with 2.9 million cases recorded in 2020, resulting in 4,000 fatalities [<xref rid="pone.0319547.ref030" ref-type="bibr">30</xref>]. On the other hand, the low prevalence of typhoid fever obtained in this study, compared to that of other Cameroonian cities such as Ngaound&#x000e9;r&#x000e9;, could be attributed to the more challenging access to good water quality in the city of Ngaound&#x000e9;r&#x000e9;, as compared to Yaound&#x000e9;. It should be noted that the diagnosis of typhoid fever was based solely on the Widal test. Although still widely used in resource-limited countries including Cameroon, the Widal test has been criticized for having lower sensitivity and specificity compared to the isolation of <italic toggle="yes">Salmonella typhi</italic> bacteria through blood culture, which is considered the gold standard method for the diagnosis of typhoid fever [<xref rid="pone.0319547.ref031" ref-type="bibr">31</xref>]. This can, therefore, be regarded as a limitation of this study.</p><p>The transmission of malaria and typhoid fever is well known to be favored by deplorable socio-economic conditions [<xref rid="pone.0319547.ref008" ref-type="bibr">8</xref>,<xref rid="pone.0319547.ref032" ref-type="bibr">32</xref>]. Accordingly, this study analyzed the influence of socio-demographic characteristics on the rates of malaria and typhoid infection. Our results showed that men were more affected than women by both malaria and typhoid fever. This observation could be justified by the fact that men are more exposed to mosquito bites compared to women, likely because they tend to spend more time outside due to their daily activities. Additionally, given that one of the major routes of typhoid fever transmission is through the ingestion of contaminated water and/or food [<xref rid="pone.0319547.ref008" ref-type="bibr">8</xref>], men are at a higher risk of contracting Salmonella infection because they are more likely to consume roadside food where adherence to basic hygiene rules is not always respected during the cooking process [<xref rid="pone.0319547.ref033" ref-type="bibr">33</xref>]. It was also observed that patients aged above 60 years were less affected by malaria or typhoid fever when compared to patients in other age groups. This could be explained by the fact that older people may have a better knowledge about the diseases and are more likely to strictly follow the preventive measures compared to younger patients. In addition, patients living in houses where pit latrines are used as a model of sanitation were significantly at risk (RR&#x02009;=&#x02009;1.92; P&#x02009;&#x0003c;&#x02009;0.0001) of being exposed to typhoid fever compared to those using water system toilets. Indeed, pit latrines are naturally unsanitary and are more susceptible to facilitating the fecal -oral transmission of Salmonella species. Furthermore, the use of tap water as a source of running or drinking water was significantly (RR&#x02009;=&#x02009;2.38; P&#x02009;&#x0003c;&#x02009;0.0001) associated with Salmonella infection. Considering the waterborne nature of typhoid fever, a treatment step such as filtration or boiling of tap water, and even spring, well, and borehole water prior to use could be beneficial in avoiding typhoid fever in endemic areas.</p><p>Despite being caused by different pathogens and transmitted in various ways, malaria and typhoid fever exhibit similar symptoms [<xref rid="pone.0319547.ref034" ref-type="bibr">34</xref>]. Accordingly, the associations between the clinical symptoms experienced by febrile patients and the infection rate of each disease were assessed. Febrile patients presenting clinical symptoms such as fever, headaches, chills, and muscle aches were significantly at risk (RR&#x02009;&#x0003e;&#x02009;2.66; P&#x02009;&#x0003c;&#x02009;0.0001) of being infected by malaria parasites, while abdominal pain, asthenia, and vomiting were significantly (RR&#x02009;&#x0003e;&#x02009;2.14; P&#x02009;&#x0003c;&#x02009;0.0001) associated with typhoid fever. These observations corroborate previous findings that report gastrointestinal complaints like abdominal pain and vomiting are predominantly seen in typhoid fever, while persistent fever, headaches, muscle pain, and chills are the most frequent symptoms found in malaria-infected patients [<xref rid="pone.0319547.ref033" ref-type="bibr">33</xref>&#x02013;<xref rid="pone.0319547.ref035" ref-type="bibr">35</xref>]. However, it is important to mention that only 51.14% (179/350) of the febrile patients enrolled in the study were diagnosed with either malaria or typhoid fever. This observation highlights the need for proper diagnosis before any treatment, despite the presence of clinical symptoms, to avoid self-medication or misuse of drugs, which can exacerbate the patient&#x02019;s condition</p><p>To better understand the reason behind the persistent high prevalence of typhoid fever and malaria among febrile patients, their attitudes toward adherence to preventive measures were assessed. This included their compliance with vector control strategies, such as maintaining a clean environment near their homes, using long-lasting treated mosquito nets, applying mosquito spray insecticides, and utilizing intermittent prophylaxis for malaria control; as well as adhering to basic hygiene rules, including hand washing before meals, washing fruits and vegetables before consumption, and proper garbage disposal for typhoid control. Results from this study revealed that up to 28% (99/350), 16.3% (50/350), 32.3% (113/350), and 37.7% (152/350) of the febrile patients stayed out late at night, had standing-water near their homes, had bushes near their homes, and were irregular or non-users of mosquito nets, respectively. Coincidentally, they were significantly at risk (RR&#x02009;&#x0003e;&#x02009;2; P&#x02009;&#x0003c;&#x02009;0.0001) of being infected by <italic toggle="yes">Plasmodium</italic> species. Indeed, risky behaviors such as staying outside late at night, retaining standing water or bushes near the home, and the inconsistent use of mosquito nets not only enhance the proliferation of vectors but also facilitate mosquito bites. Similar observations have been reported in previous studies conducted in Cameroon and Nigeria, two countries where malaria remains a major public health concern [<xref rid="pone.0319547.ref006" ref-type="bibr">6</xref>,<xref rid="pone.0319547.ref036" ref-type="bibr">36</xref>]. These findings indicate that a considerable proportion of the population living in malaria - endemic zones does not place sufficient value on adhering to the preventive measures necessary to counteract the transmission and propagation of malaria. Accordingly, more community health campaigns should be conducted in these endemic areas to continually enhance awareness about the effective implementation of preventive measures to combat malaria. Likewise, we observed that the presence of garbage dumps near residences were significantly (RR&#x02009;=&#x02009;2.34; P&#x02009;&#x0003c;&#x02009;0.0001) associated with typhoid fever. Indeed, garbage dumps are breeding grounds for the proliferation of bacteria such as <italic toggle="yes">Salmonella</italic> species, and their proximity to people&#x02019;s residences can facilitate the contamination of water and food, which subsequently transmits the disease through ingestion. Accordingly, maintaining a clean environment around residences is necessary to reduce the risk of infection by <italic toggle="yes">Salmonella</italic> species.</p><p>The pathogens responsible for malaria or typhoid fever have a compulsory hepatic phase throughout their infection life cycle in humans [<xref rid="pone.0319547.ref011" ref-type="bibr">11</xref>&#x02013;<xref rid="pone.0319547.ref014" ref-type="bibr">14</xref>], which can affect the liver, a key organ that performs numerous vital functions for the optimal functioning of the body [<xref rid="pone.0319547.ref006" ref-type="bibr">6</xref>,<xref rid="pone.0319547.ref015" ref-type="bibr">15</xref>,<xref rid="pone.0319547.ref016" ref-type="bibr">16</xref>]. In fact, <italic toggle="yes">Plasmodium</italic> and <italic toggle="yes">Salmonella</italic> species can invade liver cells, leading to organ congestion and inflammation that ultimately results in cellular necrosis and cholestasis, characterized by an abnormal alteration of serum levels of liver enzyme activities, including transaminases: alanine aminotransferase (ALT) and aspartate aminotransferase (AST), along with alkaline phosphatase (ALP) [<xref rid="pone.0319547.ref007" ref-type="bibr">7</xref>,<xref rid="pone.0319547.ref017" ref-type="bibr">17</xref>,<xref rid="pone.0319547.ref018" ref-type="bibr">18</xref>]. The elevation of serum levels of liver enzyme activity has been reported in febrile patients suffering from malaria or typhoid fever [<xref rid="pone.0319547.ref015" ref-type="bibr">15</xref>,<xref rid="pone.0319547.ref037" ref-type="bibr">37</xref>]. Furthermore, dual infections by <italic toggle="yes">Plasmodium</italic> and <italic toggle="yes">Salmonella</italic> species are often reported in endemic areas [<xref rid="pone.0319547.ref029" ref-type="bibr">29</xref>,<xref rid="pone.0319547.ref038" ref-type="bibr">38</xref>]. As a consequence, in cases of co-infection, both <italic toggle="yes">Salmonella</italic> and <italic toggle="yes">Plasmodium</italic> species can damage liver cells, either simultaneously or successively, depending on the chronological order of infection, thus exacerbating liver impairment [<xref rid="pone.0319547.ref038" ref-type="bibr">38</xref>]. In this study, we found that independently of the infection status (malaria mono-infected, typhoid mono-infected, or malaria-typhoid co-infected) of the patients, the level of alteration of liver enzyme activities varies from mild to severe increases. However, the serum activities of these enzymes were significantly (P&#x02009;&#x0003c;&#x02009;0.05) elevated in co-infected patients compared to those with malaria or typhoid mono-infections. This observation suggests that co-infection is more likely to cause severe liver injuries than mono-infection, although the serum levels of these liver enzyme activity were at least two times greater than the upper limit of the normal range of their respective reference values. Regarding the malaria-infected patients only, we observed that patients with parasite density above 2500 trophozoites/&#x000b5;L displayed a significant (P&#x02009;&#x0003c;&#x02009;0.05) increase in serum levels of liver enzyme activities compared to those with parasite density &#x0003c;2500 trophozoites/&#x000b5;L. These results suggest that parasitemia is a risk factor that negatively affects the liver. In fact, high parasite density associated with severe forms of malaria and hepatic failure, marked by increased serum levels of liver enzyme activity, have been reported [<xref rid="pone.0319547.ref022" ref-type="bibr">22</xref>,<xref rid="pone.0319547.ref039" ref-type="bibr">39</xref>]. Based on the values of ALT and ALP activities, the types of liver injuries related to their levels of alterations were defined according to the RUCAM classification as follows: Hepatocellular, Cholestasis, and a mixed pattern of cholestasis and hepatocellular damages. The Chi- squared analysis revealed that the infection status (Chi-<sup>2</sup>&#x02009;=&#x02009;18.03; P&#x02009;&#x0003c;&#x02009;0.0001) and parasite density (Chi-<sup>2</sup>&#x02009;=&#x02009;9.80; P&#x02009;=&#x02009;0.0074) were significant risk factors for liver damages. Moreover, 51.8% (29/56) of co-infected patients were more likely to develop mixed injuries compared to malaria mono-infected (38.4%; 28/73) or typhoid mono-infected (10%; 5/10) patients. Likewise, 65.2% (15/23) of malaria-infected patients with a parasitemia greater than 2500 trophozoites/&#x000b5;L displayed a mixed injury, compared to 44.4% (28/63) and 32.6% (14/43) for patients with parasite densities between [500&#x02013;2500] or less than 500 trophozoites/&#x000b5;L respectively. These findings suggest that high parasite density is a significant risk factor for developing severe liver injury and potential liver failure, which may be fatal to patients.</p><p>Consulting in an authorized health center immediately after the onset of the first symptoms is crucial for effective treatment of malaria and typhoid fever. Additionally, it has been shown that delays in seeking medical care after the initial symptoms of malaria or typhoid fever increase the risk of developing severe liver injury, characterized by high serum levels of liver enzyme activity [<xref rid="pone.0319547.ref006" ref-type="bibr">6</xref>,<xref rid="pone.0319547.ref038" ref-type="bibr">38</xref>&#x02013;<xref rid="pone.0319547.ref040" ref-type="bibr">40</xref>]. In this study, we observed that infected patients who spent more than seven days before seeking medical care exhibited a significant (P&#x02009;&#x0003c;&#x02009;0.05) increase in serum levels of liver enzyme activity compared to those who consulted before three days or between three and seven days. Regarding the initial place of treatment: health center, self-medication, or herbalism, no significant difference (P&#x02009;&#x0003e;&#x02009;0.05) was observed in the serum levels of liver enzyme activity, although the serum levels of these liver enzyme activities were at least two times greater than the upper limit of the normal range of their respective reference values for each group considered. These findings suggest that the serum levels of liver enzyme activity and the potential types of liver damage observed in infected patients are related to the time taken before consultation after the appearance of the first symptoms, whereas this is not the case with the place of treatment. These observations were confirmed by the Chi- squared analysis, which showed a significant association (Chi-&#x000b2;&#x02009;=&#x02009;13.29; P&#x02009;=&#x02009;0.0013) between the time elapsed before consultation and the occurrence of liver damage, and a non-significant association (Chi-&#x000b2;&#x02009;=&#x02009;2.78; P&#x02009;=&#x02009;0.248) between the place of treatment and the occurrence of liver damage. Furthermore, patients with a time before consultation greater than seven days (84.6%; 11/13) were more likely to develop mixed injury compared to those consulting between three to seven days (38.5%; 35/91) or within three days (21.3%; 16/75) after the onset of the first symptoms. Based on these findings, it is recommended that febrile patients refer immediately to an appropriate health center for medical attention as soon as they manifest clinical symptoms of malaria or typhoid fever. This could be helpful in preventing the occurrence of severe liver injuries often associated with the high mortality rate of malaria and typhoid fever.</p></sec><sec sec-type="conclusions" id="sec033"><title>Conclusion</title><p>As we reach the conclusion of this study, which aimed to determine the type of liver damage and associated risk factors in malaria, typhoid fever, or malaria-typhoid co-infected patients among febrile individuals consulting at the Obili District Medical Center (CMA) and the Dominican Hospital Center (CHD) Saint Martin de Porres in Mvog-Betsi, Yaound&#x000e9;, Cameroon, it can be concluded that adherence to preventive measures against malaria and typhoid fever was partially observed among the febrile patients. Furthermore, the infection rates were linked to risk factors such as unsanitary living conditions and the non- use of mosquito nets. Additionally, high parasite density, the malaria-typhoid co- infection status, and the delay in consulting after the appearance of the first symptoms of the diseases represented major risk factors associated with alterations in serum levels of liver enzyme activity and the occurrence of liver damages. Based on these findings, we therefore recommend that the population fully implement preventive measures against malaria and typhoid fever daily and seek medical attention immediately upon the appearance of the first symptoms of the diseases. Moreover, healthcare personnel should prescribe liver function tests to malaria, typhoid fever, or malaria-typhoid co-infected patients, especially for those with high parasite density or those attending the hospital more than seven days after the onset of the disease. This could be useful in detecting early signs of liver damage and prompting medical intervention to prevent further complications that may be fatal for the patients.</p></sec><sec id="sec034" sec-type="supplementary-material"><title>Supporting information</title><supplementary-material id="pone.0319547.s001" position="float" content-type="local-data"><label>S1 File</label><caption><title>Consent form and structured questionnaire.</title><p>(DOCX)</p></caption><media xlink:href="pone.0319547.s001.docx"/></supplementary-material><supplementary-material id="pone.0319547.s002" position="float" content-type="local-data"><label>S2 File</label><caption><title>Supplementary tables.</title><p>(DOCX)</p></caption><media xlink:href="pone.0319547.s002.docx"/></supplementary-material><supplementary-material id="pone.0319547.s003" position="float" content-type="local-data"><label>S3 File</label><caption><title>General database.</title><p>(XLSX)</p></caption><media xlink:href="pone.0319547.s003.xlsx"/></supplementary-material></sec></body><back><ack><p>The authors express their gratitude to all participants involved in this study and acknowledge the laboratory staff at the Obili District Medical Center for their technical assistance.</p></ack><ref-list><title>References</title><ref id="pone.0319547.ref001"><label>1</label><mixed-citation publication-type="journal"><collab>WHO</collab>. World Health Organization/news-room/fact-sheets/detail/typhoid. <year>2023</year> [cited 17 Jan 2025]. Available: <ext-link xlink:href="https://www.who.int/news-room/fact-sheets/detail/typhoid" ext-link-type="uri">https://www.who.int/news-room/fact-sheets/detail/typhoid</ext-link></mixed-citation></ref><ref id="pone.0319547.ref002"><label>2</label><mixed-citation publication-type="journal"><name><surname>Venkatesan</surname><given-names>P</given-names></name>. <article-title>The 2023 WHO World malaria report</article-title>. <source>Lancet Microbe</source>. <year>2024</year>;<volume>5</volume>(<issue>3</issue>):e214. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/S2666-5247(24)00016-8</pub-id>
<pub-id pub-id-type="pmid">38309283</pub-id>
</mixed-citation></ref><ref id="pone.0319547.ref003"><label>3</label><mixed-citation publication-type="journal"><name><surname>Sutherland</surname><given-names>CJ</given-names></name>. <article-title>Persistent Parasitism: The Adaptive Biology of Malariae and Ovale Malaria</article-title>. <source>Trends Parasitol</source>. <year>2016</year>;<volume>32</volume>(<issue>10</issue>):<fpage>808</fpage>&#x02013;<lpage>19</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.pt.2016.07.001</pub-id>
<pub-id pub-id-type="pmid">27480365</pub-id>
</mixed-citation></ref><ref id="pone.0319547.ref004"><label>4</label><mixed-citation publication-type="journal"><name><surname>Sato</surname><given-names>S</given-names></name>. <article-title>Plasmodium-a brief introduction to the parasites causing human malaria and their basic biology</article-title>. <source>J Physiol Anthropol</source>. <year>2021</year>;<volume>40</volume>(<issue>1</issue>):<fpage>1</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s40101-020-00251-9</pub-id>
<pub-id pub-id-type="pmid">33413683</pub-id>
</mixed-citation></ref><ref id="pone.0319547.ref005"><label>5</label><mixed-citation publication-type="journal"><collab>WHO</collab>. World Health Organization/World malaria report 2023. <year>2023</year> [cited 17 Jan 2025]. Available: <ext-link xlink:href="https://www.who.int/teams/global-malaria-programme/reports/world-malaria-report-2023" ext-link-type="uri">https://www.who.int/teams/global-malaria-programme/reports/world-malaria-report-2023</ext-link></mixed-citation></ref><ref id="pone.0319547.ref006"><label>6</label><mixed-citation publication-type="journal"><name><surname>Kouam</surname><given-names>AF</given-names></name>, <name><surname>Ngoum&#x000e9;</surname><given-names>NAN</given-names></name>, <name><surname>Fepa</surname><given-names>AGK</given-names></name>, <name><surname>Wainfen</surname><given-names>Z</given-names></name>, <name><surname>Ngounou</surname><given-names>E</given-names></name>, <name><surname>Galani</surname><given-names>BRT</given-names></name>, <etal>et al</etal>. <article-title>Liver injury in malaria infected patients in Douala-Cameroon and its association with poor medical practice</article-title>. <source>Egypt Liver Journal</source>. <year>2023</year>;<volume>13</volume>(<issue>1</issue>). <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s43066-023-00300-9</pub-id></mixed-citation></ref><ref id="pone.0319547.ref007"><label>7</label><mixed-citation publication-type="journal"><name><surname>Parry</surname><given-names>CM</given-names></name>, <name><surname>Hien</surname><given-names>TT</given-names></name>, <name><surname>Dougan</surname><given-names>G</given-names></name>, <name><surname>White</surname><given-names>NJ</given-names></name>, <name><surname>Farrar</surname><given-names>JJ</given-names></name>. <article-title>Typhoid fever</article-title>. <source>N Engl J Med</source>. <year>2002</year>;<volume>347</volume>(<issue>22</issue>):<fpage>1770</fpage>&#x02013;<lpage>82</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1056/NEJMra020201</pub-id>
<pub-id pub-id-type="pmid">12456854</pub-id>
</mixed-citation></ref><ref id="pone.0319547.ref008"><label>8</label><mixed-citation publication-type="journal"><name><surname>Faruku</surname><given-names>N</given-names></name>, <name><surname>Sarkinfada</surname><given-names>F</given-names></name>, <name><surname>Hafiz</surname><given-names>TR</given-names></name>, <name><surname>Magaji</surname><given-names>UF</given-names></name>, <name><surname>Idris</surname><given-names>AK</given-names></name>, <name><surname>Musa</surname><given-names>S</given-names></name>, <etal>et al</etal>. <article-title>Socio-Demographic Factors Affecting the Prevalence of Typhoid Fever Among Febrile Patients in Kebbi State, Nigeria</article-title>. <source>dujopas</source>. <year>2024</year>;<volume>10</volume>(1c):<fpage>263</fpage>&#x02013;<lpage>74</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.4314/dujopas.v10i1c.25</pub-id></mixed-citation></ref><ref id="pone.0319547.ref009"><label>9</label><mixed-citation publication-type="journal"><name><surname>Akwa</surname><given-names>T</given-names></name>, <name><surname>Simone</surname><given-names>N</given-names></name>. I<article-title>nvestigation of Typhoid Fever and their Associated Risk Factors in Children Attending &#x0201c;Deo Gratias&#x0201d; Hospital in Douala, Littoral, Cameroon</article-title>. <source>Eur J Med Educ Technol</source>. <year>2021</year>;<volume>14</volume>: em2107. <comment>doi: </comment><pub-id pub-id-type="doi">10.30935/ejmets/10910</pub-id></mixed-citation></ref><ref id="pone.0319547.ref010"><label>10</label><mixed-citation publication-type="journal"><name><surname>Njoya</surname><given-names>HF</given-names></name>, <name><surname>Awolu</surname><given-names>MM</given-names></name>, <name><surname>Christopher</surname><given-names>TB</given-names></name>, <name><surname>Duclerc</surname><given-names>JF</given-names></name>, <name><surname>Ateudjieu</surname><given-names>J</given-names></name>, <name><surname>Wirsiy</surname><given-names>FS</given-names></name>, <etal>et al</etal>. <article-title>Prevalence and awareness of mode of transmission of typhoid fever in patients diagnosed with Salmonella typhi and paratyphi infections at the Saint Elisabeth General Hospital Shisong, Bui Division, Cameroon</article-title>. <source>Pan Afr Med J</source>. <year>2021</year>;<volume>40</volume>:<fpage>83</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.11604/pamj.2021.40.83.16893</pub-id>
<pub-id pub-id-type="pmid">34909072</pub-id>
</mixed-citation></ref><ref id="pone.0319547.ref011"><label>11</label><mixed-citation publication-type="journal"><name><surname>Chora</surname><given-names>&#x000c2;F</given-names></name>, <name><surname>Mota</surname><given-names>MM</given-names></name>, <name><surname>Prud&#x000ea;ncio</surname><given-names>M</given-names></name>. <article-title>The reciprocal influence of the liver and blood stages of the malaria parasite&#x02019;s life cycle</article-title>. <source>Int J Parasitol</source>. <year>2022</year>;<volume>52</volume>(<issue>11</issue>):<fpage>711</fpage>&#x02013;<lpage>5</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.ijpara.2022.02.002</pub-id>
<pub-id pub-id-type="pmid">35367213</pub-id>
</mixed-citation></ref><ref id="pone.0319547.ref012"><label>12</label><mixed-citation publication-type="journal"><name><surname>Li</surname><given-names>Y-T</given-names></name>, <name><surname>Yu</surname><given-names>C-B</given-names></name>, <name><surname>Yan</surname><given-names>D</given-names></name>, <name><surname>Huang</surname><given-names>J-R</given-names></name>, <name><surname>Li</surname><given-names>L-J</given-names></name>. <article-title>Effects of Salmonella infection on hepatic damage following acute liver injury in rats</article-title>. <source>Hepatobiliary Pancreat Dis Int</source>. <year>2016</year>;<volume>15</volume>(<issue>4</issue>):<fpage>399</fpage>&#x02013;<lpage>405</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/s1499-3872(16)60113-3</pub-id>
<pub-id pub-id-type="pmid">27498580</pub-id>
</mixed-citation></ref><ref id="pone.0319547.ref013"><label>13</label><mixed-citation publication-type="journal"><name><surname>Vaughan</surname><given-names>AM</given-names></name>, <name><surname>Kappe</surname><given-names>SHI</given-names></name>. <article-title>Malaria Parasite Liver Infection and Exoerythrocytic Biology</article-title>. <source>Cold Spring Harb Perspect Med</source>. <year>2017</year>;<volume>7</volume>(<issue>6</issue>):a025486. <comment>doi: </comment><pub-id pub-id-type="doi">10.1101/cshperspect.a025486</pub-id>
<pub-id pub-id-type="pmid">28242785</pub-id>
</mixed-citation></ref><ref id="pone.0319547.ref014"><label>14</label><mixed-citation publication-type="journal"><name><surname>Yang</surname><given-names>ASP</given-names></name>, <name><surname>Dutta</surname><given-names>D</given-names></name>, <name><surname>Kretzschmar</surname><given-names>K</given-names></name>, <name><surname>Hendriks</surname><given-names>D</given-names></name>, <name><surname>Puschhof</surname><given-names>J</given-names></name>, <name><surname>Hu</surname><given-names>H</given-names></name>, <etal>et al</etal>. <article-title>Development of Plasmodium falciparum liver-stages in hepatocytes derived from human fetal liver organoid cultures</article-title>. <source>Nat Commun</source>. <year>2023</year>;<volume>14</volume>(<issue>1</issue>):<fpage>4631</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41467-023-40298-7</pub-id>
<pub-id pub-id-type="pmid">37532704</pub-id>
</mixed-citation></ref><ref id="pone.0319547.ref015"><label>15</label><mixed-citation publication-type="journal"><name><surname>Karoli</surname><given-names>R</given-names></name>, <name><surname>Fatima</surname><given-names>J</given-names></name>, <name><surname>Chandra</surname><given-names>A</given-names></name>, <name><surname>Singh</surname><given-names>G</given-names></name>. <article-title>Salmonella hepatitis: an uncommon complication of a common disease</article-title>. <source>J Family Med Prim Care</source>. <year>2012</year>;<volume>1</volume>(<issue>2</issue>):<fpage>160</fpage>&#x02013;<lpage>2</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.4103/2249-4863.104992</pub-id>
<pub-id pub-id-type="pmid">24479030</pub-id>
</mixed-citation></ref><ref id="pone.0319547.ref016"><label>16</label><mixed-citation publication-type="journal"><name><surname>Ratnayake</surname><given-names>EC</given-names></name>, <name><surname>Shivanthan</surname><given-names>C</given-names></name>, <name><surname>Wijesiriwardena</surname><given-names>BC</given-names></name>. <article-title>Cholestatic hepatitis in a patient with typhoid fever - a case report</article-title>. <source>Ann Clin Microbiol Antimicrob</source>. <year>2011</year>;<volume>10</volume>:<fpage>35</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/1476-0711-10-35</pub-id>
<pub-id pub-id-type="pmid">21982051</pub-id>
</mixed-citation></ref><ref id="pone.0319547.ref017"><label>17</label><mixed-citation publication-type="journal"><name><surname>Gonz&#x000e1;lez-Quintela</surname><given-names>A</given-names></name>, <name><surname>Campos</surname><given-names>J</given-names></name>, <name><surname>Alende</surname><given-names>R</given-names></name>, <name><surname>L&#x000f3;pez-Soto</surname><given-names>A</given-names></name>, <name><surname>Tom&#x000e9;</surname><given-names>S</given-names></name>, <name><surname>Otero</surname><given-names>E</given-names></name>, <etal>et al</etal>. <article-title>Abnormalities in liver enzyme levels during Salmonella enteritidis enterocolitis</article-title>. <source>Rev Esp Enferm Dig</source>. <year>2004</year>;<volume>96</volume>(<issue>8</issue>):559&#x02013;62; 563&#x02013;6. <comment>doi: </comment><pub-id pub-id-type="doi">10.4321/s1130-01082004000800005</pub-id>
<pub-id pub-id-type="pmid">15449987</pub-id>
</mixed-citation></ref><ref id="pone.0319547.ref018"><label>18</label><mixed-citation publication-type="journal"><name><surname>Goswami</surname><given-names>D</given-names></name>, <name><surname>Minkah</surname><given-names>NK</given-names></name>, <name><surname>Kappe</surname><given-names>SHI</given-names></name>. <article-title>Malaria parasite liver stages</article-title>. <source>J Hepatol</source>. <year>2022</year>;<volume>76</volume>(<issue>3</issue>):<fpage>735</fpage>&#x02013;<lpage>7</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.jhep.2021.05.034</pub-id>
<pub-id pub-id-type="pmid">34711453</pub-id>
</mixed-citation></ref><ref id="pone.0319547.ref019"><label>19</label><mixed-citation publication-type="journal"><name><surname>Morgenstern</surname><given-names>R</given-names></name>, <name><surname>Hayes</surname><given-names>PC</given-names></name>. <article-title>The liver in typhoid fever: always affected, not just a complication</article-title>. <source>Am J Gastroenterol</source>. <year>1991</year>;<volume>86</volume>(<issue>9</issue>):<fpage>1235</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="pmid">1882803</pub-id>
</mixed-citation></ref><ref id="pone.0319547.ref020"><label>20</label><mixed-citation publication-type="journal"><name><surname>Reuling</surname><given-names>IJ</given-names></name>, <name><surname>de Jong</surname><given-names>GM</given-names></name>, <name><surname>Yap</surname><given-names>XZ</given-names></name>, <name><surname>Asghar</surname><given-names>M</given-names></name>, <name><surname>Walk</surname><given-names>J</given-names></name>, <name><surname>van de Schans</surname><given-names>LA</given-names></name>, <etal>et al</etal>. <article-title>Liver Injury in Uncomplicated Malaria is an Overlooked Phenomenon: An Observational Study</article-title>. <source>EBioMedicine</source>. <year>2018</year>;<volume>36</volume>:<fpage>131</fpage>&#x02013;<lpage>9</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.ebiom.2018.09.018</pub-id>
<pub-id pub-id-type="pmid">30243492</pub-id>
</mixed-citation></ref><ref id="pone.0319547.ref021"><label>21</label><mixed-citation publication-type="journal"><name><surname>Husain</surname><given-names>EH</given-names></name>. <article-title>Fulminant hepatitis in typhoid fever</article-title>. <source>J Infect Public Health</source>. <year>2011</year>;<volume>4</volume>(<issue>3</issue>):<fpage>154</fpage>&#x02013;<lpage>6</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.jiph.2011.04.003</pub-id>
<pub-id pub-id-type="pmid">21843862</pub-id>
</mixed-citation></ref><ref id="pone.0319547.ref022"><label>22</label><mixed-citation publication-type="journal"><name><surname>Rupani</surname><given-names>AB</given-names></name>, <name><surname>Amarapurkar</surname><given-names>AD</given-names></name>. <article-title>Hepatic changes in fatal malaria: an emerging problem</article-title>. <source>Ann Trop Med Parasitol</source>. <year>2009</year>;<volume>103</volume>(<issue>2</issue>):<fpage>119</fpage>&#x02013;<lpage>27</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1179/136485909X385054</pub-id>
<pub-id pub-id-type="pmid">19208296</pub-id>
</mixed-citation></ref><ref id="pone.0319547.ref023"><label>23</label><mixed-citation publication-type="journal"><name><surname>Viriyavejakul</surname><given-names>P</given-names></name>, <name><surname>Khachonsaksumet</surname><given-names>V</given-names></name>, <name><surname>Punsawad</surname><given-names>C</given-names></name>. <article-title>Liver changes in severe Plasmodium falciparum malaria: histopathology, apoptosis and nuclear factor kappa B expression</article-title>. <source>Malar J</source>. <year>2014</year>;<volume>13</volume>:<fpage>106</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/1475-2875-13-106</pub-id>
<pub-id pub-id-type="pmid">24636003</pub-id>
</mixed-citation></ref><ref id="pone.0319547.ref024"><label>24</label><mixed-citation publication-type="book"><name><surname>R&#x000e9;my Ndam Ngoupayou</surname><given-names>J</given-names></name>, <name><surname>Firmin Bon</surname><given-names>A</given-names></name>, <name><surname>Ewodo Mboudou</surname><given-names>G</given-names></name>, <name><surname>Ngouh Abdou</surname><given-names>N</given-names></name>, <name><surname>Emmanuel Ekodeck</surname><given-names>G</given-names></name>. <article-title>Hydrogeological Characteristics of Shallow Hard Rock Aquifers in Yaounde (Cameroon, Central Africa)</article-title>. <source>Groundwater Hydrology</source>. <publisher-name>IntechOpen</publisher-name>. <year>2020</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.5772/intechopen.84631</pub-id></mixed-citation></ref><ref id="pone.0319547.ref025"><label>25</label><mixed-citation publication-type="journal"><name><surname>Galani</surname><given-names>BRT</given-names></name>, <name><surname>Mapouokam</surname><given-names>DW</given-names></name>, <name><surname>Simo</surname><given-names>FBN</given-names></name>, <name><surname>Mohamadou</surname><given-names>H</given-names></name>, <name><surname>Chuisseu</surname><given-names>PDD</given-names></name>, <name><surname>Njintang</surname><given-names>NY</given-names></name>, <etal>et al</etal>. <article-title>Investigation of dengue-malaria coinfection among febrile patients consulting at Ngaoundere Regional Hospital, Cameroon</article-title>. <source>J Med Virol</source>. <year>2021</year>;<volume>93</volume>(<issue>6</issue>):<fpage>3350</fpage>&#x02013;<lpage>61</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1002/jmv.26732</pub-id>
<pub-id pub-id-type="pmid">33325045</pub-id>
</mixed-citation></ref><ref id="pone.0319547.ref026"><label>26</label><mixed-citation publication-type="journal"><name><surname>Nyasa</surname><given-names>RB</given-names></name>, <name><surname>Fotabe</surname><given-names>EL</given-names></name>, <name><surname>Ndip</surname><given-names>RN</given-names></name>. <article-title>Trends in malaria prevalence and risk factors associated with the disease in Nkongho-mbeng; a typical rural setting in the equatorial rainforest of the South West Region of Cameroon</article-title>. <source>PLoS One</source>. <year>2021</year>;<volume>16</volume>(<issue>5</issue>):e0251380. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.pone.0251380</pub-id>
<pub-id pub-id-type="pmid">34003847</pub-id>
</mixed-citation></ref><ref id="pone.0319547.ref027"><label>27</label><mixed-citation publication-type="journal"><name><surname>Sumbele</surname><given-names>IUN</given-names></name>, <name><surname>Ning</surname><given-names>TR</given-names></name>, <name><surname>Bopda</surname><given-names>OSM</given-names></name>, <name><surname>Nkuo-Akenji</surname><given-names>T</given-names></name>. <article-title>Variation in malariometric and red cell indices in children in the Mount Cameroon area following enhanced malaria control measures: evidence from a repeated cross-sectional study</article-title>. <source>Malar J</source>. <year>2014</year>;<volume>13</volume>:<fpage>334</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/1475-2875-13-334</pub-id>
<pub-id pub-id-type="pmid">25156237</pub-id>
</mixed-citation></ref><ref id="pone.0319547.ref028"><label>28</label><mixed-citation publication-type="book"><collab>NIH</collab>. <source>Roussel uclaf causality assessment method (rucam) in drug induced liver injury</source>. <publisher-loc>Bethesda (MD)</publisher-loc>: <publisher-name>National Institute of Diabetes and Digestive and Kidney Diseases</publisher-name>. <year>2012</year>. <ext-link xlink:href="http://www.ncbi.nlm.nih.gov/books/NBK548272/" ext-link-type="uri">http://www.ncbi.nlm.nih.gov/books/NBK548272/</ext-link></mixed-citation></ref><ref id="pone.0319547.ref029"><label>29</label><mixed-citation publication-type="journal"><name><surname>Sohanang Nodem</surname><given-names>FS</given-names></name>, <name><surname>Ymele</surname><given-names>D</given-names></name>, <name><surname>Fadimatou</surname><given-names>M</given-names></name>, <name><surname>Fodouop</surname><given-names>S-PC</given-names></name>. <article-title>Malaria and Typhoid Fever Coinfection among Febrile Patients in Ngaound&#x000e9;r&#x000e9; (Adamawa, Cameroon): A Cross-Sectional Study</article-title>. <source>J Parasitol Res</source>. <year>2023</year>;2023:<fpage>5334813</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1155/2023/5334813</pub-id>
<pub-id pub-id-type="pmid">37790287</pub-id>
</mixed-citation></ref><ref id="pone.0319547.ref030"><label>30</label><mixed-citation publication-type="journal"><name><surname>Ngouakam</surname><given-names>H</given-names></name>, <name><surname>Akongem</surname><given-names>MA</given-names></name>, <name><surname>Cagetan</surname><given-names>TT</given-names></name>, <name><surname>Ngueugang</surname><given-names>ALW</given-names></name>, <name><surname>Tientche</surname><given-names>B</given-names></name>, <name><surname>Nsagha</surname><given-names>DS</given-names></name>. <article-title>Assessment of Knowledge and Attitude Regarding Risk Factors of Malaria Among Caregivers of Under-Five Children in the Buea Health District, South West Region, Cameroon</article-title>. <source>IJTDH</source>. <year>2021</year>;:<fpage>36</fpage>&#x02013;<lpage>50</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.9734/ijtdh/2021/v42i2030546</pub-id></mixed-citation></ref><ref id="pone.0319547.ref031"><label>31</label><mixed-citation publication-type="journal"><name><surname>Sattar</surname><given-names>AA</given-names></name>, <name><surname>Yusuf</surname><given-names>MA</given-names></name>, <name><surname>Islam</surname><given-names>MB</given-names></name>, <name><surname>Jahan</surname><given-names>WA</given-names></name>. <article-title>Different Diagnostic Procedure of Typhoid Fever: A Review Update</article-title>. <source>J Curr Adv Med Res</source>. <year>2014</year>;<volume>1</volume>(<issue>2</issue>):<fpage>35</fpage>&#x02013;<lpage>41</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3329/jcamr.v1i2.20517</pub-id></mixed-citation></ref><ref id="pone.0319547.ref032"><label>32</label><mixed-citation publication-type="journal"><name><surname>Ebhuoma</surname><given-names>O</given-names></name>, <name><surname>Gebreslasie</surname><given-names>M</given-names></name>, <name><surname>Ogunsakin</surname><given-names>RE</given-names></name>. <article-title>Socio-economic status as predictors of malaria transmission in KwaZulu-Natal, South Africa. A retrospective study</article-title>. <source>Afr Health Sci</source>. <year>2022</year>;<volume>22</volume>(<issue>2</issue>):<fpage>204</fpage>&#x02013;<lpage>15</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.4314/ahs.v22i2.24</pub-id>
<pub-id pub-id-type="pmid">36407392</pub-id>
</mixed-citation></ref><ref id="pone.0319547.ref033"><label>33</label><mixed-citation publication-type="journal"><name><surname>Ngogo</surname><given-names>FA</given-names></name>, <name><surname>Joachim</surname><given-names>A</given-names></name>, <name><surname>Abade</surname><given-names>AM</given-names></name>, <name><surname>Rumisha</surname><given-names>SF</given-names></name>, <name><surname>Mizinduko</surname><given-names>MM</given-names></name>, <name><surname>Majigo</surname><given-names>MV</given-names></name>. <article-title>Factors associated with Salmonella infection in patients with gastrointestinal complaints seeking health care at Regional Hospital in Southern Highland of Tanzania</article-title>. <source>BMC Infect Dis</source>. <year>2020</year>;<volume>20</volume>(<issue>1</issue>):<fpage>135</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s12879-020-4849-7</pub-id>
<pub-id pub-id-type="pmid">32050928</pub-id>
</mixed-citation></ref><ref id="pone.0319547.ref034"><label>34</label><mixed-citation publication-type="journal"><name><surname>Cunha</surname><given-names>BA</given-names></name>. <article-title>Malaria or typhoid fever: a diagnostic dilemma?</article-title>. <source>Am J Med</source>. <year>2005</year>;<volume>118</volume>(<issue>12</issue>):<fpage>1442</fpage>&#x02013;<lpage>3; author reply 1443-4</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.amjmed.2005.04.033</pub-id>
<pub-id pub-id-type="pmid">16378813</pub-id>
</mixed-citation></ref><ref id="pone.0319547.ref035"><label>35</label><mixed-citation publication-type="journal"><name><surname>Forero-Pe&#x000f1;a</surname><given-names>DA</given-names></name>, <name><surname>Carri&#x000f3;n-Nessi</surname><given-names>FS</given-names></name>, <name><surname>Chavero</surname><given-names>M</given-names></name>, <name><surname>Gamardo</surname><given-names>&#x000c1;</given-names></name>, <name><surname>Figuera</surname><given-names>L</given-names></name>, <name><surname>Camejo-&#x000c1;vila</surname><given-names>NA</given-names></name>, <etal>et al</etal>. <article-title>The clinical-epidemiological profile of malaria patients from Southern Venezuela, a critical hotspot in Latin America</article-title>. <source>Malar J</source>. <year>2021</year>;<volume>20</volume>(<issue>1</issue>):<fpage>375</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s12936-021-03913-w</pub-id>
<pub-id pub-id-type="pmid">34544438</pub-id>
</mixed-citation></ref><ref id="pone.0319547.ref036"><label>36</label><mixed-citation publication-type="journal"><name><surname>Isiko</surname><given-names>I</given-names></name>, <name><surname>Nyegenye</surname><given-names>S</given-names></name>, <name><surname>Bett</surname><given-names>DK</given-names></name>, <name><surname>Asingwire</surname><given-names>JM</given-names></name>, <name><surname>Okoro</surname><given-names>LN</given-names></name>, <name><surname>Emeribe</surname><given-names>NA</given-names></name>, <etal>et al</etal>. <article-title>Factors associated with the risk of malaria among children: analysis of 2021 Nigeria Malaria Indicator Survey</article-title>. <source>Malar J</source>. <year>2024</year>;<volume>23</volume>(<issue>1</issue>):<fpage>109</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s12936-024-04939-6</pub-id>
<pub-id pub-id-type="pmid">38632581</pub-id>
</mixed-citation></ref><ref id="pone.0319547.ref037"><label>37</label><mixed-citation publication-type="other">Haleem N, Siddique A, Muhammad W, Alam I, Umer F. Assessment of liver function in malaria, typhoid and dengue diseases in Peshawar, Pakistan. 2017.</mixed-citation></ref><ref id="pone.0319547.ref038"><label>38</label><mixed-citation publication-type="journal"><name><surname>Enemchukwu</surname><given-names>BN</given-names></name>, <name><surname>Ibe</surname><given-names>CC</given-names></name>, <name><surname>Udedi</surname><given-names>SC</given-names></name>, <name><surname>Iroha</surname><given-names>A</given-names></name>, <name><surname>Ubaoji</surname><given-names>KI</given-names></name>, <name><surname>Ogundapo</surname><given-names>SS</given-names></name>. <article-title>Liver function assessment in malaria, typhoid and malaria-typhoid co-infection in Aba, Abia State, Nigeria</article-title>. <source>Pak J Biol Sci</source>. <year>2014</year>;<volume>17</volume>(<issue>6</issue>):<fpage>860</fpage>&#x02013;<lpage>3</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3923/pjbs.2014.860.863</pub-id>
<pub-id pub-id-type="pmid">26035961</pub-id>
</mixed-citation></ref><ref id="pone.0319547.ref039"><label>39</label><mixed-citation publication-type="journal"><name><surname>Cheaveau</surname><given-names>J</given-names></name>, <name><surname>Marasinghe</surname><given-names>D</given-names></name>, <name><surname>Akakpo</surname><given-names>S</given-names></name>, <name><surname>Deardon</surname><given-names>R</given-names></name>, <name><surname>Naugler</surname><given-names>C</given-names></name>, <name><surname>Chin</surname><given-names>A</given-names></name>, <etal>et al</etal>. <article-title>The Impact of Malaria on Liver Enzymes: A Retrospective Cohort Study (2010-2017)</article-title>. <source>Open Forum Infect Dis</source>. <year>2019</year>;<volume>6</volume>(<issue>6</issue>):ofz234. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/ofid/ofz234</pub-id>
<pub-id pub-id-type="pmid">31263731</pub-id>
</mixed-citation></ref><ref id="pone.0319547.ref040"><label>40</label><mixed-citation publication-type="journal"><name><surname>Woodford</surname><given-names>J</given-names></name>, <name><surname>Shanks</surname><given-names>GD</given-names></name>, <name><surname>Griffin</surname><given-names>P</given-names></name>, <name><surname>Chalon</surname><given-names>S</given-names></name>, <name><surname>McCarthy</surname><given-names>JS</given-names></name>. <article-title>The Dynamics of Liver Function Test Abnormalities after Malaria Infection: A Retrospective Observational Study</article-title>. <source>Am J Trop Med Hyg</source>. <year>2018</year>;<volume>98</volume>(<issue>4</issue>):<fpage>1113</fpage>&#x02013;<lpage>9</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.4269/ajtmh.17-0754</pub-id>
<pub-id pub-id-type="pmid">29436349</pub-id>
</mixed-citation></ref></ref-list></back><sub-article article-type="author-comment" id="pone.0319547.r001" specific-use="rebutted-decision-letter-unavailable"><front-stub><article-id pub-id-type="doi">10.1371/journal.pone.0319547.r001</article-id><title-group><article-title>Author response to Decision Letter 0</article-title></title-group><custom-meta-group><custom-meta><meta-name>Submission Version</meta-name><meta-value>0</meta-value></custom-meta></custom-meta-group></front-stub><body><p>
<named-content content-type="author-response-date">3 Feb 2025</named-content>
</p></body></sub-article><sub-article article-type="aggregated-review-documents" id="pone.0319547.r002" specific-use="decision-letter"><front-stub><article-id pub-id-type="doi">10.1371/journal.pone.0319547.r002</article-id><title-group><article-title>Decision Letter 0</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Onohuean</surname><given-names>Hope</given-names></name><role>Academic Editor</role></contrib></contrib-group><permissions><copyright-statement>&#x000a9; 2025 Hope Onohuean</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>Hope Onohuean</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><related-article ext-link-type="doi" xlink:href="10.1371/journal.pone.0319547" id="rel-obj002" related-article-type="reviewed-article"/><custom-meta-group><custom-meta><meta-name>Submission Version</meta-name><meta-value>0</meta-value></custom-meta></custom-meta-group></front-stub><body><p>
<named-content content-type="letter-date">19 Mar 2025</named-content>
</p><p>Dear Dr. KOUAM,</p><p>Please submit your revised manuscript by May 03 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at&#x000a0;<email>plosone@plos.org</email> . When you're ready to submit your revision, log on to <ext-link xlink:href="https://www.editorialmanager.com/pone/" ext-link-type="uri">https://www.editorialmanager.com/pone/</ext-link> and select the 'Submissions Needing Revision' folder to locate your manuscript file.</p><p><list list-type="bullet"><list-item><p>A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.</p></list-item><list-item><p>A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.</p></list-item><list-item><p>An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.</p></list-item></list>
</p><p>If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.</p><p>If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: <ext-link xlink:href="https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols" ext-link-type="uri">https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols</ext-link> . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at <ext-link xlink:href="https://plos.org/protocols?utm_medium=editorial-email&#x00026;utm_source=authorletters&#x00026;utm_campaign=protocols" ext-link-type="uri">https://plos.org/protocols?utm_medium=editorial-email&#x00026;utm_source=authorletters&#x00026;utm_campaign=protocols</ext-link> .</p><p>We look forward to receiving your revised manuscript.</p><p>Kind regards,</p><p>Hope Onohuean, PhD</p><p>Academic Editor</p><p>PLOS ONE</p><p>Journal Requirements:</p><p>When submitting your revision, we need you to address these additional requirements.</p><p>1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at <ext-link xlink:href="https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf" ext-link-type="uri">https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf</ext-link> and <ext-link xlink:href="https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf" ext-link-type="uri">https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf</ext-link></p><p>2. Please remove all personal information, ensure that the data shared are in accordance with participant consent, and re-upload a fully anonymized data set.</p><p>Note: spreadsheet columns with personal information must be removed and not hidden as all hidden columns will appear in the published file.</p><p>Additional guidance on preparing raw data for publication can be found in our Data Policy (<ext-link xlink:href="https://journals.plos.org/plosone/s/data-availability#loc-human-research-participant-data-and-other-sensitive-data)" ext-link-type="uri">https://journals.plos.org/plosone/s/data-availability#loc-human-research-participant-data-and-other-sensitive-data</ext-link>) and in the following article: <ext-link xlink:href="http://www.bmj.com/content/340/bmj.c181.long." ext-link-type="uri">http://www.bmj.com/content/340/bmj.c181.long</ext-link>.</p><p>[Note: HTML markup is below. Please do not edit.]</p><p>Reviewers' comments:</p><p>Reviewer's Responses to Questions</p><p>
<bold>Comments to the Author</bold>
</p><p>1. Is the manuscript technically sound, and do the data support the conclusions?</p><p>Reviewer #1:&#x000a0;Partly</p><p>Reviewer #2:&#x000a0;Yes</p><p>**********</p><p>2. Has the statistical analysis been performed appropriately and rigorously? --&#x0003e;?&#x0003e;</p><p>Reviewer #1:&#x000a0;Yes</p><p>Reviewer #2:&#x000a0;I Don't Know</p><p>**********</p><p>3. Have the authors made all data underlying the findings in their manuscript fully available??&#x0003e;</p><p>The <ext-link xlink:href="http://www.plosone.org/static/policies.action#sharing" ext-link-type="uri">PLOS Data policy</ext-link></p><p>Reviewer #1:&#x000a0;Yes</p><p>Reviewer #2:&#x000a0;Yes</p><p>**********</p><p>4. Is the manuscript presented in an intelligible fashion and written in standard English??&#x0003e;</p><p>Reviewer #1:&#x000a0;Yes</p><p>Reviewer #2:&#x000a0;Yes</p><p>**********</p><p>Reviewer #1:&#x000a0;The authors set out " to determine the type of liver damage and the associated risk factors in malaria, typhoid fever, or malaria-typhoid co-infected patients among febrile patients" in a cohort of350 patients seen at two hospitals in Yaound&#x000e9;, Cameroon. Though not clearly articulated the working hypothesis seems to be that since the causative agents of malaria and typhoid fever pass through a liver stage they may case liver damage which is often neglected in the management of these diseases ,and may result in poor clinical outcomes or even fatalities.</p><p>To test these hypothesis the authors collected blood from febrile patients, carried out serologic diagnosis of Salmonellosis ( typhoid fever) and microscopic diagnosis of malaria using Giemsa stained thin and thick smears. Further more they measured the serum levels the enzymes ALT, ALP, AST whose elevation above normal levels generally signal liver damage. It is regrettable that the authors did not recruit a control group of study participants matched by age and sex for comparison. The authors did not mention how fever was determined, and whether this was done at the point of blood collection. This information should be given in the Methods Section.</p><p>Using a questionnaire the authors recorded a number of socio-demographic parameters as well as environmental factors that could influence the transmission of the two diseases they studied. The authors then generated copious data which they analysed using standard statistical packages. Their analyses showed correlations between the elevation of liver enzymes and the infections studied. However, the lack of proper controls makes the conclusions less convincing.</p><p>The paper is generally well written and well illustrated. However the discussion is too long and repetitive. The discussion should be shortened focus on interpreting the results rather than summarizing or restating them. The conclusion sounds like a summary. It should bring out the key finding/recommendation of the study in a sentence or two.</p><p>I found a few stylistic errors which need to be corrected in the revised paper as follows:</p><p>line 72: write '..million case..."instead of ... 'instances.</p><p>line 11-92 Write: 'Similarly...'instead of 'Conversely...'</p><p>line 161: Write washing of fruits... instead of 'hygiene...'</p><p>line 94: Write: '... liver damage instead of 'liver damages'.</p><p>line 208: Give the meaning of ULN in full. Does it mean Upper Normal limit?</p><p>lin1 247: SI and S2 should be in the main text not in the supplementary results' section</p><p>Overall Recommendation: accept after major revisions.</p><p>Reviewer #2:&#x000a0;REVIEWERS RECOMMENDATION</p><p>Serological evidence and factors associated to liver damage in malaria-typhoid infected patients consulting in two health facilities, Yaound&#x000e9;-Cameroon.</p><p>This study focused on an often-neglected area of the impact of malaria and typhoid on the liver function of infected patients in two clinics in Yaound&#x000e9;-Cameroon. The authors identify risk factors for infections and liver injury by using questionnaires, microscopy (malaria), Widal tests (typhoid), and liver enzyme assays. Key findings include higher infection rates in males, environmental risk factors (e.g., standing water), and co-infection/delayed consultation as significant predictors of liver damage. This is good research that addresses a critical gap in understanding liver injury in Africa. However, there are concerns,</p><p>&#x02022; The abstract (lines 47-48) says, &#x0201c;Men (58/118 and 44/118) were more affected than 48 women (71/232 and 62/232) for both malaria and typhoid&#x0201d;. I believe using percentage here will communicate your result better than the proportion.</p><p>&#x02022; The Widal test used for determining typhoid has been criticized for having low sensitivity and specificity. Can another confirmatory test be used to establish typhoid in the patients, or do you acknowledge this limitation in your discussion?</p><p>&#x02022; The study needs a control group of non-febrile individuals to compare the baseline liver enzyme levels in the general population.</p><p>&#x02022; There is a need to consider other cofounders, like previous or active viral infections such as hepatitis, that can further influence liver enzyme levels. Also, there is a need to analyze the potential confounding effect of drug-induced liver injury versus pathogen-induced liver damage. Statistically, you can also perform multivariate analysis to adjust for confounders.</p><p>&#x02022; In the method section, there is no clear description of how consent from underage patients was obtained.</p><p>&#x02022; While the Roussel Uclaf Causality Assessment Method (RUCAM) is an acceptable tool, it is typically used for drug-induced liver injury. Its applicability to infectious diseases should be justified.</p><p>&#x02022; Some thresholds used in the method section were not clearly defined. For example, lines 205-206, &#x0201c;In our laboratory, these reference values in humans are: from 10 to 42 UI/L, from 8 to 39 UI/L, and from 40 to 129 UI/L respectively for ALT, AST, and ALP.&#x0201d; How does your reference value compare to those used in other countries, and how did you arrive at your reference values? Also, the threshold for classification of parasite density (low: &#x0003c;500, medium: 500&#x02013;2500, high: &#x0003e;2500 parasites/&#x003bc;L) should be backed with references</p><p>&#x02022; The figures are not up to standard. Please improve the quality of your graphs.</p><p>There are a lot of grammatical errors on the document, and I will recommend a thorough revision of the manuscript. Some of the ones spotted are listed below:</p><p>&#x02022; Line 38 - "risk factors associated to" should be "risk factor associated with".</p><p>&#x02022; Line 40 - "During 8 months" should be "Over 8 months"</p><p>&#x02022; Line 43 - "Liver damage was assessed employing" should be &#x0201c;Liver damage was assessed using"</p><p>&#x02022; Line 54 - "Liver enzyme activities, reflecting liver damages" should be "Liver enzyme activity, reflecting liver damage"</p><p>&#x02022; Line 56 - "should be considered during the patient's treatment." should be "should be considered during patient treatment."</p><p>In the discussion, there are several sentences that needs to be splitted into clearer sentences. For example; &#x0201c;However, current diagnostic procedures and management approaches do not consider evaluating liver damage in infected individuals, even though their causative organisms, Plasmodium species for malaria and Salmonella serotypes for typhoid fever, have a necessary hepatic phase in their respective pathogenic mechanisms, which is not without</p><p>adverse consequences on the liver, and this can increase the morbidity and mortality as a result of complications arising from liver injuries.&#x0201d;</p><p>**********</p><p><ext-link xlink:href="https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history" ext-link-type="uri">what does this mean?</ext-link> ). If published, this will include your full peer review and any attached files.</p><p>If you choose &#x0201c;no&#x0201d;, your identity will remain anonymous but your review may still be made public.</p><p><bold>Do you want your identity to be public for this peer review?</bold> For information about this choice, including consent withdrawal, please see our <ext-link xlink:href="https://www.plos.org/privacy-policy" ext-link-type="uri">Privacy Policy</ext-link></p><p>Reviewer #1:&#x000a0;No</p><p>Reviewer #2:&#x000a0;No</p><p>**********</p><p>[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]</p><p>While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool,&#x000a0;<ext-link xlink:href="https://pacev2.apexcovantage.com/" ext-link-type="uri">https://pacev2.apexcovantage.com/</ext-link> . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at&#x000a0;<email>figures@plos.org</email> . Please note that Supporting Information files do not need this step.</p><supplementary-material id="pone.0319547.s004" position="float" content-type="local-data"><label>Attachment</label><caption><p>Submitted filename: <named-content content-type="submitted-filename">REVIEWERS RECOMMENDATION for plosONE.docx</named-content></p></caption><media xlink:href="pone.0319547.s004.docx"/></supplementary-material></body></sub-article><sub-article article-type="author-comment" id="pone.0319547.r003"><front-stub><article-id pub-id-type="doi">10.1371/journal.pone.0319547.r003</article-id><title-group><article-title>Author response to Decision Letter 0</article-title></title-group><related-article ext-link-type="doi" xlink:href="10.1371/journal.pone.0319547" id="rel-obj003" related-article-type="editor-report"/><custom-meta-group><custom-meta><meta-name>Submission Version</meta-name><meta-value>1</meta-value></custom-meta></custom-meta-group></front-stub><body><p>
<named-content content-type="author-response-date">28 Mar 2025</named-content>
</p><p>RESPONSE TO THE REVIEWER&#x02019;S COMMENTS</p><p>Note: All changes or suggestions are written in red in the revised manuscript</p><p>Dear Editor-in-Chief of the journal: PLOS ONE</p><p>Thank you for your letter dated 20th March 2025 and the opportunity given to us to revise and resubmit the manuscript entitled &#x0201c;Serological evidence and factors associated to liver damage in malaria-typhoid infected patients consulting in two health facilities, Yaound&#x000e9;-Cameroon. PONE-D-25-05617&#x0201d;. We would also like to take this opportunity to thank the editorial team and reviewers for their helpful comments, which greatly contributed to improving the current version of this manuscript. The manuscript has been updated in accordance with the reviewers' recommendations. Most of their inquiries have been answered, and some clarifications have been provided. Throughout this revised manuscript, modifications are written in red.</p><p>Editor and Reviewer comments</p><p>Editor&#x02019;s comment</p><p>Comment #1: Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at <ext-link xlink:href="https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf" ext-link-type="uri">https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf</ext-link> and <ext-link xlink:href="https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf" ext-link-type="uri">https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf</ext-link></p><p>Author Response: Dear Editor, thank you for your remark. The name of all files associated to this submission has been revised according to PLOS ONE&#x02019;s style requirements.</p><p>Comment #2: Please remove all personal information, ensure that the data shared are in accordance with participant consent, and re-upload a fully anonymized data set.</p><p>Note: spreadsheet columns with personal information must be removed and not hidden as all hidden columns will appear in the published file.</p><p>Author Response: Dear Editor, thank you for your suggestions. We have removed all personal information. Also, the spreadsheet columns do not contain any personal information and the patient&#x02019;s name has been replaced with code.</p><p>Reviewer #1:</p><p>The authors set out " to determine the type of liver damage and the associated risk factors in malaria, typhoid fever, or malaria-typhoid co-infected patients among febrile patients" in a cohort of 350 patients seen at two hospitals in Yaound&#x000e9;, Cameroon. Though not clearly articulated the working hypothesis seems to be that since the causative agents of malaria and typhoid fever pass through a liver stage they may cause liver damage which is often neglected in the management of these diseases ,and may result in poor clinical outcomes or even fatalities.</p><p>To test these hypothesis the authors collected blood from febrile patients, carried out serologic diagnosis of Salmonellosis ( typhoid fever) and microscopic diagnosis of malaria using Giemsa stained thin and thick smears. Furthermore, they measured the serum levels the enzymes ALT, ALP, AST whose elevation above normal levels generally signal liver damage. It is regrettable that the authors did not recruit a control group of study participants matched by age and sex for comparison. The authors did not mention how fever was determined, and whether this was done at the point of blood collection. This information should be given in the Methods Section.</p><p>Using a questionnaire the authors recorded a number of socio-demographic parameters as well as environmental factors that could influence the transmission of the two diseases they studied. The authors then generated copious data which they analyzed using standard statistical packages. Their analyses showed correlations between the elevation of liver enzymes and the infections studied. However, the lack of proper control makes the conclusions less convincing.</p><p>Comment #1: The paper is generally well written and well-illustrated. However, the discussion is too long and repetitive. The discussion should be shortened to focus on interpreting the results rather than summarizing or restating them. The conclusion sounds like a summary. It should bring out the key finding/recommendation of the study in a sentence or two.</p><p>Author Response: Dear Reviewer, thank you for your suggestions. Regarding the discussion section, we agree that it seems to be long. Our intention was to emphasis on each factor that could increase the malaria infection rate or represent a risk of liver damage. However, efforts have been made to shorten the length and concentrate more on interpretating the results. Concerning the conclusion, key findings have already been included, and recommendations have been added. Modification is as follows: Based on these findings, we therefore recommend that the population fully implement preventive measures against malaria and typhoid fever daily and seek medical attention immediately upon the appearance of the first symptoms of the diseases. Moreover, healthcare personnel should prescribe liver function tests to malaria, typhoid fever, or malaria-typhoid co-infected patients, especially for those with high parasite density or those attending the hospital more than seven days after the onset of the disease. This could be useful in detecting early signs of liver damage and prompting medical intervention to prevent further complications that may be fatal for the patients.</p><p>I found a few stylistic errors which need to be corrected in the revised paper as follows:</p><p>Comment #2: line 72: write '&#x02026;million cases..."instead of ... 'instances.</p><p>Author Response: Dear Reviewer, thank you for your suggestion. It has been corrected in the revised manuscript.</p><p>Comment #3: line 11-92 Write: 'Similarly...'instead of 'Conversely...'</p><p>Author Response: Dear Reviewer, thank you for your remark. It has been corrected in the revised manuscript.</p><p>Comment #4: line 161: Write washing of fruits... instead of 'hygiene...'</p><p>Author Response: Dear Reviewer, thank you for your suggestion. It has been corrected in the revised manuscript.</p><p>Comment #5: line 94: Write: '... liver damage instead of 'liver damages'.</p><p>Author Response: Dear Reviewer, thank you for your suggestion. It has been corrected in the revised manuscript.</p><p>Comment #6: line 208: Give the meaning of ULN in full. Does it mean Upper Normal limit?</p><p>Author Response: Dear Reviewer, thank you for your remark. The full meaning of ULN has been provided and it is highlighted in red in the revised manuscript. ULN stands for Upper Limit of the Normal range of values.</p><p>Comment #7: line 247: SI and S2 should be in the main text not in the supplementary results' section.</p><p>Author Response: Dear Reviewer, thank you for your remark. Supplementary Tables S1 and S2 present the frequency distribution of the socio-demographic characteristics and clinical symptoms of febrile patients enrolled in the study, respectively. We agree that these two tables can be included in the main text. However, to limit the number of tables appearing in the main text, we believe it is convenient to keep these tables in the supplementary file. Nevertheless, similar information can be seen in Tables 1 and 2 included in the main text.</p><p>Reviewer #2: REVIEWERS RECOMMENDATION</p><p>Serological evidence and factors associated to liver damage in malaria-typhoid infected patients consulting in two health facilities, Yaound&#x000e9;-Cameroon. This study focused on an often-neglected area of the impact of malaria and typhoid on the liver function of infected patients in two clinics in Yaound&#x000e9;-Cameroon. The authors identify risk factors for infections and liver injury by using questionnaires, microscopy (malaria), Widal tests (typhoid), and liver enzyme assays. Key findings include higher infection rates in males, environmental risk factors (e.g., standing water), and co-infection/delayed consultation as significant predictors of liver damage. This is good research that addresses a critical gap in understanding liver injury in Africa. However, there are concerns,</p><p>Comment #1: The abstract (lines 47-48) says, &#x0201c;Men (58/118 and 44/118) were more affected than 48 women (71/232 and 62/232) for both malaria and typhoid&#x0201d;. I believe using percentage here will communicate your result better than the proportion.</p><p>Author Response: Dear Reviewer, thank you for your suggestion. It has been corrected in the revised manuscript.</p><p>Comment #2: The Widal test used for determining typhoid has been criticized for having low sensitivity and specificity. Can another confirmatory test be used to establish typhoid in patients, or do you acknowledge this limitation in your discussion?</p><p>Author Response: Dear Reviewer, thank you for your comment. We agree that the Widal test has been criticized for having low sensitivity and specificity. However, it is still widely used for the serological diagnosis of typhoid fever, especially in resource-limited countries like Cameroon. In this study, we were unable to perform a confirmatory test, such as isolating Salmonella typhi bacteria through blood culture, considered the gold standard method for diagnosing typhoid fever, due to financial constraints. However, as you suggested, this limitation has been acknowledged in the discussion section.</p><p>Comment #3: The study needs a control group of non-febrile individuals to compare the baseline liver enzyme levels in the general population.</p><p>Author Response: Dear Reviewer, thank you for your comment. We agree that it would have been better to include a control group of non-febrile individuals to compare the baseline liver enzyme levels in the general population. However, the comparison was made based on the lower and upper limits of the normal range of values for an individual in good health for each parameter evaluated, as indicated in the instructions manual of the assay kit used. That is why we did not include the control group of non-febrile individuals.</p><p>Comment #4: There is a need to consider other co-founders, like previous or active viral infections such as hepatitis, that can further influence liver enzyme levels. Also, there is a need to analyze the potential confounding effect of drug-induced liver injury versus pathogen-induced liver damage. Statistically, you can also perform multivariate analysis to adjust for confounders.</p><p>Author Response: Dear Reviewer, thank you for your comment. We agree that it is important to consider co-founders while evaluating liver enzyme levels, as they can significantly influence the results of the test. To limit bias in our study, patients with a history of or active viral hepatitis infections or patients on known hepatotoxic drugs were excluded from the study, as indicated in the paragraph "Study Design and Target Population".</p><p>Comment #5: In the method section, there is no clear description of how consent from underage patients was obtained.</p><p>Author Response: Dear Reviewer, thank you for your comment. The procedure to obtain consent from parents or guardians of underage patients was the same as that for adult patients. This is indicated in the paragraph titled "Sampling Technique and Estimation of Sample Size".</p><p>Comment #6: While the Roussel Uclaf Causality Assessment Method (RUCAM) is an acceptable tool, it is typically used for drug-induced liver injury. Its applicability to infectious diseases should be justified.</p><p>Author Response: Dear Reviewer, thank you for your comment. We agree that the RUCAM method is primarily utilized for drug-induced liver injury. Since the parameters used in the RUCAM method (ALT and ALP) were also assessed in this study, our intention was to apply the same method to gain insight into the type of liver damage that may occur in patients with malaria, typhoid fever, or malaria-typhoid co-infection.</p><p>Comment #7: Some thresholds used in the method section were not clearly defined. For example, lines 205-206, &#x0201c;In our laboratory, these reference values in humans are: from 10 to 42 UI/L, from 8 to 39 UI/L, and from 40 to 129 UI/L respectively for ALT, AST, and ALP.&#x0201d; How does your reference value compare to those used in other countries, and how did you arrive at your reference values? Also, the threshold for classification of parasite density (low: &#x0003c;500, medium: 500&#x02013;2500, high: &#x0003e;2500 parasites/&#x003bc;L) should be backed with references.</p><p>Author Response: Dear Reviewer, thank you for your comment. The reference values used in this study were adapted from those found in the manual instructions of the assay kits, all purchased from BIOLABO, Les Hautes Rives, Maizy, France, and the reference values indicated are comparable to those applied in other countries. Regarding the threshold for classifying parasite density, an appropriate reference has been provided.</p><p>&#x02022;The figures are not up to standard. Please improve the quality of your graphs.</p><p>Author Response: Dear Reviewer, thank you for your remark. The figures have been provided in high resolution. The low quality observed in the PDF used for review is due to the online submission system, which often decreases the quality of some images when generating the PDF file intended for review purposes.</p><p>Comment #8: There are a lot of grammatical errors on the document, and I will recommend a thorough revision of the manuscript. Some of the ones spotted are listed below:</p><p>&#x02022; Line 38 - "risk factors associated to" should be "risk factor associated with".</p><p>&#x02022; Line 40 - "During 8 months" should be "Over 8 months"</p><p>&#x02022; Line 43 - "Liver damage was assessed employing" should be &#x0201c;Liver damage was assessed using"</p><p>&#x02022; Line 54 - "Liver enzyme activities, reflecting liver damages" should be "Liver enzyme activity, reflecting liver damage"</p><p>&#x02022; Line 56 - "should be considered during the patient's treatment." should be "should be considered during patient treatment."</p><p>Author Response: Dear Reviewer, thank you for your remarks. Grammatical errors have been checked and corrected in the revised manuscript.</p><p>Comment #9: In the discussion, there are several sentences that need to be splitted into clearer sentences. For example; &#x0201c;However, current diagnostic procedures and management approaches do not consider evaluating liver damage in infected individuals, even though their causative organisms, Plasmodium species for malaria and Salmonella serotypes for typhoid fever, have a necessary hepatic phase in their respective pathogenic mechanisms, which is not without</p><p>adverse consequences on the liver, and this can increase the morbidity and mortality as a result of complications arising from liver injuries.&#x0201d;</p><p>Author Response: Dear Reviewer, thank you for your remarks.</p><p>The authors are grateful to the reviewers for their valuable contributions which significantly improved the quality of this work. We very much hope the revised manuscript is accepted for publication in your Journal. Thank you for your consideration.</p><p>Sincerely yours,</p><p>Corresponding author</p><supplementary-material id="pone.0319547.s006" position="float" content-type="local-data"><label>Attachment</label><caption><p>Submitted filename: <named-content content-type="submitted-filename">Author Responses to Reviewers Comments.docx</named-content></p></caption><media xlink:href="pone.0319547.s006.docx"/></supplementary-material></body></sub-article><sub-article article-type="aggregated-review-documents" id="pone.0319547.r004" specific-use="decision-letter"><front-stub><article-id pub-id-type="doi">10.1371/journal.pone.0319547.r004</article-id><title-group><article-title>Decision Letter 1</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Onohuean</surname><given-names>Hope</given-names></name><role>Academic Editor</role></contrib></contrib-group><permissions><copyright-statement>&#x000a9; 2025 Hope Onohuean</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>Hope Onohuean</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><related-article ext-link-type="doi" xlink:href="10.1371/journal.pone.0319547" id="rel-obj004" related-article-type="reviewed-article"/><custom-meta-group><custom-meta><meta-name>Submission Version</meta-name><meta-value>1</meta-value></custom-meta></custom-meta-group></front-stub><body><p>
<named-content content-type="letter-date">15 Apr 2025</named-content>
</p><p>Serological evidence and factors associated to liver damage in malaria-typhoid infected patients consulting in two health facilities, Yaound&#x000e9;-Cameroon</p><p>PONE-D-25-05617R1</p><p>Dear Dr. KOUAM,</p><p>We&#x02019;re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.</p><p>Within one week, you&#x02019;ll receive an e-mail detailing the required amendments. When these have been addressed, you&#x02019;ll receive a formal acceptance letter and your manuscript will be scheduled for publication.</p><p>An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at <ext-link xlink:href="https://www.editorialmanager.com/pone/" ext-link-type="uri">Editorial Manager&#x000ae;</ext-link> &#x000a0;and clicking the &#x02018;Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.</p><p>If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they&#x02019;ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.</p><p>Kind regards,</p><p>Hope Onohuean, PhD</p><p>Academic Editor</p><p>PLOS ONE</p><p>Additional Editor Comments (optional):</p><p>Reviewers' comments:</p><p>Reviewer's Responses to Questions</p><p>
<bold>Comments to the Author</bold>
</p><p>Reviewer #1:&#x000a0;All comments have been addressed</p><p>Reviewer #2:&#x000a0;All comments have been addressed</p><p>**********</p><p>2. Is the manuscript technically sound, and do the data support the conclusions??&#x0003e;</p><p>Reviewer #1:&#x000a0;Yes</p><p>Reviewer #2:&#x000a0;Yes</p><p>**********</p><p>3. Has the statistical analysis been performed appropriately and rigorously? --&#x0003e;?&#x0003e;</p><p>Reviewer #1:&#x000a0;Yes</p><p>Reviewer #2:&#x000a0;Yes</p><p>**********</p><p>4. Have the authors made all data underlying the findings in their manuscript fully available??&#x0003e;</p><p>The <ext-link xlink:href="http://www.plosone.org/static/policies.action#sharing" ext-link-type="uri">PLOS Data policy</ext-link></p><p>Reviewer #1:&#x000a0;Yes</p><p>Reviewer #2:&#x000a0;Yes</p><p>**********</p><p>5. Is the manuscript presented in an intelligible fashion and written in standard English??&#x0003e;</p><p>Reviewer #1:&#x000a0;Yes</p><p>Reviewer #2:&#x000a0;Yes</p><p>**********</p><p>Reviewer #1:&#x000a0;The paper presents useful information for the prevention and contro of two diseases (malaria abd typhoid fever with common dymtoms. The authors have addressed alk my comments satisfactorily. Therefore I recommend the paper for publication in PLoS ONE journal.</p><p>Reviewer #2:&#x000a0;The authors have thoroughly addressed the previously raised concerns. The manuscript is nearly ready for publication; however, I recommend the addition of a visual representation illustrating the connection between the infectious cycles of malaria and typhoid fever, particularly highlighting their interaction at the hepatic stage. With this final inclusion, the paper will be suitable for publication.</p><p>**********</p><p><ext-link xlink:href="https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history" ext-link-type="uri">what does this mean?</ext-link> ). If published, this will include your full peer review and any attached files.</p><p>If you choose &#x0201c;no&#x0201d;, your identity will remain anonymous but your review may still be made public.</p><p><bold>Do you want your identity to be public for this peer review?</bold> For information about this choice, including consent withdrawal, please see our <ext-link xlink:href="https://www.plos.org/privacy-policy" ext-link-type="uri">Privacy Policy</ext-link></p><p>Reviewer #1:&#x000a0;No</p><p>Reviewer #2:&#x000a0;<bold>Yes:&#x000a0;</bold> Ayomikun Kade</p><p>**********</p></body></sub-article><sub-article article-type="editor-report" id="pone.0319547.r005" specific-use="acceptance-letter"><front-stub><article-id pub-id-type="doi">10.1371/journal.pone.0319547.r005</article-id><title-group><article-title>Acceptance letter</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Onohuean</surname><given-names>Hope</given-names></name><role>Academic Editor</role></contrib></contrib-group><permissions><copyright-statement>&#x000a9; 2025 Hope Onohuean</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>Hope Onohuean</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><related-article ext-link-type="doi" xlink:href="10.1371/journal.pone.0319547" id="rel-obj005" related-article-type="reviewed-article"/></front-stub><body><p>PONE-D-25-05617R1</p><p>PLOS ONE</p><p>Dear Dr. KOUAM,</p><p>I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.</p><p>At this stage, our production department will prepare your paper for publication. This includes ensuring the following:</p><p>* All references, tables, and figures are properly cited</p><p>* All relevant supporting information is included in the manuscript submission,</p><p>* There are no issues that prevent the paper from being properly typeset</p><p>You will receive further&#x000a0;instructions from the production team, including instructions on how to review your proof when it&#x000a0;is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.</p><p>Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.</p><p>If we can help with anything else, please email us at customercare@plos.org.</p><p>Thank you for submitting your work to PLOS ONE and supporting open access.</p><p>Kind regards,</p><p>PLOS ONE Editorial Office Staff</p><p>on behalf of</p><p>Dr. Hope Onohuean</p><p>Academic Editor</p><p>PLOS ONE</p></body></sub-article></article>